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SUMMARY """""""
The complete set of regulatory elements that are necessary to achieve correct 
gene expression – including enhancers, silencers and chromatin insulators – can 
be spread in the range of kilo bases to mega bases, far away from the 
corresponding coding sequence. Description of such complex picture requires 
efforts in the identification of key elements, from a functional and structural point 
of view, using reporter assays in cultured cells and trying to recapitulate gene 
expression – artificially – in transgenic mice. In this work, we describe our 
experiments aimed to unravel the structure and the functioning of the mouse Tyr 
locus. We focused our attention on chromatin boundaries, starting from previous 
results of the laboratory. By Chromosome Conformation Capture (3C), the Tyr 5’ 
boundary (or LCR, locus control region) has been characterized. Next, a second 
boundary, found on the 3’ end of the locus, was identified, tested in vitro and in 
vivo and finally – by 3C – found to be in physical contact the Tyr promoter in all 
the cell types analysed. Two different mechanisms – CTCF occupancy and 
SINEB2 polymerase II/III transcription – confer insulator property to this new 
boundary, which is also engaged in conferring a 3D structure to the Tyr locus. 
Finally, to prove the in vivo relevance of the two boundary elements described in 
this study, several transgenic mouse lines were generated carrying the 
inactivation of each of these sequences, using the new CRISPR/Cas9 system. 
Homozygous individuals carrying the inactivation of the Tyr 5’ boundary present a 
reduction in coat colour. Coat pigmentation is not fully absent – as in albino mice 
– but is strongly reduced, indicating that the Tyr 5’ element is relevant for 
coordinating Tyr expression. Finally, transgenic mouse lines carrying the 
inactivation of the Tyr 3’ boundary in albino background did not show alteration in 
coat colour pigmentation, suggesting that this second conserved element is not 
required for the control of Tyr expression, and might be necessary to control the 
flanking Nox4 gene. 
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PRESENTACIÓN 
 
 
El juego completo de los elementos reguladores que son necesarios para lograr 
la expresión correcta de los genes, lo cual incluye potenciadores, silenciadores y 
fronteras genómicas, puede estar distribuido a lo largo de muchos centenares de 
kilobases, muy alejados de la secuencia que codifica para la proteína. La 
descripción de este paisaje complejo requiere esfuerzos en la identificación de 
elementos clave, desde un punto de vista funcional y estructural, mediante el uso 
de ensayos de elementos indicadores en células en cultivo, e intentando 
reproducir la expresión génica de interés, artificialmente, en ratones 
transgénicos. En este trabajo describimos experimentos encaminados a descifrar 
la estructura y la función del locus Tyr del genoma de ratón. Hemos focalizado 
nuestra atención en las fronteras genómicas, a partir de resultados previos del 
laboratorio. Mediante experimentos de Captura de Conformación Cromosomal 
(3C), la frontera Tyr 5’ (también conocida como LCR, de Región Controladora del 
Locus), ha sido caracterizada. A continuación, una segunda frontera genómica, 
situada en la región 3’ del locus, ha podido ser identificada, probada in vitro e in 
vivo, y, finalmente, mediante 3C, se ha constatado su contacto físico con el 
promotor del gen Tyr en todos los tipos celulares analizados. Sabemos que dos 
mecanismos diferentes (la presencia de CTCF y la transcripción a partir de los 
promotores RNA polimerasa II/III de los elementos SINEB2) confieren la 
propiedad aisladora a esta nueva frontera genómica, la cual está igualmente 
involucrada en la estructura tridimensional del locus Tyr. Seguidamente, para 
probar la importancia, in vivo, de estas dos fronteras genómicas descritas en 
este trabajo, hemos generado diversas líneas de ratones transgénicos con 
mutaciones en cada una de estas secuencias, utilizando el nuevo sistema 
CRISPR/Cas9. Los individuos homocigotos que son portadores de la mutación 
en el elemento Tyr 5’ muestran una reducción en la pigmentación del pelaje. Esta 
vi" "
pigmentación no desaparece por completo, como ocurre en el caso de los 
ratones albinos, pero sí que se reduce de forma muy significativa. Estos 
resultados indican que el elemento Tyr 5’ es relevante para la expresión correcta 
del gen Tyr. Finalmente, las líneas de ratones transgénicos portadoras de 
mutaciones en el elemento Tyr 3’ no mostraron alteración aparente en la 
pigmentación del pelaje, en fondo albino, lo cual sugiere que este segundo 
elemento regulador, conservado evolutivamente, no es indispensable para el 
control de la expresión del gen Tyr, pero sin embargo podría ser necesario para 
el control del gen vecino Nox4. 
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1. Introduction
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1.1 Mouse Tyr and its regulatory elements 
 !
The tyrosinase gene encodes the key enzyme in the melanin production 
pathway, a copper-containing di-oxidase that triggers the formation of melanin. It 
catalyses the rate-limiting conversion of L-tyrosine to DOPAquinone in two 
consecutive oxidazing steps. In mice, Tyr is located in chromosome 7 (Kwon et 
al. 1989) and it is composed of 5 coding exons and 4 introns spanning a 66 kb 
large region. One main isoform is known to be translated into a protein (Muller et 
al. 1988), 533 residues long; smaller transcripts are generated by alternative 
splicing (Ruppert et al. 1988). Tyr is expressed in neural crest-derived 
melanocytes of skin, choroid, hair follicles, iris, inner ear and, among other places 
in the body, the heart (Carneiro and Kos 2008) and in the retinal pigmented 
epithelium of the retina (RPE), which derives from the outer wall of the optic cup 
(Beermann et al. 1992, Gimenez et al. 2003).  Mutations in the tyrosinase coding 
sequence are responsible for the oculocutaneous albinism type I (OCA1, OMIM 
203100, Montoliu et al. 2014). In mice, the causative albino mutation appears to 
be a change of guanine 390 to cytosine, resulting in a change of cysteine 103 to 
serine (Kwon et al., 1988; Halaban et al. 1988), named Tyrc. This amino acid 
substitution alters the copper-binding site and results in complete loss of 
enzymatic activity. Jackson and Bennett (1990) reported the molecular basis of 
albinism. Interestingly, more than 20% of OCA1 cases can’t be associated with 
mutations in the Tyr coding sequence, thus suggesting that mutations inactivating 
the locus can also occur in non-coding regulatory elements (King et al. 2003; 
Montoliu et al. 2014). 
 
1.1.1 Proximal Tyr regulatory elements 
 
The mouse Tyr promoter – along with that of other species – has been 
extensively characterized (Ganss et al. 1994; Ferguson and Kidson, 1997). 
Although a canonical TATA-binding site is absent in both mouse and human 
promoters, TATA-like sequences could be identified at approximately 32 bp 
upstream the TSS (Ruppert et al. 1988; Yamamoto et al. 1989). In 
correspondence with the TSS, a DNAse I-resistant element was found in the 
human TYR promoter and named initiator (Inr, Figure i1). 
!4!
!
Figure i1 Conserved motives in the tyrosinase promoter. Two immediate proximal elements and one distal 
element are found in the mouse Tyr upstream sequence that are conserved in many orthologs. These three 
motives can be occupied by bHLH-ZIf transciption factors, such as MITF. Adapted from Bentley et al. 1994. 
 The Inr, conserved in mouse, chicken, quail and turtle, contains an E-box 
consensus motif (CANNTG) that is essential for human promoter function 
(Bentley et al. 1994). The Inr E-box is recognized by two helix-loop-helix leucine 
zipper transcription factors (bHLH-ZIP), namely Upstream stimulatory factor 
(USF) and Microphthalmia-associated transcription factor (MITF), a transcription 
factor essential for pigment cells development (Goding, 2000). In fact, 
homozygous mutations in the Mitf gene can result in non-pigmented mice that 
develop small, unpigmented eyes (Hodgekinson et al. 1993; Arnheiter, 2010). In 
search of pigment-cell specific factors, the Tyr promoter sequence was compared 
with that of paralog genes, including Tyrp1 and Dct, in different species. A 
conserved, 11 bp motif was found between 40 and 160 bp upstream the TSS, 
termed M-box (Lowings et al. 1992), in several orthologs. Similarly to the E-box, 
the M-box contains a CANNTG motif and can be bound by MITF. An additional, 
tissue-specific enhancer element was found 1.8 kb upstream the TSS in the 
human TYR promoter, conserved in mouse (Shibata et al. 1992). This element, 
named Tyrosinase distal element (TDE) also contains an E-box (Yasumoto et al. 
1994) and can be trans-activated by MITF. Gene transfer experiments performed 
by independent groups in the early 90’s showed that indeed such promoter 
elements are able to rescue the pigmented phenotype when used to drive the 
expression of a tyrosinase minigene in albino mice (Beerman et al. 1990; Kluppel 
et al. 1991). Partial rescue of pigmentation could be obtained using different 
minigene constructs including a 5.5 kb fragment 5’ upstream the TSS as 
promoter (Beerman et al. 1990), a 2.6 kb fragment (Tanaka et al. 1990), a 2.2 kb 
fragment (Yokoyama et al. 1990), as well as minimal, 270 bp fragment able to 
drive weak and variable transgene expression in the retinal pigmented epithelium 
and in skin melanocytes (Kluppel et al. 1991, Beermann et al. 1992; Ganss et al. 
1994). Transgenic mice showed a variable degree of pigmentation, not reaching 
TDEM-boxInr
-1850 bp-100 bp-4 bp
Mouse  AAACATGTC A TA     AG T CATGTGCTTT  AA T CATGTG A GA
Human  AGACATGTC A TA     AG T CATGTGCTTT  GA T CATGTG A TG
Quail   CAACATGTG A TA     AA T CATGTGCTAG  GG T CATGTG A TG
Turtle   GAACATGTG A TA     GC T CATGTGACAG  GA T CATGTG A TG
E-boxE-boxE-box
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the wild-type level, due to chromosomal position effects (Wilson et al. 1990; 
Giraldo and Montoliu 2002), and because additional, upstream regulatory 
elements are necessary in order to reproduce the expression level of the 
endogenous gene. 
 
1.1.2 Distal Tyr regulatory elements  
 
The use of small constructs carrying minimal regulatory sequences helped 
to formulate fundamental biological statements, such as that the albino 
phenotype can be rescued by a functional tyrosinase transgene. However, to 
define all the regulatory elements of a locus, minigene constructs are definitely 
too short. Hence, larger constructs carrying all distal regulatory elements are 
necessary. Thanks to technical advances in the production of transgenic animals 
using yeast artificial chromosomes (YACs) (Schedl et al. 1992), larger DNA 
constructs could be used for to study the role of distal regulatory elements. 
Schedl, Montoliu and colleagues introduced in albino mouse fertilized eggs a 250 
kb YAC containing 80 kb of the mouse Tyrosinase coding region and 155 kb of 
upstream sequences (YRT2 YAC, Schedl and Montoliu 1993). The use of such a 
large construct allowed full rescue of the albino phenotype in all transgenic mice 
obtained, that are phenotypically indistinguishable to pigmented, wild-type 
individuals (Figure i2).  
 
!
Figure i2 Full rescue of pigmentation using the YRT2 YAC. Right Scheme of the YRT2 YAC and 
position of the probes used to detect the integrity of the YAC in transgenic mice by Southern Blot. Left Three 
F1 individuals from three independent transgenic lines showing indistinguisble, pigmented phenotype, 
compared with a non-transgenic littermate. Adapted from Schedl et al. 1993  
Using large, genomic-type constructs, copy number-dependent and position-
independent expression of the transgene could be achieved (Giraldo and 
Montoliu, 2001). The observed differences with respect to the variegated Tyr 
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expression obtained using minigene vectors depends uniquely on distal Tyr 
regulatory elements contained in the 155 kb non-coding DNA included in the 
YRT2 YAC. This observation opened a quest aimed to the cis-acting element 
responsible for the successful rescue of pigmentation in the YRT2 transgenic 
mouse line (reviewed in Giraldo and Montoliu, 2002). The nature of the distal, yet 
unknown element is discussed in the original paper (Schedl et al. 1993). 
Hypothesis were formulated whether a dominant Locus control region (LCR) was 
found, similar to what had been reported using a human β-globin large transgene 
for generating a transgenic mouse (Grosveld et al. 1987) or in gene transfer 
experiments using elements from the chicken lysozyme gene (Stief at al. 1989).  
Molecular analysis of a spontaneous mutant mouse, the chinchilla-mottled 
mouse (Tyrc-m), was instrumental in the identification of the Tyr distal upstream 
element (Porter et al. 1991). Melanocytes from Tyrc-m mice showed reduced Tyr 
expression and distinct DNAse I hypersensitivity with respect of melanocytes 
from wild-type mice. In particular, a hypersensitive site in melanocytes obtained 
from wild-type mice found 15 kb upstream the Tyr TSS was missing in Tyrc-m 
melanocytes. This region underwent chromosomal rearrangement in Tyrc-m 
mouse likely resulting in the observed reduction and striped-like pigmentation 
phenotype. Comparing DNAse I hypersensitivity of the Tyr upstream sequence in 
distinct mouse cell lines, a cell-type specific DNAse I HS site was found in B16 
mouse melanoma cells (Figure i3) (Ganss et al. 1994). 
!
Figure i3 DNAse I hypersensitivity of Tyr upstream sequences. A Position of the Tyr locus along with the 
southern blot probe used for the DNAse hypersentivity assay. B A cell-type specific HS site was identified 15 
kb upstream the Tyr conding sequence. The same HS signal could not be detected in fibroblasts nor in 
hepatocytes. Adapted from Ganss et al 1994. 
The inclusion of such Tyr -15 kb HS element into tyrosinase minigene transgenes 
fully rescued the albino phenotype in transgenic mice (Figure i4), but also 
conferred position-independent and copy number-dependent expression of the 
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transgene (Ganss et al. 1994; Porter and Meyer, 1994). For this reason, this 
element is referred as the Tyr Locus Control Region (thereafter, LCR). In 
addition, the Tyr LCR acts as enhancer in transient transfection in human and 
mouse melanoma cells (Ganss et al. 1994; Giraldo et al. 2003). The key element 
contained in the 155 kb non-coding DNA of YAC YRT2 was therefore identified. 
 
Figure i4 Tyr HS element in transgenic mice. A Coat colour of transgenic F1 offspring carrying a mini Tyr 
gene coupled with the -15 kb HS element (LCR). Mice are ordered with respect to the degree of 
pigmentation. An albino, NMRI mouse is shown as control at the left. Similarly a wild-type agouti mouse is 
shown at right. Estimation of transgene copy number obtained by Southern Blot, indicated between brackets 
for each transgenic line. B Scheme of the phsTyr4 transgene used to generate the transgenic animals in A. A 
3.7 kb EcoRI fragment of the Tyr 5’ upstream region is coupled with a 5.5 kb fragment upstream the Tyr 
coding region and a Tyr minigene including the first intron. Adapted from Ganss et al. 1994. 
 
The nature of the Tyr LCR was extensively characterized in vitro and in vivo. The 
cell type-specific enhancer activity was confirmed in vitro and found to be 
associated with the binding of the transcription factors CREB (cAMP responsive 
element binding) and AP-1 (activator protein 1), whose binding motives were 
identified in two fragments named A and B boxes, respectively (Ganss et al. 
1994). The putative boundary activity of the Tyr LCR was studied in transgenic 
NMRI (0) 6433 (3) 6440-2 (3) 6336 (3) 6440-1 (25) 6085 (9) wt
Ec
oR
I
Ec
oR
I
LCR
ex1 ex2-5i1
A
B
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flies and mice (Giraldo et al. 2003) and in vitro (Angel Garcia Diaz, PhD Thesis, 
2007 and Lucia Regales, PhD thesis 2005).  
In mice, the inclusion of the 3.7 kb LCR fragment rescued the expression of a 
luciferase reporter cassette driven by the HSV-TK promoter, which would be 
otherwise subjected to silencing and variegation because of chromosomal 
position effect, indicating that such sequence acts as chromatin boundary. 
Similarly, using the white minigene assay in drosophila (Kellum and Schedl, 
1991), the barrier activity of the Tyr LCR was demonstrated (Giraldo et al. 2003) 
in transgenic flies. Thee element were found to be linked with the Tyr 5’ insulator 
activity: the A and B boxes, bound by CREB and AP-1 and G-rich box, a simple 
repeat of 15 G nucleotides located at the boundary with a heavily methylated in 
vivo, LINE1 repeat element. Although the sum of the elements conveys a strong 
insulator property (Bessa et al. 2009), the contribution of each element – taken 
individually – has not been explored in sufficient detail, hence suggesting a 
complex mechanism of action. 
A second regulatory element was described 48 kb 5’ upstream the Tyr 
gene. Using a BAC carrying 186 kb of the mouse Tyr locus (including the Tyr 
coding region and 86 kb of 5’ upstream non-coding sequences) the rescue of the 
albino phenotype could be obtained. A series of lacZ large constructs based of 
this BAC were generated carrying deletions in region 5’ upstream to the Tyr LCR. 
Interestingly, a non-coding element that seems to be relevant for the expression 
of Tyr in the RPE was identified using transient BAC transgenesis (Murisier et al., 
2007). However, the analysis was only carried in transient transgenic mice, 
without establishing lines, and the number of transient transgenic embryos 
analysed was very limited (n = 7), not constituting statistically significant data. 
Additionally, the use of lacZ as a reporter gene could be source of confusion 
(Rosenberg et al. 1992; Montoliu et al. 2000; Montoliu et al. 2004; Bolon et al., 
2008).  
The presence of an additional boundary element at the 3’ end of the locus 
was hypothetized in our laboratory (Angel Garcia Diaz thesis, 2007; Molto et al. 
2009) although this hypothesis hasn’t yet been supported by experimental data. 
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1.2 Appoaches for the inactivation of Tyr cis-acting elements in vivo  
 
1.2.1 Approximations using large transgenes 
 
Inactivation of a fundamental cis-acting regulatory element in vivo is expected to 
produce evident alteration in the expression of the target associated gene or 
genes. If no differences in gene expression are observed in the absence of the 
element in study, this is probably dispensable or secondary. Several laboratories 
achieved the inactivation of regulatory elements using large transgene constructs 
(BACs and YACs), coupled to a reporter gene, or carrying endogenous gene 
whose activity can be easily measured – in the absence of the endogenous gene 
product. Using recombineering techniques in yeast (Reeves et al. 1992; Schedl et 
al. 1992; Giraldo et al. 1999) and in bacteria (Copeland et al. 2001), the relevant 
cis-acting sequence is deleted or mutated within a large stretch of genomic 
sequence of the locus. Transgenic animals are generated using such constructs 
and their phenotype is compared with that of control animals carrying the intact 
large transgene (Montoliu et al 1996; Peterson et al. 1996, 1998; Gimenez et al. 
2001; Gimenez et al. 2005; Horvath et al. 2013; van den Boogaard et al. 2014). 
To investigate whether the Tyr LCR is the main player in the regulation of Tyr 
expression – or if additional elements are required to coordinate gene expression 
in distinct tissues and developmental stages, a series of deletions and other 
genetic modifications based on the original YRT2 YAC (Schedl et al. 1993) were 
produced (Figure i5) and the corresponding YACs were used to generate 
transgenic mouse lines (Figure i6).  
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Figure i5 YRT2 YAC and its derivatives constructs. The Tyr LCR is shown as a red box. Black bars 
indicates the A,B and G boxes (Giraldo et al. 2003). The CNS-2 element described in Murisier et al. 2007 is 
shown as a blue box. YRT2 (250kb) carries the entire Tyr expression domain. YRT3, 100 kb YAC with a 
deletion of 5’ LCR upstream sequences. YRT4, 100 kb YAC with a deletion of LCR and its upstream 
sequences. YRT5, 250 kb YAC carrying a targeted deletion of the LCR, substituting A and B core sequences 
by a yeast selectable marker (lys2). Also, transgenic animals were obtained using a YAC carrying individual 
deletion of the A box, the B box, or both sequences. Telomers are indicated as arrowheads, centromers as 
circles. 
!
Figure i6 Transgenic mice generated with different Tyr YACs.  Representative adult individuals from 
each line obtained with some of the YAC constructs shown in Figure i5. A FVB/N  is shown as albino 
control. A YRT2 and agouti mice serve as wild-type controls. Adapted from Montoliu et al. 1996 !
Results indicated that the rescue of the albino phenotype correlates strictly with 
the presence of the Tyr LCR (Montoliu et al. 1996): the Tyr LCR guarantees 
position independent and copy number-dependent Tyr expression, in both neural 
crest-derived melanocytes and cells of the retinal pigmented epithelium. In fact, 
removing the 140 kb of genomic DNA upstream the LCR (in YAC YRT3), leaving 
the latter intact, did not rendered the tyrosinase transgene affected by position 
effects, indicating that no additional relevant regulatory elements are contained in 
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the deleted region. In contrast, experiments using engineered BAC-based 
reporter constructs, indicated that additional regulatory elements might lay 
upstream the LCR (Murisier et al. 2007). These experiments, however, were 
performed using transient transgenic lines and are based on the analysis of a 
very small number of embryos, thus not being stastistically significant, hence 
suggesting the limited relevance, if any, of the additional regulatory element. 
Additional evidences support the central role of the Tyr LCR: replacing the LCR 
sequence with the Lys2 yeast marker gene in the YRT5 YAC, does affect the 
correct transgene expression, making it vulnerable to position effects. YACs 
carrying additional modifications were also produced in our laboratory. By 
homologous recombination in yeast, the YRT2 YAC was modified in order to 
completely remove the LCR sequence in the absence of selection markers 
(differently form the YRT5 YAC which carries the yeast Lys2 selection marker 
gene instead) or other leftover sequences, and transgenic mice were obtained 
(Moreira et al., 2004). Similarly, small 20-60 bp deletions were introduced into the 
YRT2 YAC sequence, targeting two key elements contained in the Tyr LCR, the 
A and B boxes (Giraldo et al., 2003) (Figure i5). Transgenic mice were obtained 
from YRT2DA and YRT2DAB YACs that showed a reduction of coat pigmentation. 
However, the observed phenotype was not consistent in all the transgenic lines 
generated with each construct (Figure i7 A). From the YRT2DAB YAC, 
transgenic lines could be obtained carrying both a darker and a lighter coat 
colour, a result difficult to interpret but suggesting that additional regulatory 
elements might lay in the locus, or that these mutated YAC transgenes became 
sensitive to chromosomal position effects. Nonetheless, lines could be generated 
that show pigmentation levels similar to that of the YRT2 lines, indicating that 
correct expression can be achieved when suboptimal constructs are integrated in 
a favourable genomic locus (Giraldo and Montoliu, 2002 and Giraldo, PhD thesis, 
1999). 
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Figure i7 Tyr-YAC transgenic mice lacking the A and AB boxes. A NMRI albino and YRT4 mice are 
shown as control. Two individuals from two independent transgenic lines generated using the YRT2DA 
resulted in distinct levels of pigmentation. Three independent lines generated using the YRT2DAB display 
coat color alterations that are highly variable between lines. A YRT2 individual is shown as control. B 
Scheme of the transgenes used in A. Telomers are indicated as arrowheads, centromers as circles.  
 
Although milestone results have been obtained with the inactivation of cis-acting 
element within large transgenes, this approach suffers of several limitations that 
might jeopardize the result obtained. Chromosomal-type transgenes such as 
YAC and BAC are considerably larger than plasmid-based transgene and 
normally result in optimal expression levels (Giraldo and Montoliu, 2001; Van 
Keuren et al. 2009). Nevertheless, BACs and YACs still behave as a transgene: 
they integrate randomly in the genome, sometimes also in multiple copies and in 
a non-controllable fashion, and can undergo rearrangements. Transgene 
integrity, copy number and the integration site should be determined for each 
newly generated transgenic line, which is technically demanding and time-
consuming and often not possible. Certain variability can be also observed 
between lines generated with the same construct (Figure i7A; Giraldo, 2002 PhD 
thesis), depending on the integration site and copy number. This observation 
represents a caveat to be kept in mind when comparing transgenic lines 
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YRT2
YRT4
DA
DAB
B A G
A
B
! 13!
generated using variants of the same large transgene, as done for the YRT2-
derived constructs. 
From a merely technical point of view, large constructs that accommodate multi-
gene large chromatin domains (such as gene clusters) might be hard to obtain 
and difficult to handle, modify and deliver to the mouse embryo.  
In addition, the disruption of boundary elements – such as the mouse Tyr LCR - 
will likely affect the regulation of close-by genes (Volpi et al. 2012), but also the 
organization of the chromatin of the entire topological domain and, in some 
cases, also the expression of genes far away from the inactivated element. For 
these reasons it is desirable to inactivate cis-acing elements in their endogenous 
location and not on a large transgene, in order to minimize the number of 
experimental variables the must be taken into account. However, it must be noted 
that the used of genomic-type transgenes has greatly facilitated the analysis of 
cis-acting elements in vivo (Giraldo and Montoliu, 2001). 
 
1.2.2 Inactivation of cis-acting elements using RNA interference 
 
RNA interference (RNAi) technology (Fire et al. 1998) is routinely employed to 
achieve transient partial depletion of a given protein, known as gene knock-down 
(KD). Gene KD by RNAi is obtained by various cellular mechanisms including 
endonucleolytic cleavage of the gene transcript mRNA and inhibition of 
translation initiation. In addition, RNAi is capable of inducing de novo methylation 
of the targeted DNA region (Verdel et al. 2004; Buhler et al. 2006). Targeted, 
siRNA-mediated chromatin remodelling was described in mammalian cells 
(Morris et al. 2004; Kawasaki et al. 2005; Kim et al. 2006) and used to inactivate 
DNA regulatory elements in mouse and human cells (Gonzalez et al. 2006). The 
delivery of a pool of short interfering (si)RNAs targeting the INK4/ARF regulatory 
domain (RDINK4/ARF) triggered the increase of the repressive histone mark 
H3K9me3 at the targeted DNA sequence as well as a decrease in the transcript 
and protein levels of the three genes regulated by the RDINK4/ARF(Gonzalez et al. 
2006). 
In our laboratory, RNAi was used to target the key sequences found within the 
Tyr LCR, in the tyrosinase-expressing mouse melanoma B16 F1 cells (Figure 
i8). Using the MicroRNA-adapted retroviral vector MSCV/LTRmiR30-PIG (Dickins 
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et al. 2005), siRNA were designed targeting the AB and G boxes (Giraldo et al. 
2003) along with control siRNA targeting the Tyr promoter and first exon.   
 
!
Figure i8 Changes in Tyr expression induced by RNAi. The LCR was targeted using RNAi vectors 
specific for the AB boxes (AB-s3 and AB-s18) and the G box (poliG). As positive controls, RNAi constructs 
targeting the three MITF-binding site in the Tyr proximal regulatory elements were used (E-box, M-box and 
TDE). Similarly, sequences of the Tyr first exon were used as positive control (exon1-s36 and s-62). Adapted 
from Moltó and Montoliu, unpublished. 
Although a reduction in Tyr expression was achieved upon delivery of RNAi 
vectors specific for the AB boxes and for two sequences in Tyr exon 1, targeting 
basic and fundamental proximal regulatory elements in the Tyr promoter failed to 
perturb significantly gene expression. In addition, due to difficulties in the genetic 
manipulation in B16 cells, stable expression of the RNAi vectors could not be 
achieved and key experiments – such as the analysis of the deposition of 
repressive histone marks after RNAi – could not be performed. 
 
1.2.3 Chromosomal inactivation using gene targeting in mouse ES cells 
 
Classical gene targeting by homologous recombination in embryonic stem cells 
represents the golden standard technique to produce a wide variety of custom 
site-specific mutations in mice over the last 30 years (Capecchi 2005). These 
include subtle point mutation, constitutive and conditional gene inactivation 
(knock-out, KO and cKO), chromosomal deletion as well as targeted integration 
(knock-in, KI). Generation of targeted mutant mice is a routine but complex 
process based on accurate design of targeting vectors, standardized ES cell 
culture and transfer of selected, recombinant ES cell clones into blastocysts, that 
will contribute to development and hopefully colonize the mouse germ line 
(Figure i9).  
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Figure i9 Gene targeting in mouse ES cells. 1 Blastocysts are obtained from a donor mouse strain and 2 ES 
cell lines are established. 3 DNA constructs targeting a given locus are delivered to the ES cells and 4 
recombinant clones carrying the desired genetic alteration are selected and expanded. 5 Blastocysts are 
obtained from the recipient mouse strain, with a different coat colour genetic background. 6  A number of ES 
cells from the selected clones are injected into recipient blastocysts and 7 transferred into pseudopregnant 
females. 8 The obtained animals are chimeras. Coat colour contribution indicates the percentage of cells 
derived from recipient blastocyst and injected ES cells. 9 Breeding selected chimeras with individual from the 
donor mouse strain is necessary to check for germline transmission of the mutation in a isogenic background. 
10 The resulting, targeted mutant animal will have the same coat color as that of the original donor mouse in 
1. Adapted from Montoliu, 2000. 
The vectors used for gene targeting contain two large stretches of DNA that are 
homologous with the region to be targeted. For the targeting event to happen 
efficiently, these homology arms must be obtained from isogenic DNA (te Reile et 
al. 1992; Andreasson et al. 2013) and should not contain repetitive DNA.  Upon 
homologous recombination, with a frequency ranging between 10-5 to 10-6 (Reid 
et al. 1991), the genomic sequence located in between the homology arms will be 
!16!
replaced by the sequence flanked by the same homology arms in the targeting 
vector. Positive and negative selection cassettes are included inside and outside 
the homology arms, respectively, in order to select those rare cells where the 
correct recombination event had occurred (Figure i10). Chromosomal 
inactivation of a non-coding region can be obtained by mutating a known, 
relevant transcription factor binding site, or – more frequently – by a large 
chromosomal deletion including all putative protein binding sites. Obtaining a 
chromosomal deletion requires a targeting vector carrying homology arms that 
flank the sequence to be deleted. Alternatively, a positive selection cassette can 
be used to replace the region to be deleted. If wisely flanked by loxP sites, the 
selection cassette can be removed using Cre recombinase, either in vitro (Ryder 
et al. 2013) or in vivo using ubiquitous Cre-driver mouse lines (Nagy, 2000). 
!
Figure i10: Classical strategy for targeted chromosomal deletion. A targeting vector containing large 
homology arms flanking the DNA sequence to be deleted is delivered to mouse ES cells. Positive selection 
can be applied thanks to a Neomycin resistance gene cloned inside the homology arms. Randon integration of 
the targeting vector can be prevented by using a negative selection cassette, cloned outside the homology 
arms (in this case, a Thymidine kinase cassette), Cre-mediated recombination is then used to remove the 
positive selection cassette that was previously flanked with loxP sites. 
The inactivation of the mouse β-globin LCR, performed by the group of Mark 
Groudine (Fred Hutchinson Cancer Research Center, Seattle WA, USA) is one of 
the attempts to study regulatory element by inactivating them in vivo (Bender et 
al. 2000). The human and mouse β-globin genes are ordered in a linear array 
that reflects their order of expression. The β-globin locus is embedded in a large 
array of olfactory receptor genes, expressed in sensory neurons of the nasal 
epithelium (Buck and Axel 1991). DNAse HS sites were found at both 5’ and 3’ 
extremities of the β-globin genes (Bulger et al. 1999) (Figure i11). The series of 
HS sites at 5’ acts as a strong erythroid-specific positive regulatory element and 
therefore defined as LCR (Grosveld et al. 1993). By several round of gene 
targeting, using a suitable combination of selection markers, the authors could 
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delete a 24 kb region containing the LCR sequence. In the absence of the LCR 
sequence, the expression of the β-like globin genes is reduced to the 2-8% of the 
normal expression level. Interestingly, even if at lower levels, all the β-globin 
genes can be detected at the proper tissue and developmental stage, even in the 
absence of the LCR. Analysis of the chromatin state in mice carrying the LCR 
deletion indicated that the LCR does not contribute to the establishment and to 
the maintenance of the open chromatin state of the locus. Rather, the LCR is 
necessary to reach the physiogical expression levels required to fulfill the 
biological function underneath. 
!
Figure i11 Diagram of the mouse β  globin locus. The β globin gene cluster is embedded in a olfactory 
receptor genes array. Several DNAse I hypersensitivity sites were identified at both sides of the β globin 
cluster, indicated as black arrowes. The β globin LCR, conserved in the human genome, is found at 5’. 
DNAse I hypersensitivity sites are.  Genes position and CTCF/Rad21 occupancy were extracted from the 
UCSC Genome Browser. Adapted from Burger et al. 1999. 
 
Using a similar strategy, Volpi and colleagues deleted 8 kb of an insulator 
element at the 3’ end of the mouse Igh locus. Upon deletion, no histological or 
haematological alterations were observed in transgenic animals compared with 
controls. Interestingly, 65 kb downstream the deletion, a non-Igh gene, Hole, was 
found to be overexpressed during B-cell stimulation (Volpi et al. 2012). Notably, 
several control experiments were required to ascertain that the phenotype 
observed was due to the deletion of the cis-acting sequence and not to genetic 
differences between the ES cell genetic background, the recipient background 
and that of the cohort of animals used as control.  
These works and other (Danielian et al. 1997; Yanagisawa et al. 2003; 
Visel et al. 2010; Shim et al. 2012) demonstrated that gene targeting is ES cells 
can be used produce cis-ruptions in the natural chromosomal surroundings of 
many loci, in mice. Nevertheless, the generation of such animal models is 
technically demanding, complex and time consuming. Notably, a key aspect for 
successful gene targeting is the choice of optimal homology arms to be included 
in the targeting vector. Homology arms length may range from 500 bp to 2 kb (or 
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larger) and should be obtained from isogenic DNA, be free of repeated elements 
and match perfectly (and uniquely) with the sequence to be targeted. Due to the 
presence of large stretches of repetitive DNA in the mouse Tyr locus (Figure i12) 
the design of an optimal targeting vector, devoid of DNA repeats, is complicated. 
In fact, in our laboratory, a previous attempt to obtain the Tyr 5’ deletion using 
classical gene targeting approaches failed (Tovar and Montoliu, unpublished). 
!
Figure i12: Repetitive sequences flanking the mouse Tyr 5’ boundary. Schematics illustrating sequence 
conservation and content in repeat elements, obtained from RepeatMasker and displayed using UCSC 
Genome Browser. Repetitive DNA sequences are shown as black and grey boxes. The Tyr 5’ boundary is 
surrounded by LINE-1 repeats. The LINE-1 repeat at 3’, described in Giraldo 2003, is methylated in both 
B16 mouse melanoma and L929 mouse fibroblast cells. 
Using the targeting strategy indicated in Figure i10, CK35 mouse embryonic 
stem cells (Kress et al. 1998) were electroporated with a target vector. More than 
400 Neomycin-resistant colonies were screened. Eventually, by Southern Blot 
analyses two ES cells colonies were found displaying the expected restriction 
pattern (Figure i13). After microinjection into mouse blastocysts, a total of 4 
chimeras were obtained that were able to transmit the targeted allele to the 
progeny. Nevertheless, upon crossing with an albino Cre-driver mouse, no 
alteration in pigmentation was observed. Careful molecular analyses indicated 
that the targeting happened on at a different chromosomal location, highly 
homologous with the region found 5’ in the Tyr locus, but – unfortunately – not on 
the actual Tyr locus on chromosome 7, as shown by FISH analyses (Figure i14). 
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Figure i13 Targeting the Tyr 5’ boundary in mouse ES cells. Homology arms are indicated in yellow. 
Using the probe 3’ on HpaI-digested genomic DNA, a 20 kb band is expected for wild-type clones and a 
second, 5.3kb large band is expected for targeted clones, as shown for clones 349 and 494. Adapted from 
Tovar and Montoliu, unpublished. 
!
Figure i14 FISH analysis. Due to extreme repeats in the Tyr locus, targeting to incorrect positions is frequent 
event. A FISH image is shown. No colocalization is detected between a Tyr probe (in green) and a Neo probe 
(in red). Adapted from Tovar, Nadal and Montoliu, unpublished. 
 
 
1.2.4 Chromosomal inactivation using targeted nucleases 
 
As an alternative to RNAi or gene targeting in mouse ES cells, chromosomal 
deletions can be generated in mammalian cells and embryos using targeted 
nucleases such as Zinc Fingers (ZFNs), Transcription Activators-Like Effector 
Nucleases (TALENs) and, recently, Clustered Regularly Interspaced Short 
Palindromic Repeats (CRISPRs) (Seruggia and Montoliu, 2014). Targeted 
nucleases are engineered proteins able to recognise – by different mechanisms – 
a short unique DNA sequence and induce a double strand break (DSB) at the 
targeted sequence. The sequence constraints associated with the use of targeted 
Tyr
Neo
!20!
nucleases are minimal; as much as twenty to sixty base pairs are necessary to 
define a targetable site in a vertebrate genome. In contrast, for classical gene 
targeting, two 500 bp-2 kb large unique sequences must be identified at both 
sides of the target site, a condition that can’t be fulfilled in many loci and 
particularly this is true for most non-coding region, as illustrated in the previous 
paragraph with the Tyr locus. 
Using targeted nucleases, genetic modifications can be obtained in vivo by 
microinjecting the nuclease (as DNA, mRNA or protein) into mouse fertilized 
eggs. A wide variety of genetic modifications can be obtained using individual 
targeted nucleases, multiple nucleases or in combination with donor DNA 
molecules (Figure i15). Nuclease-induced DSBs can be repaired by homology 
directed repair (HDR) or by the error-prone non-homologous end-joining pathway 
(NHEJ, Barnes 2001). In the presence of a donor plasmid or a single stranded 
oligonucleotide, HDR can lead to the targeted introduction of a transgene (KI) or 
to target subtle base changes. In the absence of a DNA repair template, NHEJ-
mediated DNA repair will result in small insertions and deletions (indels) that 
might cause the disruption of the targeted gene. 
!
Figure i15 Editing possibilities using targeted nucleases. After a targeted double strand break is produced, 
two alternative DNA-repair pathways can be exploited to obtain a variety of genetic manipulations. Gene 
Knock Out (KO), chromosomal deletions and inversions can be obtained in the absence of a DNA donor 
template. Conditional Knok Out (cKO), subtle point mutations and targeted insertions can be achieved 
through the homology-driven repair pathway in the presence of a DNA donor template. Adapted from 
Seruggia and Montoliu, 2014.  
 When two DSBs are generated on distal positions on the same DNA 
molecule, the intervening DNA can be excised (or inverted) and the two DNA 
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ends joined by NHEJ or by micro-homology mediated end joining (MMEJ, Lieber 
et al. 2003) (Figure i16 A).  
!
Figure i16 Strategy to produce chromosomal deletions using nucleases A Two adjacent DSBs result in 
deletion of the intervening DNA. B Only DSBs occurring on the same DNA molecule, in cis, can yield a 
deletion. C Two DSBs must be produced within a short time frame. Namely, the second DSB must happen 
before the first one is repaired. 
This approach can be challenging, considering that both nucleases must cleave 
the respective target sites on the same allele, not on different alleles (Figure i16 
B). Also, the two DSB events must happen simoultaneously or within a short 
interval of time, namely the second DSB before the first one has been repaired 
(Figure i16 C).  
In the next paragraphs, each of the three main targeted nucleases family (ZFN, 
TALEN and CRISPR-Cas9) will be introduced, along with the attempts to produce 
targeted, chromosomal deletions using each tool, reported to date. 
 
1.2.4.1 Zinc Finger Nucleases (ZFNs) 
 
Zinc Finger Nucleases (from now on, ZFNs) are the first class of targeted 
nucleases that were generated and therefore the most characterized to date. 
ZFNs are composed of a custom DNA-binding motif coupled with the catalytic 
domain of the FokI endonuclease (Bibikova et al. 2002; Urnov et al. 2010) 
(Figure i17). The DNA-binding motif used in ZFNs is a Cys2-His2 class of zinc-
finger domain, which is the most common DNA-binding motif in eukaryotes 
(Rubin et al. 2000) and the second most frequently encoded type of protein 
domain in the human genome. Individual fingers contain an average of 30 amino 
acids and recognise 3 base pairs each. Arrays of zinc fingers can be assembled 
using artificial peptide linkers (Liu et al. 1997; Moore et al. 2001) and can be 
designed to recognise unique targets in  
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end-joining (NHEJ or MMEJ)
A B
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complex genomes, such as rat. (Geurts et al. 2009). Designing optimal zinc-
finger arrays is a complex task that can be achieved by modular assembly of pre-
selected zinc-fingers recognising individual nucleotide triplets (Beerli et al. 2002; 
Bhakta et al. 2013). However, the affinity and specificity of each zinc finger 
towards the corresponding triplet may vary because of context-dependant 
interactions between neighbouring fingers. This observation led to the 
development of selection-based approaches to empirically choose the best array 
from large, pre-existing arrays libraries. The principal algorithm of ZFNs design is 
proprietary of Sigma Aldrich/Sangamo (St. Louis, MO, USA). Alternately, non-
proprietary algorithms are available that can be used for ZFNs design and 
assembly (Hermann et al. 2012). 
The FokI nuclease domain used in ZFNs has been extensively engineered in 
order to increase the specificity and the mutagenic activity of ZFNs and reducing 
its toxicity. The development of heterodimeric mutants allowed two ZFN 
monomers to bind the target sequence in order to reconstitute an active FokI 
protein (Guo et al. 2010; Doyon et al. 2011). Furthermore, directed evolution was 
used to generate a hyperactive FokI variant, 15-fold more active than the original 
protein (Guo et al. 2010).   
Chromosomal deletions using two ZFN pairs targeting distal sequences have 
been reported in vitro, but not yet in vivo. Liu and colleagues produced a 240 bp 
deletion in the DHFR gene in CHO cells, although with low efficiency (Liu et al. 
2010). Similarly, deletions were generated in human cells using combinations of 
Figure i17 Structure of Zinc Finger Nucleases. Designed zinc-finger protein in complex with target DNA (grey). 
Each zinc-finger consists of approximately 30 amino acids in a ββα arrangement (inset). Surface residues (-1, 2, 3 
and 6) that contact DNA are shown as sticks. Each zinc- finger domain contacts 3 or 4 bp in the major groove of 
DNA. The side chains of the conserved Cys and His residues are depicted as sticks in complex with a Zn2+ ion 
(purple). A cartoon of a ZFN dimer bound to DNA. ZFN target sites consist of two zinc-finger binding sites 
separated by a 5–7-bp spacer sequence recognized by the FokI cleavage domain. Zinc-finger proteins can be 
designed to recognize unique ‘left’ and ‘right’ half-sites. Adapted from Gaj et al. 2013 
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ZFN pairs (Sollu et al. 2010). Lee and colleagues reported that deletions in the 
range of tens, hundreds and thousands of kilobases could be produced and 
detected in human cells (Lee et al. 2010). Notably, ZFNs producing non-
compatible overhangs generated chromosomal deletions, indicating that cellular 
DNA end-processing event occur after nuclease-mediated DNA cleavage and 
that this cellular process is involved in the sealing of the two DNA extremities. In 
transgenic plants a transgene flanked by four copies of the ZFN target sequence 
could be efficiently deleted by breeding with a second transgenic plant stably 
expressing a single corresponding ZFN (Petolino et al. 2010). 
 
1.2.4.2 Transcription Activators-Like Effector Nucleases (TALENs) 
 
Transcription Activators-Like Effector Nucleases (TALENs), represent the second 
generation of targeted nucleases (Joung and Sander, 2013). TALENs are, 
similarly to ZFNs, composed of an artificial DNA-binding domain coupled to a 
FokI nuclease domain (Figure i18). The mechanism of action is identical to that 
of ZFNs: two TALEN monomers recognise and bind the target DNA sequence. 
Upon DNA-binding, two inactive FokI monomers form an active dimer that 
mediates a targeted DSB at the desired locus.  
!
Figure i18 Structure of TALENs. TALE protein in complex with target DNA (grey). Individual TALE 
repeats contain 33–35 amino acids that recognize a single base pair via two hypervariable residues (repeat-
variable diresidues; RVDs) (shown as sticks) (inset). A cartoon of a TALE nuclease (TALEN) dimer bound 
to DNA is shown. TALEN target sites consist of two TALE binding sites separated by a spacer sequence of 
varying length (12–20 bp). TALEs can be designed to recognize unique left and right half-sites. RVD 
compositions are indicated. Adapted from Gaj et al. 2013 
A TALEN contains the same FokI domain previously used for ZFNs. On the 
contrary, the DNA-binding domain contained in TALENs is radically different. It is 
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derived from a series of secreted proteins found in Xanthomonas, called 
Transcription Activator-Like Effectors (TALEs) that these pathogens use to alter 
gene expression in the hosting  
plant cells, upon infection (Boch et al. 2010). The sequences of several TALE 
proteins were aligned and found to be composed of arrays of highly conserved 
33-35 amino acids repeats carrying two central hypervariable residues at 
positions 12 and 13 (Figure i19).  !
Figure i19 Structure and DNA-binding specificity of TALE proteins. A Sketch of a TALE from 
Xanthomonas. Red rectangles indicate the array of tandem repeats. The sequences of the first array is 
indicated, with the amino acids at position 12 and 13 boxed. B The protein-DNA code at the basis of the 
TALE DNA-binding specificity. Adapted from Miller et al. 2010. 
Following a specific code (Moscou et al. 2009), repeats carrying different amino 
acids at position 12-13 were found to bind a single DNA base (Boch et al. 2009). 
Custom arrays of 15-30 repeats can be assembled seamlessly in order to design 
DNA-binding proteins with the desired specificities. The transparency of the 
protein-DNA code, the public distribution of reagents from the original laboratories 
(Cermak et al. 2011) and the development of efficient cloning techniques (Engler 
et al. 2009, and sections 3.1.4 and 3.1.10), determined the rapid success of 
TALEN in the genome-engineering field, as compared with ZFNs.  
Large chromosomal deletions could be obtained in cultured cells by co-
transfection of two TALEN pairs targeting distal sites on the same chromosome 
(Ma et al. 2014). Few reports have described the production of large deletion 
using TALENs in mice. By injecting the four RNA molecules necessary to express 
two TALEN pairs, Svodoba and colleagues generated a transgenic mouse 
carrying a targeted deletion of an intronic retrotransposon, that is responsible of 
driving the expression of a Dicer isoform specifically expessed in oocytes (DicerO, 
Flemr et al. 2013). Targeted deletions are much more frequently reported in 
zebrafish (Ma et al. 2013; Lim et al. 2013; Liu et al. 2013; Xiao et al. 2013), an 
organism that tolerates the injection of higher amount of nucleic acids, as 
compared to mice. Ekker and colleagues reported the efficient production of 
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deletion in the range of 16-18 kb by microinjection of two TALENs pairs in 
zebrafish embryos (Ma et al, 2013). ! 
 
 
 
1.2.4.3 CRISPRs 
 
CRISPR/Cas9 is the latest piece of genome editing to be included, very recently, 
in the genome engineering toolbox. The basis or this system is derived from the 
world of microbiology, similarly to TALENs: CRISPRs (clustered regularly 
interspaced short palindromic repeats) sequences and Cas (CRISPR-associated) 
proteins are the two elements of an ancient prokaryotic adaptive defensive 
system conserved in archaeal and other bacterial genomes (Jansen et al. 2002; 
Makarova et al. 2011; Jinek et al. 2012) (Figure i20). CRISPR sequences are 
accumulated in a specific locus at every infection event and represent the 
memory of the system; they form a repository of short, directly repeating 
nucleotide sequences that alternate with small unique DNA fragments (Ishino et 
al. 1987; Bolotin et al. 2005). Cas proteins process CRISPR sequences into small 
RNAs (Haurwitz et al. 2010) that are used to recognise sequence of infectious 
agents at a successive event of infection (Haft et al. 2005). Finally, Cas proteins 
cleave the infectious DNA molecules that match the CRISPR-derived RNA 
(Maraffini and Sontheimer 2008; Garneau et al. 2010; Gasiunas et al. 2012). 
 
!
Figure i20 CRISPR/Cas restriction system. A Upon infection, the exogenous genetic material of the 
invader is processed by a Cas complex. Small fragments of the exogenous DNA are integrated in the CRISPR 
locus. B Small crRNAs are generated from the CRISPR locus. When a DNA matching with one crRNA is 
found, a second Cas complex cleave the DNA of the invader. Adapted from Horvath and Barrangou, 2010 
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The two main RNA molecules required for CRISPR to work, namely the crRNA 
(CRISPR RNA) and the tracrRNA (trans-activating crRNA) were fused into a 
single sequence (the sgRNA, small guide RNA) to facilitate the translation of the 
CRISPR system to the genome editing field (Jinek et al. 2012). Thus, the sgRNA 
contains an 80 bp hairpin RNA structure that resembles the tracrRNA, connected 
to a 20 bp sequence homologous to the target sequence (the crRNA). Among 
several elements of the Cas proteins (Chylinski et al. 2013), Cas9 is sufficient to 
complex with the CRISPR RNA and the DNA target (Nishimasu et al. 2014; Jinek 
et al. 2014; Anders et al. 2014) and to cleave both target DNA strands upon 
Watson&Crick homologous base pair matching between the target DNA and the 
sgRNA. Few sequence constraints are required for CRISPR/Cas9 genome 
editing. The PAM (Protospacer adjacent motif) NGG must be found 3’ to the 
target sequence, that should be as long as 20 bp. An example is given for the 
mouse Tyr exon 1 (Figure i21 A). Several Cas9 and sgRNA expression vectors 
are available  (Ran et al. 2013). Typically, CRISPR/Cas9 induces a DSB 3 bp 
upstream the PAM motif (Figure i21 B). Alternatively, a Cas9-nickase variant can 
be used together with two sgRNA vectors. The Cas9-nickase carries a poin 
mutation (D10A) that inactivates one of the two nuclease domains of the protein. 
As a consequence, the nickase will only impose non-mutagenic single strand 
breaks (nicks, Figure i21 C). When two nicks are produced close-by with the 
proper distance and orientation (Figure i21 D), similar signals of DNA break are 
produced that are able to trigger indel formation at the targeted site (Ran et al. 
2013; Shen et al. 2014). 
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Figure i21 Mechanism of CRISPR/Cas9 genome editing. A Example of a potential CRISPR target site in 
the mouse Tyr exon 1. A N20–NGG sequence is shown in bold. The PAM motif is underlined. B Cas9 protein, 
complexed with a small guide RNA specific for a desired locus, mediates a double-strand break 3 bp 
upstream the PAM motif. C If the D10A Cas9 mutant (referred as ‘’nickase’’) is used, a single strand break 
(or nick) is produced. D In order to obtain a mutagenic DBS, two nicks must be directed using two guide 
RNAs located as close as 4 bp and as far as 20 bp with each other, and designed being a first sgRNA 
complementary to the forward strand of the target, followed by a guide RNA complementary to the minus 
strand, 3’ downstream. Adapted from Seruggia and Montoliu 2014. 
 
The first transgenic animal generated using CRISPR/Cas9 system was reported 
in the first half of 2013. Huang and colleagues used CRISPR/Cas9 to disrupt an 
EGFP transgene in mouse and in zebrafish embyos (Shen et al. 2013). Using this 
system, multiple genes can be disrupted simoultaneously by co-injection of 
several sgRNA molecules with Cas9 mRNA. Wang and colleagues targeted up to 
five genes in one single experiment (Wang et al. 2013). Such experiments 
illustrate the great potential of CRISPR/Cas9 system, although the genetics of the 
obtained animal models can be difficult to handle in practice, with different alleles 
segregating independently. Achieveng the same result using TALEN or ZFN is 
technically demanding, as the total amount of RNA involved would easily reach 
toxic concentrations before each individual nuclease would reach its working 
concentration. In fact, multiple genome editing using TALENs or ZFNs has not  
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been reported so far. Multiplex CRISPR/Cas9 genome editing is mostly useful to 
target two genes on the same chromosome in mouse (Zhou et al. 2013) and rat 
(Li et al. 2013), that would otherwise require – using standand techniques - 
several breeding rounds of two independent KO mouse lines, or two sequential 
rounds of gene targeting in embryonic stem (ES) cells using compatible selection 
strategies.  
Genetic manipulation using CRISPR/Cas9 is robust and reproducible. But still, 
key methodological details remain to be standardized, including correct RNA 
concentration (or range) and microinjection route (pronuclear-only, cytoplasmic-
only, or a combination of the two). This problem was addressed on a recent 
report from Horii and colleages. After having compared different microinjection 
protocols, the authors concluded that cytoplasmic-only microinjections yield the 
best results (Horii et al. 2014). Nevertheless, injection of some RNA material in 
the pronuclei to observe pronuclear swelling will serve as positive control of the 
microinjection. To further expedite genetic manipulation of mice and rat using 
haploid genomes (Li et al. 2012), CRISPR/Cas9 were successfully used in mouse 
(Horii et al. 2013) and rat (Li et al. 2014) haploid ES cells.  
Although already possible using the previous generation of nucleases 
(Meng et al. 2008; Bedell et al. 2012), zebrafish KO lines could be easily 
generated using CRISPRs (Jao et al. 2013). 
Gross chromosomal rearrangements, including deletions and inversions, 
can be obtained targeting distal sequences on the same chromosome. Targeted 
deletions were obtained in mouse zygotes (Fujii et al. 2013) and haploid ES cells 
(Horii et al. 2013). In zebrafish, a 40 kb DNA region was deleted and inverted 
(Xiao et al. 2013). Such approach is mostly useful to study large non-coding 
regulatory elements that might need full deletion, rather than point inactivation, to 
observe the underlying phenotype, as in the case of the Tyr regulatory elements. 
With the CRISPR/9Cas system, many of the non-coding elements described in 
the ENCODE project (Bernstein et al. 2012) or other non-coding genes, such as 
lncRNAs, can be functionally validated in vivo.  
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1.3 Open questions and technical advances 
 
The Tyr locus is an optimal experimental model to study the mechanisms that 
control gene expression. In fact, Tyr expression pattern is very specific, as 
introduced at the beginning of this section, and can be directly traced, being itself 
a reporter gene (Beermann et al. 1991) as well as a cell lineage marker 
(Gimenez et al. 2003).  
!
Figure i22 Known regulatory elements in the mouse Tyr locus. The five Tyr coding exons are shown as 
black boxes and spans a region of 66 kb. Three Mitf-binding sites identified on the Tyr promoter are depicted 
as yellow circles. The LCR, indicated as a red box, is a 3.7 kb EcoRI fragment located 12 kb upstream the Tyr 
promoter and includes A, B and G boxes, depicted as black bars. Two CTCF sites were previously described 
in our laboratory and are indicated as green circles. A LINE1 element, indicated as black box, found 
immediately upstream the LCR, was found to be methylated in vitro in L929 and B16 mouse cells. A second 
regulatory element was identified by Murisier et al. 2007, 48 kb upstream the Tyr promoter, and depicted as 
blue box. 
A considerable amount of knowledge on the Tyr regulatory circuits has been 
accumulated during the past years and summarized in Figure i22. Nevertheless, 
information is still lacking regarding the chromatin structure of the locus, the 
relationship with close-by genes and the existence of a second chromatin 
boundary, at the 3’ end of the locus. These questions will be addressed in the 
present work using Chromosome Confromation Capture (3C), a technology used 
to detect the interaction of distal DNA sequences, that have noy been applied yet 
to study the mouse Tyr locus. Moveover, a series of assays, developed in our 
laboratory and aimed to assess the enhancer-blocking activity of putative 
insulator sequences, will be applied to search for a candidate boundary at the 3’ 
end of the locus.  
It is well known and demonstrated that the presence or the absence of the Tyr 
LCR in Tyr-YAC transgenes is a key factor to achieve faithful regulation of Tyr in 
vivo. But what happens if the LCR is surgically removed or inactivated from the 
endogenous Tyr locus? Will the phenotype will be consistent in all lines 
eventually generated, or will suffer great variability, as observed when the A and 
B boxes were inactivated in YAC-based transgenes? The targeted nuclease 
systems, reviewed in this introduction, will be instrumental to obtain the 
necessary genetic manipulations, that couldn’t be achieved to date, after several 
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attempts using with both standard gene targeting techniques and RNA 
interference experiments. 
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2. Objectives
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The aim of this Thesis is the functional and structural description of the 
mouse Tyr locus along with the identification of the DNA regulatory 
element that are necessary to recapitulate the expression of Tyr gene. To 
achieve this goal, the following objectives were addressed: 
 
1. To analyze Tyr genomic sequence conservation and synteny across 
vertebrates to identify new potential boundary elements. 
2. To validate in vitro previously known boundary elements and to test 
additional newly identified boundaries, in vitro and in vivo, using the 
Enhancer-blocking assays developed in our laboratory in cultured cells 
and in zebrafish embryos. 
3. To describe the physical organization of the mouse Tyr locus in its 
active and inactive conformation by Chromosome Conformation 
Capture (3C). 
4. To generate a series of transgenic mouse lines carrying the inactivation 
of the Tyr boundary elements in the endogenous locus 
5. To analyze the phenotype of the obtained transgenic mouse lines and 
compare it with previously generated, Tyr transgenic mice available in 
the laboratory. 
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3. Methods
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3.1 Original vectors and cloning 
 
3.1.1 pELuc for Enhancer Blocking Assay in HEK 293 cells 
 
All plasmids used in the in vitro enhancer-blocking assay are derivative of the 
pLuc (4.9 kb) and pELuc (5.5 kb, Figure m1) vectors, originally obtained from Dr. 
Satoshi Watanabe (Department of Developmental Biology, National Institute of 
Agrobiological Sciences, Tsukuba, Japan)(Watanabe et al. 2006). The pLuc 
vector contains the firefly luciferase reporter gene under the control of human 
cytomegalovirus minimal promoter (CMV-mP). pELuc includes, in addition, the 
CMV enhancer (CMV-IE). The poly(A) signal of both vectors derives from the 
SV40 virus. 
!
Figure m1: Map of the pELuc vector. The sequences to be tested are cloned in XhoI and PstI position. The 
Asp718I site is used to linearize the vector before transfection. 
The 1.2-kb chicken 5’HS4 beta-globin insulator element was used as positive 
control. Similarly, the internal II/III boxes from the chicken 5’HS4 beta-globin 
insulator element (0.2 kb), both wild type and mutated, were used as positive and 
negative controls, respectively (Bell et al. 1999; Chung et al. 1993; Recillas-Targa 
et al. 1999). In addition, pCMV-lacZ (7.2 kb) was used as a transfection control 
for normalization purposes (MacGregor & Caskey, 1989). 
 Tyr 3’ (2.5 kb) XhoI and Tyr 3’ (2.5 kb) PstI pELuc-derivative vectors were 
generated by cloning a 2.5 kb sequence amplified with the primers indicated in 
Appendix 9.1.1. Similarly, a 241 bp fragment of the 2.5 kb sequence was PCR-
cloned, to obtain Tyr 3’ core XhoI and Tyr 3’ core PstI vectors. The Tyr 3’ core 
MUT XhoI and PstI vectors were obtained by site directed mutagenesis using the 
Tyr 3’ core XhoI and Tyr 3’ core PstI vectors as template. All vectors produced 
were confirmed by restriction digest and sequencing. Cloning procedure is 
described in sections 3.1.9 and 3.1.10 
CMV-IE CMVmP Firefly Luciferase pAT7 T3
XbaI
BamHI
PstI XhoI
HindIII
NcoI SphI XbaI
BamHI
Asp718I
0.5kb 120bp
pELuc (5.5kb)
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3.1.2 p48RCAR for Enhancer-blocking Assay in zebrafish 
 
!
Figure m2: map of the p48RCAR vector. The putative insulator is cloned between a midbrain enhancer 
(Z48) and a somite promoter (CAR) using the Asp718I site. The enhancer/promoter/EGFP cassette is flanked 
by inverted Tol2 inverted repeats for transposase-based transgenesis. 
The vectors used for the enhancer-blocking assay in zebrafish are based on the 
p48RCAR vector (Bessa et al. 2009) (Figure m2). The Xenopus laevis cardiac 
actin promoter (CAR, Mohun et al. 1986) and a midbrain enhancer (Z48 or 
Z54390) from Danio rerio (de la Calle-Mustienes et al. 2005) drive EGFP 
expression to the somites and midbrain, respectively. Tol2 sites for transposon-
based transgenesis flank the expression cassette. The Tyr 3’ core and its 
mutated counterpart were released from the Tyr 3’ core and Tyr 3’ core MUT PstI 
vectors and blunt-cloned in the Asp718I site of p48RCAR. Cloning procedure is 
described at section 1.1.9 
 
3.1.3 Bacterial Artificial Chromosomes used in this study  
!
Figure m3 BACs used in this study. A BACs carrying the sequence of the mouse Tyr locus and B of the 
mouse Ercc3 locus. All BACs are based on the pTARBAC backbone and pBACe3.6 (Osoegawa et al. 2000). 
Bacterial Artificial Chromosomes (BACs) were obtained from CHORI 
(https://bacpac.chori.org/) and validated by end-sequencing. The presence of the 
sequences of interest was furthermore verified by PCR. For the Chromosome 
Conformation Capture study we used BAC RP24-276I14, RP23-359C16 and 
Z48 CARp EGFP pATol2
XbaI Asp718I
HindIII
SphI NotI
0.6kb 0.8kb
p48RCAR (5.9kb)
Tol2
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BAC RP23-148C24
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chr7
chr18
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B
! 39!
RP23-148C24. The genomic content of these BACs is illustrated in Figure m3. 
BAC DNA was purified using Large-Construct Kit (QIAGEN) as indicated by the 
manufacturer, and stored at +4ºC. 
 
3.1.4 TALEN Golden gate vectors 
 
Custom TALENs were assembled by Golden Gate cloning (a procedure 
explained extensively in sections 3.1.9 and 3.1.10) using the Golden Gate TALEN 
kit (Addgene TALEN Kit #1000000024 and Cermak et al. 2011) from Dr. Daniel 
Voytas’ laboratory. The kit contains three series of Golden Gate-compatible 
vectors including: 
-60 BsaI-based plasmids (pHD1-10; pNG1-10; pNI1-10; pNN1-10; pNK1-10; 
pNH1-10) containing individual RVD (repeat variable diresidue) flanked by BsaI 
sites and generating different combinations of 5’ and 3’ 4bp-overhangs upon BsaI 
digestion. These plasmids contain a tetracycline resistance gene (TetR) for 
selection in E. coli. 
-13 BsaI-based intermediate recipient vectors, designed to accommodate up to 
10 RVDs in one Golden Gate reaction (pFusA, pFusA30A; pFusA30B, pFusB1-
10). These plasmids contain a Spectinomycin resistance gene (SpectR) for 
selection in E. coli and a lacZ cassette for white/blue screening. The RVD array 
can be released with Esp3I generating 4-bp overhangs. 
-5 Esp3I-based vectors each containing the last half-repeat (pLR-HD; pLR-NG; 
pLR-NI; pLR-NN; pLR-NK; pLR-NH) necessary to complete each RVD array.  
-2 Esp3I-based expression vectors containing the FokI nuclease domain. These 
vectors are designed to accommodate the final RVD array and can be selected in 
E. coli using Ampicillin.  
The destination vectors used in these study are the heterodimeric pCAG-T7-
TALEN(Sangamo)-FokI-KKR-Destination and pCAG-T7-TALEN(Sangamo)-FokI-
ELD-Destination (Figure m4) generated in Dr. Pawel Pelczar’s laboratory (UZH, 
Zurich). CAG promoter drives the expression of the TALE-FokI fusion. These 
vectors contain a bovine poly-adenilation signal and a T7 promoter upstream the 
ORF to be used for in vitro transcription. A SacI site downstream the TALEN 
sequence can be used for plasmid linearization. 
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Figure m4: map of the TALEN heterodimeric destination vectors. The CAG promoter can be used for 
TALEN expression in mammalian cells. The T7 promoter allows in vitro transcription of RNA from SacI-
linearized plasmid. 
The heterodimeric FokI-KKR nuclease includes I538K, E490K, and H537R 
mutations that prevent the homodimeric activity as well as "Sharkey" mutations 
S418P and K441E, which enhance the FokI activity. The heterodimeric FokI-ELD 
nuclease includes Q486E, I499L and N496D mutations as well as "Sharkey" 
mutations S418P and K441E (Guo et al. 2010). Detailed maps and sequences of 
all plasmids can be obtained on Addgene: 
addgene.org/TALeffector/goldengateV2. Detailed information regarding all FokI 
domain variants is available at: eendb.zfgenetics.org/util-foki.php 
 
3.1.5 CRISPR/Cas9 vectors  !
hCas9 plasmid (Mali et al. 2013) contains a human codon-optimized Cas9 
sequence from Streptococcus pyogenes under control of the CMV Enhancer and 
promoter. A SV40 NLS is fused with the Cas9 C-term (Figure m5).  
 
Figure m5: hCas9 vector used in this study, reported in Mali et al.!2013.!!!
Bioinformatic prediction using cNLS Mapper (nls-mapper.iab.keio.ac.jp/cgi-
bin/NLS_Mapper_form.cgi, Kosugi et al. 2009) indicates that a second, internal 
monopartite NLS is present at aa 647-660. The sequence of hCas9 vector can be 
obtained from Addgene: addgene.org/41815. 
CAG
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Figure m6: sgRNA expression vector used in this study. The sgRNA vector MLM3636 can be easely 
modified thanks to the two Esp3I sites downstream the hU6 promoter sequence. 
MLM3636 (Figure m6) contains the invariable sgRNA sequence under the 
control of hU6 promoter. The sequence of the MLM3636 plasmid can be obtained 
on Addgene: addgene.org/43860. 
 
3.1.6 Classic restriction-ligation cloning 
 
Restriction-based cloning was performed using standard cloning techniques 
(Sambrook, Fritsch, & Maniatis, 1989). The amount of 20 µg of plasmid DNA are 
digested with 20 U of restriction enzyme for three hours at +37ºC in a 50 µl 
reaction. If necessary, the restriction enzyme is heat-inactivated at +80ºC for 15’ 
and then treated with 10 U of rAPID Phosphatase. Ligation reactions are 
assembled in 10 µl volume containing 50 ng of vector DNA and insert DNA in a 
1:4 molar ratio. Ligations are incubated O/N in a water bath at +16ºC. The Wizard 
SV Gel and PCR Clean-up System (Promega) has been used for the purification 
of DNA fragments from agarose gel or from PCR and other enzymatic reactions. 
Restriction enzymes, T4 DNA ligase and rAPID Phosphatase were purchased 
from Roche and New England Biolabs and used according manufacturers. 
 
3.1.7 Site directed mutagenesis 
 
Site-directed mutagenesis of the CTCF binding motif in the Tyr 3’ core 
element was conducted with the GeneArt® Site-Directed Mutagenesis System 
(Invitrogen), according to the supplier’s indications. Briefly, a set of overlapping 
mutagenic primers (Appendix 9.1.2) with centrally located mutations sites served 
to PCR-amplify a previously methylated plasmid that contained the sequence to 
mutate. Recombination between the ends of the PCR product was promoted in 
vitro, and circularized mutated DNA was transformed into DH5αTM-T1R chemically 
competent bacteria. These bacteria are positive for McrBC, an endonuclease that 
hU6p sgRNA
Esp3I
230bp
MLM3636 (2.2kb) - Addgene #43860
Esp3I
100bp
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digests methylated DNA. This property allowed the removal of the methylated 
plasmid with the original wild-type sequence, leaving only the mutated product, 
which was purified and checked by restriction digestion and sequence analyses. 
 
3.1.8 T-A cloning 
 
pGEM-T Easy vector (Promega) was used for TA-cloning of PCR products for 
sequencing purposes, as indicated by the manufacturer. Transformants were 
spread on LB-agar plates containing 50 µg/ml Ampicillin, 0.1 M IPTG and 40 
µg/ml Xgal. Several independent clones are sequenced using universal T7 and 
SP6 primers. 
 
3.1.9 Golden Gate Cloning 
 
Golden Gate cloning is a technique that allows precise assembly of up to ten 
DNA sequences in a single reaction (Engler et al, 2009). It is based on Type IIs 
restriction enzymes, such as BsaI or Esp3I, that cut DNA 1-2 bp away from their 
recognition site and leave a 4 bp-overhang, that can be imposed by the user 
(Figure m7). Thus, unique overhangs can be assigned to the 5’ and 3’ termini of 
each DNA fragment. By assigning compatible overhangs to adjacent DNA 
fragments, complex constructs can be designed and assembled. 
 
!
Figure m7: Type IIs restriction enzymes. Recongnition site and distal overhangs generated by type IIs 
restriction enzymes Esp3I and BsaI, used for Golden Gate cloning. 
After digestion, each overhang will anneal only with its cognate overhang and the 
intervening fragments will be joined by the T4 DNA ligase. Such a reaction is 
really efficient because, unlike standard cloning, digestion and re-ligation of the 
same fragment to its parental DNA molecule is not possible.  
 
All DNA fragments are mixed in one-tube reaction, together with T4 DNA ligase 
and a type IIs enzyme. BsaI-based reactions were assembled as follows: 
 
5’-CGTCTCNNNNNNNNNNN-3’
5’-NNNNNNNNNNNGAGACG-3’
Esp3I 5’-GGTCTCNNNNNNNNNNN-3’
5’-NNNNNNNNNNNGAGACC-3’ BsaI
recognition site recognition site
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Circular plasmids   100 ng each 
10x T4 DNA ligase buffer  2 µl 
10x BSA    2 µl 
T4 DNA ligase (NEB)   1 µl [400 cohesive ends units] 
BsaI (NEB)    1 µl [20 units] 
H20     up to 20 µl 
 
Esp3I-based reactions were assembled as follows: 
 
Circular plasmids   100 ng each 
10x T4 DNA ligase buffer  2 µl 
20mM DTT    1 µl 
T4 DNA ligase (NEB)   1 µl [400 cohesive ends units] 
Esp3I (Thermo Scientific)  1 µl [20 units] 
H20     up to 20 µl 
 
Reactions were cycled as follows: 
  +37ºC 5’; +16ºC 10’ [10 cycles] 
+55ºC 10’ 
+80ºC 10’ 
 
For assembly reactions including more than five circular plasmids, the reaction 
was treated for 30’ at +37ºC with 10 U of Plasmid-Safe Dnase (Epicentre), an 
ATP-dependent Exonuclease, to digest incomplete products and linear 
concatamers: 
 
Golden Gate reaction  20 µl 
25mM ATP   1 µl 
Plasmid-Safe DNAse  1  µl [10 units] 
 
3.1.10 Golden Gate Cloning of TALENs 
 
Two rounds of Golden Gate cloning are necessary to assemble one final 20 RVD-
long TALEN plasmid (Figure MM6 A). Firstly, two independent BsaI-reactions are 
performed (Figure MM9 B and section 3.1.9). RVDs 1 to 10 of the desired array 
are assembled into the intermediate vector pFusA vector. In parallel, RVDs 11 to 
19 are assembled into the intermediate vector pFusB10 vector. Before 
transformation, the Golden Gate reaction is treated with Plasmid-Safe DNAse 
(Epicentre) as indicated in 3.1.9. Transformants are plated on LB-Agar plates 
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containing 100 µg/ml Spectinomycin, 0.1 M IPTG and 40 µg/ml. Three white 
colonies for each construct are analysed by colony PCR (Figure m8 A) with the 
primers pCR8_F1 and pCR8_R1 (5’-TTGATGCCTGGCAGTTCCCT-3’ and 5’-
CGAACCGAACAGGCTTATGT-3’) and by restriction digest (Figure m8 B) with 
AflIII and XbaI. 
!
Figure m8: TALEN Golden Gate cloning reaction 1. A PCR analysis of the colony resulting from the 
transformation of the TALEN Golden Gate reaction 1. B Positive clones are confirmed by AflIII/XbaI 
restriction digest. 
To clone the full RVD array into the FokI expression vector, the pFusA and pFusB 
vectors are assembled into an Esp3I-based destination vector, along with the 
pLR plasmid, encoding the last half-RVD of the array and a linker peptide 
connecting the RVD array and the FokI domain (Figure m9 C).  
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Figure m9: Principle of  TALEN Golden Gate Cloning. A A TALEN consists in a pair of TAL arrays, 
each of them fused to a FokI nuclease domain. Each TAL array binds to a target sequence. Two TAL arrays 
bind distal sequeces separated by a spacer sequence 10-30 bp large. B A first reaction is set to assembly 
intermediate vector containing 10 repeats, each capable of binding one base pare of the intended target. 
Individual RVDs are assembled in arrays of 10 units by a BsaI-GGC reaction. C The intermediate array 
vectors, assembled in B, are then joined with their halves and transferred to a TALEN destination vector by a 
Esp3I-GGC reaction. D Different destination vectors carrying homodimeric or heterodimeric FokI domain 
can be used. 
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The second golden gate reaction is performed as indicated in 3.1.9. No Plasmid 
Safe treatment is necessary in this step. Transformants are plated on LB-Agar 
plates containing 50 µg/ml Ampicillin, 0.1 M IPTG and 40 µg/ml Xgal. Three 
colonies for each construct are analysed by colony PCR (Figure m10 A) with the 
primers TAL_F1 and TAL_R1 (5’-TTGGCGTCGGCAAACAGTGG-3’ and 5’-
GGCGACGAGGTGGTCGTTGG-3’). Two selected clones are analysed by 
restriction digest with BamHI and StuI (Figure m10 B). !
 
 
Figure m10: TALEN Golden Gate Cloning reaction 2. A Typical result of a colony PCR of the final 
TALEN golden gate reaction. A smear/ladder is observed in all positive samples. B BamHI + StuI restriction 
digest of clones resulting from the second TALEN golden gate reaction. 
Typically, more than 95% of the clones show the expected pattern at both PCR 
and restriction digest. All constructs are verified by sequencing using the same 
primers indicated above. 
 
3.1.11 Golden Gate Cloning of CRISPR sgRNA vectors  
Two Esp3I sites in between hU6 promoter and the invariable sgRNA sequence 
allow Golden-gate cloning of the sgRNA target sequence in the MLM3636 vector 
(Figure m11). The 20 bp sgRNA target sequence (not including the PAM motif) is 
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flanked by MLM363-compatible Esp3I overhangs and ordered as a single strand 
oligonucleotide, one for the forward and one for the reverse DNA strand, 
according to the following design: 
-Forward oligonucleotide: ACACC-target sequence-G, 26-mer 
-Reverse oligonucleotide: AAAAC-reverse complement of the target sequence-G, 
26-mer 
 
!
Figure m11: Golden Gate cloning of CRISPR sgRNA vectors. A Example of oligonucleotides-based 
golden gate cloning into the empty MLM3636 vector. B Detail of the annealed oligonucleotides carrying 
overhangs that are compatible to the MLM3636 vector. C Diagram of the cloning reaction. D Colony PCR of 
sgRNA vector obtained by Golden-gate cloning. A 93 bp band is expected when the annealed oligonucleotide 
is correctly inserted in between the Esp3I sites of MLM3636 empty vector. 
 
The Forward and Reverse oligonucleotides are mixed in 100 µl H20 to a final 
concentration of 10 µM of each oligonucleotide. The oligonucleotide mix is melted 
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at 95ºC for 5’ and annealed 30’ at RT. 1 µl of the annealing reaction is Golden 
Gate cloned in MLM3636 as follows: 
 
Circular MLM3636  100 ng  
Annealed oligonucleotide  mix 1 µl 
10x T4 DNA ligase buffer 2 µl 
20 mM DTT   1 µl 
T4 DNA ligase (NEB)  1 µl [400 cohesive ends units] 
Esp3I (Thermo Scientific) 1 µl [20 units] 
H20    up to 20 µl 
  
Transformants are plated on LB-Agar plates containing 50 µg/ml Ampicillin. 
Three colonies are analysed by colony-PCR with LKO_1 5' as forward primer (5’-
GACTATCATATGCTTACCGT-3’) and using the reverse oligonucleotide of the 
golden gate reaction as reverse primer (Figure m11 D). This procedure has been 
published and reported in detail in Harms et al. 2014. 
 
3.1.12 Bioinformatic tools 
 
Snapgene Viewer (GSL Biotech LLC) was used to annotate plasmid and genomic 
DNA sequences, to analyse chromatograms and to build plasmid maps. bl2seq 
tool (BLAST/blastn, NCBI) and BLAT (UCSC) were used to align sequences. 
Primers were designed using PRIMER3 (BioTools, 
biotools.umassmed.edu/bioapps/primer3) and PRIMERBLAST (NCBI). Molar 
ratio for restriction-ligation cloning were calculated usign Biomath Calculator 
(Promega). TALEN Targeter was used to design TAL arrays (tale-
nt.cac.cornell.edu/node/add/talen). CRISPR DESIGN (crispr.mit.edu) was used to 
search for sgRNA binding site and to predict potential off-target sequences. 
Bowtie (Langmead et al. 2009) was also used to select the most unique sgRNA 
sequences. All mouse genomic sequences were retrieved from the NCBI37/mm9 
mouse genome assembly and browsed using UCSC Genome browser (genome-
euro.ucsc.edu) and Ensembl (ensembl.org). 
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3.2 Enhancer-Blocking assay in HEK 293 cells 
 
3.2.1 Plasmid preparation  
 
All constructs used for Enhancer-blocking assay are described in section 3.1.1 
and in Lunyak et al. 2007.  Prior transfection, plasmid preparations (Genopure 
plasmid MIDI kit, Roche) are linearized and purified with Wizard SV Gel and 
PCR-cleanup kit (Promega). Briefly, 20 µg of each plasmid are linearized with 
Asp718I (Roche), with exception of the control plasmids containing the chicken 
II/III 5’HS4 element, which are linearized with ApaI (Roche). A plasmid carrying 
the lacZ coding sequence under the control of the CMV promoter, pZ (Hall et al. 
1983), is used for transfection efficiency normalization. pZ is linearized using ScaI 
(Roche). 
 
3.2.2 Cell culture and transfection  
 
Human HEK 293 cells (Shaw et al. 2002) were grown in DMEM medium 
(Dulbecco’s Modified Eagle Medium, Gibco) supplemented with sterile-filtered 
10% fetal bovine serum (FBS, Sigma-Aldrich), 2 mM L-glutamine (Invitrogen) and 
10 mM HEPES pH 7.4 (Invitrogen) under aseptic conditions using a sterile hood 
(Telstar Bio II Advance). Cells were cultured at +37ºC, 95% of humidity and 5% 
CO2 (CO2 water-jacketed incubator, Forma Scientific) in plates of different sizes 
according to the number of cells required for each experiment: 24-well plates (2 
cm2) or p100 (58.10 cm2) dishes were purchased from Falcon.  Usually, cells 
were grown to 80-90% confluency before they were detached by incubation with 
0.25% trypsin-0.02% EDTA (Gibco) for 5 min at +37ºC, and reseeded at 1:8 to 
1:10 dilution. Whenever it was necessary to determine the cell number, a cell 
counting chamber (Sigma) was used according to the manufacturers’ 
specifications. Some 24 hours before transfection, cells are seeded at a density 
of 2 x 105 cells/well (4 x 105 cells/ml) in a 24-well plate, using DMEM complete 
medium. Transfection is performed using Lipofectamine 2000 (Life Technologies) 
diluted in OptiMEM (Life Technologies) as indicated by the manufacturer. 660 ng 
of each construct is transfected along with 140 ng of the β-galactidase vector pZ. 
Each transfection is performed in three technical replicates. At least two 
biological replicate per experiment are performed. 
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3.2.3 Preparation of cellular extracts 
  
About 24 hours post-transfection, cells are gently washed with ice-cold PBS and 
lysed in 125 µl 1x Reporter Lysis Buffer (Promega), with the help of a rubber 
policeman. Lysates are vortexed and spun 2 min at 12’000 x g in a refrigerated 
centrifuge. Cleared lysates are transferred to a fresh tube and kept on ice. A 
1:100 dilution is prepared in lysis buffer. The remaining volume is stored at -
80ºC. 
 
3.2.4 β-galactosidase activity measurement 
 
To measure β-galactosidase activity we used the the hydrolysis of the 
chromogenic substrate o-nitrophenyl-b-D-galactoside (ONPG, Sigma Aldrich), as 
reported by Hall (Hall et al. 1983). First, 100 µl of a 1:100 dilution of each lysate 
are mixed with 400 µl of Z-buffer (100 mM Na2HPO4 pH 7.2, 10 mM KCl, 1 mM 
MgSO4, 50 mM β-mercaptoethanol) and 100 µl of ONPG (4 mg/ml in 100 mM 
Na2HPO4 pH 7.2). Plain lysis buffer was used as negative control to blank the 
microplate reader. Samples are incubated at +37ºC for 30’ and observed at 10’ 
intervals. As soon as a pale yellow colour is observed, the reaction is stopped 
with 250 µl 1M Na2CO3. Then, 200 µl of the reaction are transferred to a 
transparent 96 well-plate (Nunc) and 414 nm absorbance is measured in a 
microplate reader. 
 
3.2.5 Luciferase activity measurement 
 
A volume of 100 µl of a 1:100 lysate dilution of each sample is transferred to a 
opaque-white 96-well plate (Berthold). Luminescence is measured in an Orion 
Microplate Luminometer (Berthold), programmed to inject 50 µl Luciferin 
(Promega) in each well, with an exposure time of 10 seconds and a well-to-well 
delay of 2.05 seconds. 
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3.2.6 Data analysis 
 
Luciferase activity was corrected for transfection efficiency using the β-
galactosidase activity, obtaining a value of Relative Luciferase activity. This value 
is then normalized for the amount of transfected DNA (pmol). Enhacer-blocking 
activity is obtained dividing the Relative Luciferase activity of pELuc by that of 
each sample. This ratio is shown along with the standard deviations of the 
triplicates. 
 
3.3 Enhancer-blocking Assay in zebrafish embryos 
 
Experiments with zebrafish embryos were carried out in Dr. José Luis Gómez-
Skarmeta’s laboratory, at the CABD, Seville, with the help of Dr. Ana Fernández-
Miñán. All procedures met the EU animal research guidelines (Directive 
2010/63/UE) and the Spanish animal research legislation (L32/2007; RD53/2013; 
L6/2013) and were approved by the CSIC and local Ethics Committee. 
 
3.3.1 Plasmid purification 
 
All constructs used for EBA in zebrafish are described in section 3.1.2. Plasmid 
DNA preparations are obtained using Genopure plasmid MIDI kit (Roche). To 
remove traces of RNAse, 20 µg of DNA are diluted in water in a total volume of 
400 µl. 1 volume of phenol:chloroform:isoamyl alcohol (25:24:1) is added. The 
sample is vigorously mixed and spun 5’ at 20’000 x g at RT. The superior, 
aqueous phase is transferred to a fresh tube. An equal volume of 
chloroform:isoamyl alcohol is added and the aqueous phase is collected after the 
same procedure. Two volumes of ice-cold absolute ethanol are used to 
precipitate the DNA. The sample is centrifuged 15’ at 20’000 x g at +4°C. The 
DNA pellet is then washed with 400 µl of 70% ethanol, air-dried and resuspended 
in RNAse-free water.   
 
3.3.2 Microinjection into zebrafish embryos 
 
Transient transgenic zebrafish embryos were generated by Tol2-based 
transgenesis (Kawakami et al. 2009). p48RCAR-based construcs (3.1.2) were 
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microinjected into one-cell stage zebrafish embryos (AB strain) using a IM-300 
microinjector (NARISHIGE) as previously reported (Bessa et al. 2009). Plasmid 
DNA was injected at a concentration of 40 ng/ul along with 50 ng/ul of Tol2-
transposase mRNA. Phenol red (0.05%) was added to the microinjection mix in 
order to track visually the success of the injection. The microinjection mix was 
delivered at the yolk/cell interphase. After microinjection, embryos were kept in 
E3 medium (5 mM NaCl, 0.17 mM KCl, 0.4 mM CaCl2, 0.16 mM MgSO4) at 
+28°C. No more than 50 individuals were kept in each plate. After 24 hours, all 
plates are inspected for the presence of dead or deformed embryos, which are 
removed. The medium is replaced with fresh E3 medium supplemented with 
0.003% PTU (1-Phenyl-2thiourea, Sigma) to inhibit the development of 
pigmentation that would quench the GFP fluorescence. 
 
3.3.3 Imaging 
 
Embryos were imaged at 36 hfp (hours post-fertilization) using an Olympus 
SZX16 fluorescence microscope and the CellSens Entry 1.6 software (Olympus). 
Briefly, zebrafish embryos were dechorionated using two pairs of fine-tip 
tweezers and anesthetized by adding several drops of 0.4% tricaine (Sigma-
Aldrich) to the E3 medium. All embryos were imaged using the same settings. 
 
3.3.4 Image processing and data analysis 
 
LasexPix image analysis software (Bio-Rad) was used to measure the GFP+ 
areas in zebrafish embryos fluorescence images. Fluorescent areas observed in 
midbrain or somites are manually divided and summed for each individual. A 
Median, non-parametric test is used to assess the statistical significance of the 
differences observed between experimental groups. 
 
3.4 Chromosome Conformation Capture (3C) 
 
Chromosome conformation capture technology allows the detection of physical, 
long-range interaction between distal DNA sequences that can be used to infer 
the three-dimensional chromatin organization of a given locus. The current 
procedure is based on Hagege et al. 2007 and was set up with the help of Dr. 
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Ana Fernández-Miñán and Dr. Jose Luis Gomez-Skarmeta, CABD, Seville, 
Spain. 
 
3.4.1 Cell culture 
 
Mouse melanoma cell line B16-F1 and mouse fibroblast NIH-3T3 L929 cell line 
were grown in DMEM medium (Dulbecco’s Modified Eagle Medium, Gibco) 
supplemented with sterile-filtered 10% fetal bovine serum (FBS, Sigma-Aldrich), 2 
mM L-glutamine (Invitrogen) and 10 mM HEPES pH 7.4 (Invitrogen) under 
aseptic conditions using a sterile hood (Telstar Bio II Advance). Cells were 
cultured at +37ºC, 95% of humidity and 5% CO2 (CO2 water-jacketed incubator, 
Forma Scientific) in T175 flasks (Falcon). Usually, cells were grown to nearly 
100% confluence before they were detached by incubation with 0.25% trypsin-
0.02% EDTA (Gibco) for 5 minutes at 37ºC, and reseeded at 1:8 to 1:10 dilution. 
Whenever it was necessary to determine the cell number, a heamocytometer 
(Sigma) was used according to the manufacturers’ specifications. 
 
3.4.2 RNA extraction and quantification of Tyr expression 
 
RNAeasy kit (QIAGEN) was used to extract RNA from 1 x 106 cells, as indicated 
by the manufacturer. Two µg of RNA were treated with RNAse-free DNAse 
(Roche). Subsequently, cDNA was obtained from 1 µg of RNA using Superscript 
III (Life technologies) and randon hexamer oligonucleotides (Life Technologies) 
as indicated by the vendor. One µg of RNA was kept without reverse transcription 
as a control for DNA contamination. A 1:20 dilution of cDNA was used for RT-
qPCR using gene-specific TaqMan Gene Expression Assays (Applied 
Biosystems) in a ABI 7500 machine. qPCRs were conducted in triplicates and 
repeated twice. Mm00495817_m1 probe was used for mouse Tyr expression. 
Mm00446973_m1 probe was used for mouse TBP (TATA binding protein) 
expression, for normalization (Gimenez et al. 2003; Lavado et al. 2006).  
 
3.4.3 3C Primer design 
 
Primers were designed using Primer3 and PrimerBLAST, 70-150 bp away from a 
DpnII site flanking fragments of interest (promoters, CTCF-binding sites…) and 
‘’neutral’’ sequences, included as control. Each oligonucleotide is design outward 
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looking, pointing to the closer restriction site (Figure m12 A). The specificity of a 
primer is evaluated using PrimerBLAST and Ensembl BLASTN optimized for 
near-exact matches. Nevertheless, digestion and re-ligation process produce a 
scrambled, shuffled genome that current algorithms are not capable of predicting. 
PCR validation is therefore the golden standard. 
!
Figure m12 3C primer design. A Primers are design 70-150 bp away from the chosen restriction site, 
outward-looking. In the given example, primers are designed not yielding any amplification in the untreated 
genome. B In the 3C procedure, sequences that are in physical proximity are cross-linked. C Only upon 
digestion and religation, fragment 1 and 3 eventually came in contact and the designed oligonucleotide can 
anneal and yield a PCR product. !
3.4.4 Production of BAC control template 
 
A template containing all 3C chimeric ligation products is produced for absolute-
qPCR calibration (Figure m13). Two BACs covering the region object of the 
study (3.1.3) where obtained from CHORI (bacpac.chori.org/). Equimolar 
amounts of each BAC are mixed to a total of 2 µg and digested o/n using 50 U of 
DpnI (Roche) in 500 µl of 1x DpnI buffer. After digestion, a 20 µl aliquot is kept for 
electrophoretic analysis. The rest of the volume is phenol-extracted, ethanol-
precipitated and resuspended in 88 µl of mqH20. Ligation is performed with 2 µl (6 
Weiss U) of T4 DNA ligase (Promega) in 100 µl volume in a thermocycler, using 
the following program: +4ºC, 3 hours; +14ºC, 3 hours (4x). A 4 µl aliquot is kept 
for electrophoretic analysis. Next, 80 µl H20 and 20 µl NaAc 3M pH 5.2 are added 
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to the rest of the reaction. The mixture is phenol-extracted, ethanol precipitated 
and resuspended in 100 µl H20. 
!
Figure m13 Production of 3C BAC control template. A Two BACs are mixed in equimolar amount, 
digested and religated in order to produce a library of all possible chimeric ligation products. B After ligation, 
a high-molecular weight band is observed, indicating the success of the digestion-ligation reaction. !
3.4.5 Cross-link and isolation of intact nuclei 
 
Confluent cells (80-90%) are washed with PBS, collected by trypsinization and 
counted using a haemocytometer (Sigma). Ten million cells are resuspended in 5 
ml of PBS in a 15 ml falcon. 5 ml of filtered, 4% PFA/PBS (Merk) are added and 
the solution is incubated 10 min at room temperature with continuous agitation in 
order to prevent the formation of cell clumps. Fixation is quenched by adding 
1.425 ml of ice-cold 1M glycine (Calbiochem). The sample is spun 8 min at 1300 
rpm in a refrigerated centrifuge. The pellet is then resuspended in 5 ml ice-cold 
lysis buffer (10 mM Tris HCl, 10 mM NaCl, 0.3% NP40 supplemented with fresh 
protease inhibitors, 1x Complete, Roche) and incubated on ice 10 min with gentle 
agitation. The sample is then centrifuged 5 min at 1300 rpm in a refrigerated 
centrifuge, resuspended in 500 µl lysis buffer and transferred to a 1.5 ml tube. 
With the help of a plastic pestle the cells are homogenized on ice every 10 
minutes until complete lysis. MGP staining (methyl green pyronin, Sigma Aldrich) 
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restriction enzyme T4 DNA ligase
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is used to follow the lysis of cellular membranes and the release of intact nuclei. 
Complete lysis is obtained when the cytoplasm, stained in pink, in no longer 
visible by MGP staining. 
 
3.4.6 Chromatin digestion and ligation 
 
Intact nuclei are spun 5’ at 2600 rpm at 4ºC and resuspended in 485 µl of 1x 
restriction digestion buffer (NEB). This step is repeated to remove traces of lysis 
buffer that may inhibit the restriction enzyme. Fifteen µl of 10% SDS are added 
and the sample is incubated 1h at +37ºC with shaking. To precipitate the SDS, 55 
µl of 20% Triton X-100 are added. The sample is incubated 1h at 37ºC with 
shaking. A 10 µl aliquot is kept as undigested control. Then, 300 U of restriction 
enzyme (NEB, Roche) are added and the sample is digested o/n at +37ºC with 
shaking. After digestion, a 10 µl aliquot is kept as digested control. Digestion 
efficiency was determined at this point. The control aliquots were taken up to a 
volume of 95 μl, using 10 mM TrisMHCl pH 7.5. Next, 5 µl of 10 mg/ml proteinase 
K (Roche) were added to each sample. They were incubated at 65ºC for 1 hour 
to reverse the  cross-links and the DNA was purified by 
phenol:chloroform:isoamyl alcohol extraction.  The  purified  undigested  and  
digested  controls  for  each  cell type  were  run on  a  0.6%  agarose  gel and 
compared. If digestion had taken place, the samples were ready for the next step. 
The restriction enzyme is heat-inactivated by incubating 25 min at +65ºC. The 
digested chromatin is then transferred to a 15 ml falcon and diluted in 7 ml of 1x 
T4 DNA ligase buffer (30 mM TrisHCl, 10 mM MgCl2, 10 mM DTT, 10 mM ATP). 
Fifteen μl of T4 DNA ligase (Promega, 15-45 Weiss Units) are added. The 
sample is incubated o/n at +14ºC. To determine ligation efficiency, aliquots of 100 
µl were taken and processed as in the  previous  step. Purified ligated samples 
were run along undigested and digested controls and compared. If ligation had 
occurred as expected, the samples were further processed. 
3.4.7 Cross-link reversal and DNA purification 
 
Digested, re-ligated chromatin is incubated o/n at +65ºC, after the addition of 30 
μl of 10mg/ml Proteinase K (Roche), to reverse the DNA cross-link and facilitate 
DNA extraction. Next, 30 μl 10mg/ml RNAse A (Roche) are added to digest 
! 57!
cellular RNAs. Seven ml of Phenol-Chloroform-Isoamyl alcohol (25:24:1) are 
added. The sample is vigorously mixed and spun 10 min at 4000 rpm. The 
supernatant is carefully transferred to a fresh 15 ml tube. An equal volume of 
Chloroform-isoamyl alcohol (24:1) is added, the sample is then mixed and 
centrifugated 10 min at 4000 rpm. The supernatant is carefully transferred to a 50 
ml falcon. Seven ml mq H20, 933 µl 3M NaAc pH 5.2 and 24 ml 100% Ethanol are 
added and the sample is centrifuged 45 min at 4000 rpm at +4ºC. The resulting 
pellet is washed in 70% ethanol, air-dried and resuspended in 150 µl TE (10 mM 
TrisHCl, 1 mM EDTA). 
 
3.4.8 Quantification of distal DNA interactions by qPCR 
 
A standard, end-point PCR to detect the conserved interaction at the Ercc3 locus 
(see Appendix for oligonucleotide sequences) is performed prior to qPCR 
quantification using three different dilutions of the 3C sample. The success of this 
PCR is a first indication that the 3C procedure was performed correctly and it is 
ready for quantification using qPCR. The linear range of amplification was 
determined by performing qPCR on serially diluted BAC control and 3C sample 
templates, with different primer pairs. Once the working DNA concentration range 
had been established, qPCRs were conducted, in triplicates. Enrichment in a 
given ligation product was taken as a measure of the interaction frequency 
between two genomic loci. Hence, relative interaction frequencies were 
calculated by using a standard curve generated from a serial dilution of the BAC 
mix control template (3.4.4), which contained all possible ligation products in 
equimolar amounts. To enable the comparison of the results from different 3C 
samples, the interactions observed in each cell line were normalized to that of the 
Ercc3 region, an unrelated locus that is often used as control, since it is 
considered to adopt the same spatial conformation regardless the cell type (De 
Laat & Grosveld, 2003; Palstra et al., 2003; Drissen et al., 2004). qPCR 
quantification was performed using SYBR Green PCR Master Mix (Applied 
Biosystems) using an ABI 7500 Real-Time PCR Machine. Two biological 
replicates of each cell type were analysed at least twice. 
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3.5 Transcription-Activators Like Effector Nucleases 
 
3.5.1 TALEN design 
 
Repeat Masker (Tempel, 2012) was used to identify repeat-free sequences in the 
target region. TALEN Targeter (Doyle et al. 2012, tale-
nt.cac.cornell.edu/node/add/talen) was used to identify TALEN binding sites in 
the selected repeat-free sequences and to obtain the corresponding RVD arrays. 
We selected DNA spacer length range of 12-23 bp and TAL arrays of 15-20 
RVDs each. The RVD used to recognise G was NN.  
TALENs with the lowest predicted off-targets were considered and RVD arrays 
with the highest NG and HD content were selected. The selected TALENs were 
assembled by Golden Gate Assembly (Engler et al. 2009), using the Voytas 
Golden Gate TALEN kit (Addgene #1000000024). Moreover, to reduce off-
targeting possibility, an obligate heterodimeric FokI mutant was used (Doyon et 
al. 2011, Addgene #40131 and #40132). Details of the cloning process and of the 
destination vectors used are available in section 3.1.9 and 3.1.10 of this PhD 
thesis. 
 
3.5.2 TALEN validation in mouse Neuro2A cells 
 
Combination of TALEN pairs targeting adjacent DNA sequences, that would 
induce deletion of the intervening DNA, were transfected in mouse Neuro2a cells. 
Briefly, 1 x 106 cells were plated in 6-well plates in 2 ml of complete DMEM 
medium in the absence of antibiotics. Then, 300 ng of each TALEN plus 100 ng 
of pEGFP-N1 (Clontech) - to follow the transfection efficiency - were transfected 
with 6 µl of Lipofectamine 2000 (Life Technologies) as indicated by the 
manufacturer. Some 72 hours post-transfection, the cells are lysed in 800 µl of a 
SDS-free lysis buffer (50 mM KCl, 10 mM TrisHCl pH 8, 0.45% NP40, 0.45% 
Tween-20, 500 ng/mL Proteinase K) to bring DNA in solution. Lysates are 
incubated for 3 hours at +56°C. The Proteinase K is then heat-inactivated at 
+95°C for 10 minutes.  One microliter of the sample is directly used for PCR, or 
stored at 4°C.   
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3.5.3 In vitro cleavage assay for TALEN validation 
 
We used an in vitro cleavage assay (modified from Jinek et al., Elife 2013) to 
assess the cleavage activity of purified TALEN proteins on a PCR product 
containing the corresponding target sequence.  Briefly, HEK293 cells were plated 
at a density of 4x 105 cells/ml in a p24 plate, in complete DMEM without 
antibiotics. The next day, 400 ng of each TALEN (200 ng of each TALEN 
monomer) plus 50 ng of pEGFP-N1 plasmid were transfected using 
Lipofectamine 2000 (Life Technologies). Some 72 hours post-transfection, cells 
were washed with ice-cold PBS and lysed in 250 µl of 1x cleavage buffer (20 mM 
HEPES pH 7.5, 100 mM KCl, 5 mM MgCl2, 1 mM DTT, 5% Glicerol, 0.1% Triton 
X-100, and 1x Roche Complete Protease Inhinitor cocktail). Lysates were 
collected in a 1.5 ml tube, vortexed 10’’ and spun 2’ at 12’000 x g at +4°C. 
Cleared lysates were transferred to a fresh tube. 
Ten µl of each TALEN lysate were mixed with 500 ng of a PCR product 
containing the relative target site, in 1x Cleavage buffer, in a total volume of 20 µl. 
Samples were incubated at +30°C for 3 hours. Prior to gel electrophoresis, 
samples were treated with 500 ng Proteinase K for 10’ at +65°C. As control, each 
target PCR product was incubated with a TALEN lysate specific for a different 
target of with a lysate of mock-transfected cells. 
 
3.5.4 TALENs RNA in vitro transcription 
 
TALEN mRNAs (5’-capped and 3’-polyA tailed) were transcribed in vitro from 
plasmid templates, using the mMessage mMachine T7 ULTRA kit (Ambion) as 
indicated by the manufacturer. Briefly, 20 µg of each TALEN expression vectors 
(described extensively in section 3.1.4 and 3.1.10) were linearized with 20 units 
of SacI (Roche) for three hours in 50 µl volume. DNA was purified with Wizard SV 
Gel and PCR Clean-up system (Promega) and quantified using a Nanodrop 
device. The successful linearization was also confirmed by agarose gel 
electrophoresis. One µg of linear DNA was used for T7 RNA polymerase-
mediated RNA transcription. The 5’-cap was added in this first step. After DNAse 
treatment, a poly A tail was added to the RNA with an enzymatic reaction as 
indicated by the manufacturer. Capped, polyA tailed mRNA was then purified by 
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gel filtration using Nucaway Spin Columns (Ambion) rehydrated in RNAse-free 
microinjection buffer (1 mM TrisHCl pH 7.5, 0.1 mM EDTA pH 7.5) (Figure m14). 
!
Figure m14: in vitro transcription of TALENs. A The SacI-linearized vector, containing the T7 promoter 
sequence upstream to the TALEN open reading frame, was used as template for in vitro transcription. B A 
sample of each step of the transcritpion and tailing is run in a TBE-agarose gel. A clear supershift is observed 
in the RNA after A-tailing (pA). 
Different 2.5 µl aliquots of each step of the RNA production were kept, heat-
denatured and run in a TBE-agarose gel. Bands are visualized under UV light 
after staining with SYBR Safe (Invitrogen). RNA concentration was measured 
using a Nanodrop device. RNA was next diluted at 200 ng/µl and stored at -80°C 
in 20 µl aliquots until use. Before proceeding with microinjection into mouse 
fertilized eggs, TALEN mRNA are mixed and diluted to the proper working 
concentration in microinjection buffer (1 mM TrisHCl, 0.1 mM EDTA) and 
centrifuged at 30’000 x g for 1 hour at +4°C, to clear the solution from any particle 
or debris that may clog the microinjection needle and/or interfere with mouse 
embryo development. 
T7 pA c T7 pA c T7 pA c T7 pA c
TAL 5’0 LELD TAL 5’0 RKKR TAL 5’5 RKKRTAL 5’5 LELD
CAG bpAT7 TALE array FokI
SacI
A
B
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3.6 CRISPR 
 
3.6.1 CRISPRs design 
 
 
CRISPR/Cas9 nucleases can virtually target any 20 bp-long DNA sequence that 
is followed by the PAM (Protospacer Adjacent Motif) motif 5’-NGG-3’. An example 
of possible CRISPR target sites within the mouse Tyr exon 1 is given in Figure 
m15. 
!
Figure m15: PAM motifs found in the mouse Tyr exon. PAMs on the forward strand are indicated in green. 
PAMs on the reverse strand are shown in purple. One selected sequence is shown below.  
 
For the CRISPRs used in this study, N20-NGG sequences were picked manually 
or with the help of Zhang Lab CRISPR Design online tool (crispr.mit.edu) in the 
same DNA region used to design TALENs, previously identified using 
RepeatMasker (3.5.1). These sequences are then screened to find those that are 
unique within the mouse genome. CRISPRs have a reported tendency of off-
targeting even when mismatches are present between the desired target site and 
the undesired (Fu et al. 2013; Mali et al. 2013; Pattanayak et al. 2013 and Hsu et 
al. 2013). Therefore, a ‘’relaxed’’ BLAST analysis is used to detect sequences 
that display multiple mismatches with the desired target. To this end, a script was 
compiled using Bowtie and run for each of the possible CRISPR target 
sequences. An example for the 3’3 CRISPR is given in Table m1. 
GCTAAAGTGAGGTAAGAAAAGAACTTATTCTTTTCGGAGACACTCAAATCAAAAATGTTTCTTCTAATCAAGA
CTCGCTTCTCTGTACAATTTGGGCCCCCAAATCCAAACTTACAGTTTCCGCAGTTGAAACCCATGAAGTTGCC
TGAGCACTGGCAGGTCCTATTATAAAACACAGAGGGCCAGGACTCACGGTCATCCACCCCTTTGAAGGGGAAC
TGAGGTCCAGATGGTGCACTGGACAGAAGGATATCCTGGCAGGAACCTCTGCCTGAAAGCTGGCCGCAGGGAC
TCCCATCACCCATCCATGGTGGGCAGCATTCTTTTGCCAACAAGTTCTTAGAGGAGGCACAGGCTCGAGGAAA
ACACAGAGGGCCAGGACTCA-CGG
target site P.A.M.
mouse Tyr locus
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In this case, the three off-targets found by Bowtie map in intronic regions of the 
Stx1a, Nup210 and Gabrb1. The potential off-targets show 2, 3 and 3 bases of 
mismatch, respectively.   
Recently, online tools for CRISPR design and off-target prediction became 
available. The selected CRISPRs were therefore re-analysed using newly 
available tools design by members of the Zhang laboratory at the MIT, Boston, 
USA. Those tools can be browsed at crispr.mit.edu. This second analysis 
confirmed the good quality of the selected targets. Detailed results of the potential 
off-target search are listed in the result section. CRISPR sequences are ordered 
as oligonucleotides (Sigma Aldrich), annealed and cloned as described in the 
section 3.1.9 and 3.1.11 of this PhD thesis. 
 
3.6.2 CRISPR/Cas9 validation in mouse Neuro2a cells 
 
For in vitro tests, mouse Neuro2a cells were plated in a 24-well plate at a density 
of 4 x 105 cells/ml in a 0.5 ml volume of complete DMEM without antibiotics. On 
the next day, 400 ng of hCas9 plasmid and 100 ng of the sgRNA plasmid were 
transfected along with 50 ng of pEGFP-C1 as transfection efficiency reporter. 
Transfection was performed using Lipofectamine 2000 as reported previously. 
Thereafter, 72 hours post-transfection, genomic DNA was obtained with a SDS-
free buffer( 50 mM KCl, 10 mM TrisHCl pH 8, 0.45% NP40, 0.45% Tween-20, 
500 ng/ml Proteinase K) and used directly for PCR. CRISPRs activity was 
evaluated by T7 Endonuclease I assay or by PCR using primers designed to 
detect chromosomal deletions. 
 
3.6.3 T7 Endonuclease I assay  
 
In order to detect nuclease-induced mutations, insertions and deletions (indels), 
we used a mismatch-detection assay based on T7 Endonuclease I digestion of 
PCR products (Figure m16). Briefly, the region surrounding the nuclease target 
 ./bowtie -c m_musculus_ncbi37 AGCTCAGTAGAGTACTAGGTAGG -v 3 -l 23 -k 100 
0   
0 + 135522000 AGCTCAGTAGAGTACTAGGTAGG IIIIIIIIIIIIIIIIIIIIIII 0 7:G>T,13:C>A 
0 - 91016905 CCTACCTAGTACTCTACTGAGCT IIIIIIIIIIIIIIIIIIIIIII 0 12:C>A,16:C>T,19:G>A 
0 + 72174498 AGCTCAGTAGAGTACTAGGTAGG IIIIIIIIIIIIIIIIIIIIIII 0 12:A>T,15:A>T,16:G>A 
Table m1 Bowtie script used to identify potential off-target sites. 
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site is PCR-amplified with primers yielding a PCR product not smaller than 400 
bp and not larger than 1 kb. 
!
Figure m14: Principle of the T7 Endonuclease I. PCR products are melted and re-annealed to favour the 
formation of heteroduplexes. The T7 Endonuclease I is used to detect eventual mispairing of wild-type with 
mutated DNA strands. 
 
To produce heteroduplexes, the PCR product is denatured at +95°C and allowed 
to re-nature slowly, in a thermocycler, using the following cycling parameters: 
 
+95°C 10’ 
+95°C -> +85°C -2C/sec 
+85°C 1’ 
+85°C -> +75°C -0.3C/sec 
+75°C 1’ 
+75°C -> +65°C -0.3C/sec 
+65°C 1’ 
+65°C -> +55°C -0.3C/sec 
+55°C 1’ 
+55°C -> +45°C -0.3C/sec 
+45°C 1’ 
+45°C -> +35°C -0.3C/sec 
+35°C 1’ 
+43°C -> +25°C -0.3C/sec !
The reaction is prepared as follows: !
PCR product    10 µl [out of a 25 µl PCR reaction] 
10x NEB buffer 2   2 µl 
T7 Endonuclease I, NEB  0.5 µl [5 units] 
H20     7.5 µl !
and incubated at +37°C for 25 min. All reaction volume is resolved in a 2% TBE-
agarose gel. A typical result is shown in Figure m17 using a sgRNA designed to 
target the EGFP coding sequence (Auer et al. 2014). 
wt allele mutated allele
     (indels)
melt and cool down+
heteroduplex
T7 Endonuclease I
digestion 
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Figure m17 Example of T7 Endonuclease I assay. A Mouse Neuro2A cells are transfected with the GFP 
expression vector pEGFP-N1 (Clontech), along with the hCas9 expression vector and a sgRNA expression 
vector targeting a sequence within the EGFP open ready frame. B EGFP coding sequence is PCR amplified 
using the primers indicated. The expected nuclease cut site is found 117 bp downstream the forward primer. 
C Fluorescence microscopy images of cells transfected with either pEGFP alone or in combination with 
CRISPR plasmids. EGFP signal is reduced by CRISPR. D T7 Endonuclease I digestion of total DNA 
extracted from transfected cells. The PCR product is cleaved at the expected position indicating that indels 
have been produced at the CRISPR target site 
 
3.6.4 Cas9 and sgRNA in vitro Transcription 
  
 
Cas9 ORF including NLS was PCR amplified from the vector hCas9 with Expand 
Long Template PCR system (Roche) with the following conditions: 
 
1. +94°C   2’ 
{2. +94°C   20’’ 
3. +50°C   30’’ 
4. +72°C   6’ } 30 cycles 
5. 72°C  8’ 
 
The T7 RNA promoter sequence was added 5’ to the forward oligonucleotide. 
One microgram of the purified PCR was used as template for in vitro RNA 
transcription using the mMessage mMachine T7 ULTRA kit as indicated by the 
manufacturer. 
  
M     -       +
EGFP Cas9
eGFP sgRNAsgRNA target
800bp117bp
117bp
800bp
917bp
T7EI
A
B
D
C pEGFP-N1 pEGFP-N1 + hCas9+ EGFP sgRNA
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Figure m18 sgRNA and hCas9 in vitro transcription. A The sgRNA fragment is amplified with primers 
carrying the T7 RNA polymerase promoter. B The PCR product is used as template for in vitro transcription. 
The transcribed RNA is then purified using NucAway spin columns (Ambion). C The T7 promoter sequence 
is added to the hCas9 ORF by PCR. D One microgram of the purified PCR product is used for RNA in vitro 
transcription, followed by polyA-tailing. A clear supershift is observed after the A-tailing reaction. 
The capped and A-tailed Cas9 mRNA was then purified using Nucaway Spin 
Columns (Ambion) rehydrated in microinjection buffer and stored at -80°C in 10 µl 
aliquots until necessary. The sgRNA region (a 20 bp target-specific sequence 
followed by 80 invariable nucleotides, shown if Figure m19) is PCR-amplified 
from MLM3636-based vectors (described in section 3.1.9). As in the case of the 
hCas9 mRNA, the T7 RNA polymerase promoter was added 5’ to the Forward 
oligonucleotide. For this PCR, an invariable reverse oligonucleotide was 
combined with a forward oligonucleotide specific for the sgRNA to be amplified 
and carrying the T7 RNA promoter sequence (Table m2). 
 
Table m2 PCR primers used to add the T7 RNA polymerase promoter to the sgRNA sequence. 
 
sgRNA-FwJae 5’-TTAATACGACTCACTATAGGNNNNNNNNNNNNNNNNNNNN-3’ 
sgRNA-RvJae 5’-AAAAGCACCGACTCGGTGCC-3’ 
 
T7
    
 
hU6p sgRNA
T7
T7 sgRNA
T7
T7
A
B
co
l
hCas9CMVp NLS TK pA
C
T7 pA co
lD
hCas9 NLS TK pA
M
102 bp
4140 bp
4140 bp + A tail
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Figure m19 PCR template for sgRNA in vitro transcription. An example is given using a sgRNA 
targeting the mouse Tyrosinase exon 1. A Each target-specific sgRNA is PCR-amplified from MLM3636-
based vectors using a Forward oligo carrying the T7 promoter sequence and a costant Reverse 
oligonucleotide (underlined). B The resulting RNA molecule is shown. 
First, 10 ng of sgRNA plasmid were used for PCR with the following conditions: 
 
1. +94°C   4 min 
{2. +94°C   30 sec 
3. +50°C   30 sec 
4. +72°C   20 sec } 35 cycles 
5. +72°C  2 min 
 
Next, 500 ng of the sgRNA PCR was used for standard T7 RNA polymerase 
transcription, as follows: 
 
T7 RNA polymerase 10x buffer  4 µl 
10x BSA solution   4 µl 
sgRNA PCR    5 µl 
80mM rNTP solution (NEB)   1 µl 
T7 RNA polymerase (NEB)  2 µl 
H20     up to 40 µl. !
After o/n incubation at +37°C, the RNA was purified with Nucaway Spin Columns 
(Ambion) as done previously. RNA is stored in 10 µl aliquots at -80°C until 
necessary. Before proceeding with microinjection into mouse fertilized eggs, 
Cas9 mRNA and sgRNA RNAs are mixed and diluted to the proper working 
concentration in microinjection buffer (1 mM TrisHCl, 0.1 mM EDTA) and 
centrifuged at 30’000 x g for 1 hour at +4°C. These procedures have been 
recently described in details in Harms et al. 2014. 
 
3.7  Transgenic mice  
 
All procedures involving the use of mice complied with the European Union 
animal research legislation (2010/63/UE), as well as with the! Spanish legislation 
(RD53/2013 and L32/2007, L6/2013). Also, they were reviewed and approved by 
the corresponding CNB and CSIC Ethics Committees on animal experimentation 
5’-TTAATACGACTCACTATAGGACACAGAGGGCCAGGACTCAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT-3’
 mTyr exon 1
gRNA target site (N20)
T7 RNA pol 
promoter
gRNA scaffold
5’-GGACACAGAGGGCCAGGACTCAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT-3’
3’-AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAACTGAGTCCTGGCCCTCTGTGTCCTATAGTGAGTCGTATTAA-5’
sgRNA molecule obtained by T7 RNA polymerase in vitro transcription
A
B
120bp
102bp
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in Spain or by the corresponding bodies in Switzerland, depending on the place 
of injection. Transgenic mice were produced at the Transgenic and Reproductive 
Techniques laboratory at the Institute for Animal Science, University of Zurich, 
Switzerland, headed by Pawel Pelczar, and by the Transgenic Core Facility of the 
CNB-CBMSO-CSIC, Madrid headed by Belen Pintado. RNA was microinjected 
into the cytoplasm (Horii et al. 2014) or into cytoplasm and pronucleus (to confirm 
positive microinjection) using standard procedures (Montoliu, 1997; Behringer et 
al. 2014; Yang et al. 2014; Harms, Quadros, Seruggia et al. 2014). 
 
3.7.1 Genotyping 
 
Mouse genomic DNA was extracted from tail or toe biopsies (< 1 cm) obtained at 
the time of weaning, in a two-step procedure (Montoliu, 1997). First, the tissue 
was digested overnight with a Proteinase K-containing lysis solution (0.5 mg/ml 
proteinase K, Roche; 100 mM NaCl, 50 nM Tris-HCl pH 8, 100 mM EDTA pH 8, 
1% SDS, Merck). In the second step, the DNA was purified by ethanol 
precipitation, resuspended in TE buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA pH 
8, Merck) and stored at 4ºC until further use. Alternatively, toe clips were digested 
overnight in 100 µl of a SDS-free lysis buffer (50 mM KCl, 10 mM TrisHCl pH 8, 
0.45% NP40, 0.45% Tween-20, 500 ng/mL Proteinase K). The samples are then 
incubated 10’ at 95C to inactivate the Proteinase K and used directly for PCR 
analyses. Transgenic founders were further analysed by sequencing. Briefly, 2 µl 
l of PCR were cloned into pGEM T-Easy vector (Promega) as indicated by the 
manufacturers. Several independent clones were sequenced using the external, 
universal oligonucleotides T7 or SP6.  
 
3.7.2 Gene expression analyses in mouse tissues 
 
Mice were euthanized by cervical dislocation. Organs were collected and snap-
frozen in liquid nitrogen. RNAeasy kit (QIAGEN) was used to extract RNA as 
indicated by the manufacturer. Two µg of RNA were treated with RNAse-free 
DNAse (Roche). Subsequently, cDNA was obtained from 1 µg of RNA using 
Superscript III (Life technologies) and randon hexamer oligonucleotides (Life 
Technologies) as indicated by the vendor. One µg of RNA was kept without 
reverse transcription as a control for DNA contamination. A 1:20 dilution of cDNA 
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was used for RT-qPCR using gene-specific TaqMan Gene Expression Assays 
(Applied Biosystems) in a ABI 7500 machine. qPCRs were conducted in 
triplicates and repeated twice. Mm00495817_m1 probe was used for Tyr, 
Mm00690332_m1 for Grm5 and Mm00479246_m1 for Nox4 expression. 
Mm00446973_m1 probe was used for mouse TBP (TATA binding protein) 
expression, for normalization (Gimenez et al. 2003).  
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4.1 The Tyr gene is flanked by chromatin boundaries 
 
4.1.1 Synteny and gene expression analysis of the mouse Tyr locus 
 
Synteny analyses (Figure r1 A and Figure r2) of the Tyr locus were performed 
by aligning known genomes from different vertebrates. Results indicate that 
evolutionary forces kept Tyr linked to its neighbouring genes, namely Nox4 
(Cheng et al. 2001), a nuclear-encoded mitochondrial protein involved in the 
respiratory chain, and Grm5, Glutamate metabotropic receptor 5, involved in the 
regulation of neural network activity and synaptic plasticity (Winder et al. 1996). 
Notably, these genes are not part of a gene cluster – a genomic structure often 
associated with syntenic conservation (Elizondo et al. 2009). On the contrary, 
they have dissimilar expression patterns (Figure r1 B and Figure r3). Nox4 is 
broadly expressed in kidney, liver, and lung. Grm5 is specifically expressed in 
several central nervous system structures including dorsal striatum, nucleus 
accumbens, cortex, hypothalamus, hippocampus as well as in peripheral nervous 
structures, such as the spinal cord and the neuroretina. Tyr, located in between 
Nox4 and Grm5, is specifically expressed only in pigmented cells: in neural crest-
derived skin and iris melanocytes and in the pigmented epithelium cells of the 
retina (Gimenez et al. 2003).  
 
!
Figure r1: Differently expressed gene within the Tyr syntenic block A Synteny of the mouse Tyr locus 
was analysed using Ensembl. The Tyr locus is contained in a large syntenic block, conserved from chicken to 
human, along with the flanking genes Nox4 and Grm5. A list of the tissues where each gene is expressed in 
mice – extracted from BIOGPS datasets – is shown in B. Note that the three genes are never coexpressed. !!
Tyr Grm5Nox4A
B
Nox4 (NADPH oxidase 4)
Kidney
Lung 
Liver
Iris
Tyr (Tyrosinase)
Retinal pigment epithelium
Iris (melanocytes)
Eyecup (melanocytes)
Ciliary bodies
Grm5 (Metabotropic glutamate receptor 5)
Dorsal striatum
Nucleus accumbens
Cerebral cortex
Hypothalamus
Hippocampus
Amigdala
Spinal cord
Neuroretina
Mouse chr 7:94394439-95054071
Rat   chr 1:157106652-158095289
Dog   chr 21:10615972-11492456
Cow   chr 29:6147990-7240131
Human chr 11:88799113-89057524
Pig  chr 9:25067392-25427981
Chicken chr 1:186948732-187407442
syntenic block:
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Figure r2: Synteny analyses of the Tyr locus  across vertebrates (Ensembl). A detailed view of the 
synteny analyses obtained from Ensembl is given for all tested species. A region of the mouse chromosome 7, 
containing Nox4, Tyr and Grm5 is syntenic with human chromosome 11 (A), pig chromosome 9 (B), rat 
chromosome 1(C), chicken chromsome 1 (D), dog chromosome 21 (E) and cow chromosome 29 (F). 
The observation that these genes were kept physically together through evolution 
despite their divergent expression patterns let us hypothesize that chromatin 
boundaries – or insulators - must be present to insulate the cis-acting, regulating 
elements of the Tyr locus and preventing deleterious transcriptional cross-talk 
(Molto et al. 2009). The conserved synteny of Nox4, Tyr and Grm5 indeed 
suggests that a fine mechanism have emerged, and eventually fixed and 
conserved, in order to protect the three independent expression units present in 
the locus. 
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 Previously, 15 kb 5’ upstream the Tyr gene, a chromatin boundary was 
identified and characterized extensively in our laboratory (Montoliu et al. 1996; 
Giraldo et al. 2003). The 5’ Tyr boundary, or Locus Control Region (LCR), 
introduced in section 1.1.2 and 1.2.1, is the element that could contribute to the 
correct functioning and conservation of Tyr-Grm5 syntenic block, and was also 
found in the human genome (Regales et al. 2003). The search and 
characterization of a potential Tyr 3’ boundary, hypothetically needed to insulate 
Tyr and Nox4 expression domains, is one of the objectives of this work. 
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Figure r3: Expression profile of Nox4, Tyr and Grm5 (BioGPS). Data were extracted from two 
independent datasets (GeneAtlas MOE430 1448821_at and 1417717_a_at). Means and standard deviations 
are shown for the three genes. 
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4.1.2 Identification of a Tyr 3’ candidate insulator element 
 
Preliminary experiments carried out in our laboratory suggested the existence of 
some CTCF binding sites within the Tyr 3’ region (Angel Diaz, PhD thesis 2007). 
In order to identify new putative insulators 3’ upstream the Tyr gene, we analysed 
the intergenic region between Tyr and Nox4. We used multi-species sequence 
conservation and we took advantage of several published CTCF and cohesin 
ChIP-seq datasets (Figure r4). In fact, cohesin contributes to the insulator activity 
mediated by CTCF (Wendt et al. 2008; Parelho et al. 2008) and to the formation 
of long-range contacts between distal DNA sequences, which is another 
mechanism to mediate insulator property. In addition, the presence of repetitive 
sequences and ancient transposable elements was also considered, since 
insulator activity was previously found associated with such elements (Lunyak et 
al. 2007; Roman et al. 2011). We focused our attention of a bi-partite 2.5 kb 
conserved non-coding element centered on the CTCF-Cohesin binding site. This 
non-coding region contains a CTCF-binding site, overlapping with a repeated 
element of the Short Interspersed element class B2 (SINEB2) family, a 
combination that often functionally serves as chromatin insulator. Odom and 
colleagues observed that among the all CTCF-binding sites found in several 
mammals, those that are embedded into mobile retro-elements are species-
specific and often convey insulator activity (Schmidt et al. 2012). The likely origin 
of this type of boundaries depends on the internalization of a CTCF-binding site 
into an active retrotransposon, and in successive mobilization of the new retro-
element carrying the CTCF binding motif. Such a mechanism is shared with 
many other transcription factor-binding sites, for example Myc, indicating that 
transposable elements play an important role in expanding the repertoire of their 
binding sites (Bourque et al. 2008). Those CTCF/transpositions events that result 
useful (or not detrimental) will be positively selected and fixed during evolution. 
Thus, an internal 241 bp fragment of the 2.5 kb conserved non-coding element, 
containing the strongest CTCF-binding ChIP-seq signal (Figure r5 A) and 
including the full SINEB2 element (Figure r5B), was also considered for 
functional validation. 
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Figure r4 Identification of a Tyr 3’ candidate insulator sequence. A Diagram of the Tyr locus. The Tyr 5’ 
boundary is indicated as a red box. The Grm5-Tyr intergenic region is indicated as a yellow box. B Diagram 
extracted from UCSC Genome Browser illustrating mammalian, multi-species conservation of the Grm5-Tyr 
intergenic region, repeat elements and CTCF occupancy in several mouse tissues as found in several publicly 
available ChIP-seq datasets. C Colocalization of CTCF and Rad21-Cohesin binding.!!
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Using the CTCF motifs dataset provided by Xie and co-workers (Xie et al. 2007), 
we identified a sequence resembling the CTCF LM7 motif in the selected putative 
Tyr 3’ core element (Figure r5 C and D). By site-directed mutagenesis (see 
section 3.1.7 for detailed procedure), we introduced three point mutations (Figure 
r5 E) aimed to avoid or reduce the CTCF occupancy at the described sequence. 
!
Figure r5 Sequence analysis of the putative Tyr 3’ boundary. A The highest CTCF-binding signal is 
detected in correspondence of a 241 bp sequence, containing a SINEB2-type repeat (shown in red in B). C A 
CTCF-binding site was found matching the LM7 CTCF-binding motif, shown in D, described by Xie et al. 
2007. E Three base pair in the CTCF-binding motif were mutated to eventually abolish CTCF binding. 
 
 
4.1.3 Enhancer-blocking Assay in HEK 293 cells 
 
We used the Enhancer-blocking assay in HEK 293 cells (Lunyak et al. 2007 and 
section 3.3) to confirm the insulator property of the previously described 5’ 
boundary and to analyse the putative boundary on the 3’ extremity of the Tyr 
locus. 
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Briefly, the candidate insulator sequences were cloned in a plasmid carrying the 
CMV enhancer and its minimal promoter, linked to the luciferase coding 
sequence (pELuc, section 3.1.1). 
 
 !
Figure r6: Principles of the Enhancer-Blocking Assay. Several luciferase-reporter constructs are 
transfected in HEK293 cells. A basal level of expression is observed when the minimal CMV promoter drives 
luciferase expression (A), while adding an enhancer will result in a higher luciferase activity (B). If an 
insulator is positioned in between the enhancer and the promoter, the luciferase expression drops down to a 
level similar to the basal vector (C), according to the strength of the insulator. When cloned upstream the 
enhancer, a true insulator does not affect reporter expression (D), while a silencer does (E). 
 
Two series of vectors were generated. By cloning into the XhoI site of pELuc, the 
putative boundary is positioned in between the CMV enhancer and promoter. The 
reporter gene expression will sense the capability of the insert of blocking the 
enhancer activity: strong insulators will reduce the luciferase activity, whereas 
neutral sequences will not affect the reporter gene expression levels (Figure r6). 
A second series of vector was generated by cloning the candidate insulators in 
the PstI site, which is located upstream the CMV enhancer. This series of vectors 
is meant to sense silencing activity of the cloned sequence. A reduction in the 
expression of the reporter gene in this series of vectors indicates that the cloned 
sequence is indeed not an insulator, but a silencer. Neutral sequences will not 
affect the reporter gene expression when cloned in this position. Along with test 
sequences, a set of control vectors is used: the cHS4 element (obtained from 
plasmid pBC1, described in Lunyak et al. 2007), from the chicken β-globin locus, 
and a smaller fragment of the latter (fragment II/III, Recillas-Targa et al. 1999; 
Recillas-Targa et al. 2002) were used as positive controls. A mutated version of 
the II/III fragment was used as negative control (Recillas-Targa et al. 1999). !
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Figure r7 Enhancer-blocking assay in HEK 293 cells. A Candidate Tyr 3’ boundary sequences, including a 
2.5 kb fragment, a 241 bp subfragment and a mutated version were cloned into pELuc vector. The full 3.7 kb 
fragment of the Tyr 5’ boundary (LCR, Giraldo et al. 2003) and the LCR core element GAB were cloned also 
in pELuc vector (B), downstream and upstream the CMV enhancer. C Enhancer-blocking activity is shown 
for the newly described Tyr 3’ boundary and for the Tyr 5’ boundary (LCR and GAB core), described in 
Giraldo et al. 2003. Anova-Bonferroni multiple comparison test. Significant P<0.05. 
The candidate Tyr 3’ insulator sequence that we identified has indeed insulator 
properties: the full-length, 2.5 kb Tyr 3’ element displayed the highest enhancer-
blocking activity. The Tyr 3’ core element, a 241 bp element containing a CTCF-
binding site embedded in a SINEB2 repeat, retains more than 50 % of the activity 
of the full-length counterpart in less than one tenth of the size. By mutagenesis of 
the CTCF-binding motif (Figure r5 E) the insulator activity is reduced, but not 
fully abolished. This result indicates that either the mutated CTCF-binding motif 
can still be partially bound by CTCF, or that the SINEB2 alone display a moderate 
boundary activity. EBA assay of the 3.7 kb Tyr 5’ element (LCR) and its core 
element (GAB), confirms that this sequence, previously characterized in our 
laboratory (Giraldo et al. 2003), acts as a chromatin boundary (Figure r7). In 
conclusion, these results indicate that the Tyr expression unit is flanked by two 
elements capable of blocking enhancer activity in vitro. 
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4.1.4 Enhancer-blocking Assay in zebrafish embryos 
 
Mammalian cultured cells represent a useful model to easily test several 
elements in parallel, in a relatively fast and cheap way. Nevertheless, in vitro 
assays lack the higher level of complexity, typical of a living organism. To 
overcome this limitation, we developed in the laboratory, and in collaboration with 
JL Gomez-Skarmeta (CABD, Seville) a second series of Enhancer-Blocking 
Assays, using zebrafish embryos as a model organism (Bessa et al. 2009; 
Roman et al. 2011; Martin et al. 2011; Tiana et al. 2012), described in section 
3.3.  
Using the p48RCAR vector (section 3.1.2) the putative insulator is positioned in 
between a midbrain-specific enhancer and a muscle-specific promoter. Thanks to 
the Tol2-transposase system (Kawakami et al. 2007), transient-transgenic 
individuals are generated with high efficiency by embryo microinjection. Injected 
embryos are imaged by fluorescence microscopy 36 hours post-fertilization. The 
ratio of GFP fluorescence between CNS and somites will be indicative of the level 
of insulator activity, low values indicating neutral/weak sequences and high 
values indicating sequences capable of blocking enhancers. 
We used this assay to confirm the properties of the Tyr 3’ core element in vivo. 
We included in the experiment the mutated Tyr 3’ core element, to confirm that 
the enhancer-blocking activity of the Tyr 3’ boundary is largely CTCF-dependent. 
The in vivo enhancer-blocking assay confirmed the insulator property of the Tyr 3’ 
core element (Figure r8 C and E), which shows a statistically significant 
reduction in mid-brain fluorescence (p < 0.000726). When a mutated Tyr 3’ 
element, carrying three mutation in the CTCF-binding site, the enhancer-blocking 
activity is reduced (Figure r8 F) and no statistically significant difference is 
observed when compared with control embryos (p < 0.135; Figure r8 C and D), 
thereby proving that the boundary activity has been impaired in vivo. 
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Figure r8 Enhancer-blocking assay in zebrafish embryos. A 241 bp of the Tyr 5’ core boundary, and its 
CTCF-mutated counterpart were cloned in the pCAR48R plasmid. B This vector contains a midbrain-specific 
enhancer and a muscle-specific minimal promoter, linked to the GFP coding sequence. This expression 
cassette is flanked by Tol2 inverted sites to be used for transposase-mediated transgenesis in zebrafish 
embryos. C Ratio of somites vs brain fluorescence. Differences between groups were examined for statistical 
significance using Median test; n = 11-39. Tyr 3’ versus control, p<0.00726; Tyr 3’ mut versus control, 
p<0.135;  Tyr 3’ versus Tyr 3’ mut, p<0.591. D Control embryos injected with the empty pCAR48R vector. 
Expression in both midbrain and somites can be observed E Representative embryos injected with the Tyr 3’ 
construct. F Embryos injected with the mutated Tyr 3’ element. The location of midbrain is indicated by 
yellow boxes. 
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4.2 Tri-dimensional organization of the mouse Tyr locus 
 
In the previous section we focused on the enhancer-blocking property associated 
with the Tyr 5’ and 3’ insulators. However, chromatin insulators and other cis-
acting elements play additional roles in the genome organization (West et al. 
2002; Molto et al. 2009). Insulators are able to physically partition individual 
expression domains into independent chromatin loops (Yang and Corces, 2012; 
Dixon et al. 2012). Such structural role mainly rely on the capability of insulators 
to recruit CTCF, a transcription factor often referred as the ‘’main vertebrate 
insulator protein (Phillips and Corces, 2009). CTCF is able to form dimers 
(Williams and Flavell, 2008), putting in contact distal DNA region bound by CTCF 
(or other protein partners) resulting in the formation of a chromatin loop with the 
intervening DNA inside (Hou et al. 2008).  
With this in mind, we aimed to study the physical structure of the Tyr 
locus. We used Chromosome Conformation Capture (3C, de Laat and Dekker, 
2012) to observe the Tyr locus architecture in an active and inactive status, using 
appropriate mouse cell lines and experimental designs. 
  
4.2.1 Tyr expression in B16 and L929 cells 
 
B16-F1 mouse melanoma cells (Ganss et al. 1994) were chosen as a cellular 
model in which the Tyr gene is actively transcribed. We confirmed that B16 cell 
line expresses Tyr by mRNA quantification (Figure r9 A) and by the observation 
that melanin, the downstream product of the tyrosinase enzyme, is accumulated 
in these cells and clearly visible (Figure r9 B) in cellular pellets. On the other 
side, in mouse L929 fibroblast cells we could not detect Tyr mRNA or melanin. 
Therefore L929 cells were used to model a non-transcribing, inactive Tyr locus. 
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Figure r9: Tyr expression cultured cells. A Taqman RT real-time PCR quantification of Tyr mRNA in B16 
and L929 cells. Tyr mRNA levels are normalized to that of TATA-binding protein mRNA levels. B Melanin, 
downstream product of the enzyme tyrosinase, is accumulated in B16 cells, but not in L929 cells. 
 
4.2.2 Chromosome Conformation Capture (3C) 
 
The Tyr promoter contains the minimal information necessary to correctly drive 
Tyr expression in vivo (Beerman et al. 1990; Kluppel et al. 1991; Tanaka et al. 
1990; Yokoyama et al. 1990). This information is conveyed by two conserved 
motifs, the Tyr Initiator (Irn) and the M-box (Bentley et al. 1994), both bound by 
the transcription factor Mitf. We therefore selected a 367 bp DpnII fragment 
containing these elements as anchor fragment for the 3C assay (Figure r10). 
Combining oligonucleotides mapping on several DpnII fragments in the Tyr locus 
with a primer mapping on the promoter, we interrogated our 3C libraries (section 
3.4) in order to detect which DNA elements were physically contacting the Tyr 
promoter in Tyr-positive and negative cells, with the highest resolution (Comet et 
al. 2011; Sexton et al. 2012). 
Results of the 3C assay indicate that the Tyr promoter acts as the hub of 
chromatin interactions in the Tyr locus (Figure r11 B). A strong interaction is 
observed between the promoter and a fragment 80 kb 3’ upstream (highlighted 
by circle number 1). This DpnII fragment colocalizes with the Tyr 3’ boundary 
element, previously characterized by the Enhancer-blocking assay in human cells 
(2.1.3) and zebrafish embryos (2.1.4). The interaction is observed in both B16 
cells and L929, indicating the constitutive nature of the chromatin loop, likely 
having a structural role, in virtually all cell types, independently from Tyr 
expression. The Tyr 3’ boundary sequence is in fact occupied by both Rad21 and 
CTCF. No interactions are observed with control sequences immediately 
upstream and downstream the Tyr 3’ element.  
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Figure r10 DpnII fragment containing the Tyr promoter. A 367 bp DpnII fragment was selected as anchor 
for the 3C study, containing the Tyr promoter Initiator (in red) and the M-box (in green). The sequence of the 
oligonucleotide used is underlined.! Genomic sequences are extracted from the mouse genome assembly 
NCBI37/mm9 (July 2007).!
A second interaction is observed 48 kb 3’ upstream the Tyr promoter, specifically 
in the B16 cell 3C library, located in the 3rd tyrosinase intron (circle 2). Regulatory 
elements are often found in introns (i.e. Ried et al. 1990). Conversely, in the first 
intron, which was included in most tyrosinase minigene constructs (Beermann et 
al. 1990), there is no detectable chromatin interaction. 15 kb 5’ upstream the Tyr 
TSS, a cell-type specific interaction is found with the promoter (circle 3). The 
interacting sequence co-localizes with the Tyr 5’ element, or LCR. The interaction 
is restricted to a DpnII fragment containing the Tyr LCR A and B boxes (Ganss et 
al. 1994; Giraldo et al. 2003). Flanking, control fragments are not interacting with 
the Tyr promoter. Notably, a DpnII fragment containing the LCR G box, (Giraldo 
el al. 2003) is not interacting with the Tyr promoter (circle 4). No interaction is 
observed with far 5’ upstream elements, including one element previously 
described to be involved in Tyr expression regulation (Murisier et al. 2007) (circle 
5). Next, the 3C libraries were interrogated using the DpnII fragment containing 
the Tyr 5’ element as bait region. The Tyr locus was scanned for sequences 
interacting with the Tyr 5’ element (Figure r11 C). Interactions are only observed 
with the Tyr promoter (circle 6) and not with the Grm5 promoter, located 75 kb 5’ 
upstream, indicating that this regulatory element is not shared with other 
expression units. No interactions are observed between the Tyr 5’ and Tyr 3’ 
GATCATACAAAATCTGCACCAATAGGTTAATGAGTGTCACAGACTTCTTTTCCAGCAACCCCTGGAGT
GACTATCACATGTTTTGGCTAAGACCTATATAACCACTCCCCTTCTTACATCAAATACTCTCAGCCTG
TTTTACACTAAGCTTTTATCTTCTGCAAAGCACATGACTAACTTTTTCTTGGAGTTTGTACATAGCCC
ATAGTGAGGTAACTAAATTGAAGGAAGATATATTATTCTAATTGATATGAAATTAATAATAATTGGAA
TTTGCAAATGAGAAGTAGTATCAAGAATACATCATCTCTTATGAATAAAGGTCATGAAACATCTAGAT
TCTGAATACAAGCCTGTTGTATTTAGA
chr7:94641872-94642238
TyrNox4
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elements, indicating that these two boundary elements probably compete with the 
same binding sites in the Tyr promoter.  
!
Figure r11 3C study of the Tyr locus. A Diagram of the Tyr locus along with multi-species sequence 
conservation track obtained from the UCSC Genome Browser. The Tyr 3’ and 5’ boundary elements are 
shown as red boxed. The CNS-2 sequence (Murisier et al. 2007) is shown as a blue box. B Chromosome 
conformation capture using a bait primer located on the Tyr promoter. C 3C using a bait on the Tyr 5’ 
boundary fragment containining the AB boxes. D 3C using a bait on the CNS-2, - 47 kb element.  
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Finally, the anchor primer was positioned on a fragment containing a conserved 
region described by Murisier et al. 2007 and observed to be dispensable in 
transgenic mice generated with different YAC Tyr transgenes (Montoliu et al. 
1996). Using this bait fragment, we could not observe any interaction within the 
Tyr locus in both 3C libraries (Figure r11 D) in the cell lines we used. 
 
4.2.3 Sequencing confirmation 
!
In order to confirm the 3C findings, the PCR products deriving from chimeric 
ligation products were cloned and sequenced using universal sequencing 
oligonucleotide contained in the cloning vector. Figure 12 shows the sequencing 
confirmation of the interaction detected between the Tyr promoter and the Tyr 5’ 
boundary element located 15 kb upstream. Alignments of the sequences of DNA 
strands using BLAT indicate that the PCR amplicon indeed represent a chimeric 
ligation product of two distal DNA fragments (Figure r12 B).  !
!
Figure r12: Sequencing confirmation of Tyr 5’-Tyr promoter interaction. A A chimeric PCR product 
obtained with oligonucleotides mapping on distal region in the Tyr locus was TA-cloned using pGEM T-Easy 
vector. Independent clones were sequenced using T7 and SP6 oligonucleotides. B Scheme of the position of 
the primers used to generate the chimeric fragment that has been sequenced. Genomic coordinates refer to the 
mouse genome assembly NCBI37/mm9 (July 2007). 
 !
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Figure r13 illustrates the sequencing confirmation of the interaction detected 
between the Tyr promoter and the Tyr 3’ element located 80 kb upstream. 
Sequence alignments of both DNA strands using BLAT indicate that the PCR 
product indeed represent a chimeric ligation product of two distal DNA fragments. !
!
Figure r13 Sequencing confirmation of Tyr 3’-Tyr promoter interaction. A chimeric PCR product 
obtained with oligonucleotides mapping on distal region in the Tyr locus was TA-cloned using pGEM T-Easy 
vector. T7 and SP6 sequencing confirmed that the PCR product contains a chimeric sequence derived from 
the Tyr 3’ boundary (red box) and Tyr promoter DpnII fragments. Genomic coordinates refer to the mouse 
genome assembly NCBI37/mm9 (July 2007). 
 
4.2.4 Structure of the Tyr locus in mouse RPE cells 
 
As introduced elsewhere in this work, Tyr is expressed in neural crest-derived 
melanocytes and in RPE cells that derive from a different embryonic structure, 
the optic cup. To test whether different regulatory elements are required to 
activate Tyr expression in a different lineage, we wanted to perform 3C on RPE 
cells. Although several established human RPE cell lines are available, including 
ARPE-19 (Dunn et al. 1996) and D407 cells (Davis et al. 1995), only one mouse 
RPE cell line is available, called B6-RPE07 (Chen et al. 2008), a cell line cloned 
from a primary culture of mouse RPE cells. We obtained this cell line from Dr. 
Heping Xu (Centre for Vision and Vascular Science, Queen's University Belfast, 
UK). Unfortunately, B6-RPE07 cells do not express Tyr, nor the typical RPE-
markers Rpe65 and Otx2 (Figure r14 A). Actually, loss of Tyr expression was 
readily detected also in primary cultures of mouse RPE cells (Figure r14 A), 
probably as a consequence of the Epithelial-mesenchymal transition (EMT) and 
likely caused by Zeb1, a inhibitory transcription factor that binds to E-box 
elements, also found at the Tyr and Mitf promoters.  Liu and colleagues reported 
that the formation of spheres reverses EMT, represses Zeb1 and restores both 
Tyr and Mitf expression (Liu et al. 2009). By obtained spheres from the B6-
RPE07 cells (Figure r14 B), we observed an increase in Mitf expression but not 
in Tyr expression or a reduction in Zeb1 levels. These technical limitations avoid, 
for the moment, the study of the structure of the Tyr locus in RPE cells, by 3C. 
Tyr
DpnII DpnII
3x Mitf
DpnII DpnII
5’-CCATCTGCCCATGAGCATTTCAGTAGGTCAAGTTCAAATGCACTTAGAAGACAAGATCATACAAAATCTGCACCAATAGGTTAATGAGTGTCACAGACTT-3’
3’-GGTAGACGGGTACTCGTAAAGTCATCCAGTTCAAGTTTACGTGAATCTTCTGTTCTAGTATGTTTTAGACGTGGTTATCCAATTACTCACAGTGTCTGAA-5’
chr 7: 94561880-94561936 chr 7: 94641872-94641917DpnII
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Figure r14 Characterization of the mouse B6-RPE07 cell line. A RT-PCR analysis. Tyr expression is 
detected in B16 mouse melanoma cells, but not in L929 fibroblasts, primary mouse RPE cultures at day 3, in 
B6-RPE07 and in sphere obtained for the latter. Mitf is strongly expressed in B16 cells and weakly in all other 
tested cells using primers detecting all Mitf isoforms. The formation of spheres increases Mitf expression. 
Rpe65 cannot be detected in all tested cells. Zeb1 is strongly expressed in primary RPE at day 3 of culture, in 
B6-RPE07 cells and in spheres. Otx2 is only detected in primary RPE cells. B Morphology of primary mouse 
RPE cultures. C Morphology of the B6-RPE07 cell lines. D Spheres obtained by culturing B6-RPE07 cells in 
non-adherent plates. 
 
4.3 Chromosomal inactivation of the mouse Tyr boundaries 
 
In the previous sections the two identified boundaries in the mouse Tyr locus 
were studied using two different systems. First, the putative insulators were 
challenged using an artificial locus composed by a heterologous enhancer and 
promoter, linked to a reporter gene and aimed to assess the effect of the 
boundary in interfering the enhancer-promoter interaction, in cultured cells and in 
zebrafish embryos. Then, by Chromosome Conformation Capture (3C), the Tyr 
boundaries were analysed from the structural point of view, in their natural 
chromosomal context, in vitro, using cellular models mimicking an active (B16 cell 
line) and inactive (NIH 3T3 - L929 cell line) Tyr expression unit. By performing the 
3C study, we gained insight into the importance of the interaction of boundaries 
and other cis-acting elements with respect of the Tyr promoter. However, this 
approach is still an approximation, considering that stable cell lines are only a 
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‘’snapshot’’ of the real biological complexity, made of different tissues, cell types 
and developmental stages. To investigate the function and structure of the Tyr 
locus in a higher complexity, it is necessary to produce genetically modified mice 
harbouring the targeted inactivation of the two Tyr boundaries. Only with these 
animal models, the mechanisms that regulate the activity of Nox4, Tyr and Grm5 
– and the role of Tyr boundaries – can be fully described. In the next paragraphs, 
the generation of transgenic mouse lines bearing the inactivation of the Tyr 5’ and 
Tyr 3’ boundaries using targeting nucleases is presented. !
 
4.3.1 Transcription Activator-Like Effector Nucleases (TALENs) 
 
 
First, we used targeted nucleases (1.3.5) to achieve the chromosomal 
inactivation of the desired cis-acting elements in mice. We first focused on 
TALEN nucleases, introduced in section 1.3.5.2. Two TALEN series flanking the 
Tyr 3’ and 5’ boundaries were designed (Table r1) as described in section 3.5 
using TALEN Targeter online tool (Doyle et al., 2012) and assembled by Golden 
Gate Cloning (3.1.9). Each TALEN DNA-binding array was cloned into two 
different series of expression vectors. The first series of TALEN vectors are 
based on homodimeric FokI nuclease domain. The second series of TALEN 
vectors are based on an improved obligate heterodimeric FokI domain (Guo et al. 
2010; Doyon et al. 2011) (section 3.1.4).  Figure r15 illustrates the chromosomal 
position of the twelve TALEN pairs assembled for this study. Six TALEN pairs 
were assembled in our laboratory for the inactivation of the Tyr 5’ boundary 
(Figure r15 A). Because of the presence of a large LINE1 repeat, the G-box 
element of the Tyr 5’ boundary could not be targeted using TALENs. Another six 
pairs of TALENs were produced for the chromosomal inactivation of the Tyr 3’ 
boundary (Figure r15 B). 
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Figure r15 TALENs assembled in this study. A Six TALEN pairs were designed to target the Tyr 5’ 
boundary. B Similarly, six TALENs were design to inactivate the Tyr 3’ boundary. TALEN target sites are 
indicated as purple triangles. Core elements of each insulator are indicated as red boxes.!!
Table r1: TALEN target and spacer sequences. Left and right target sequence, and spacer sequences are 
provided for the TALENs generated in this work.!
TALEN 
ID 
 target sequence spacer target sequence 
5' 0 TACTATCTTTCACTGAATTGC   TCATGTTGCTTCCTGACCCTTGG AGATGTCTGAATTGGAGGAG 
5' 1 TATTTTCTTACCACCCACCC  TGTGTTATTGTGCTT AAGGCTTTAGAGGAATATGA 
5' 2 TCTTCATTCAGTAGACCAAAG  AAATGCATATTTTGTGTTTTTAT TTTCCCAAGAATTAAGTGTGA 
5' 3 TAAACAAGCCACATTCC GCTTTGTAGAAGTTC ACAATCTGAATAGGAATATAA 
5' 4 TGGAACACAGACATCACTGTC  TTGACAAAGTCAGCTGGC AGGAACTATGACCTTGGAGA 
5' 5 TACCCAAAATTTAAATCTAAC   AGAGGATTGATGAGTCATTT AGTCTAGAAAATCTGTAATAA 
3' 1 TGAACACATTAACTAAAAAAA  GCAGTTTTTTTTTTAAATT TTCAACTTGATCTTGAATGTA 
3' 2 TGATTTGCAATTGCCATTACC  AAAAATTTTTATTTTC TTGTGGTTATAATTTGTTTAA 
3' 3 TGCCATTACCAAAAATTTTTA   TTTTCTTGTGGTTATAATTTGTT TAAATCAATCTGGATTTAAGA 
3' 4 TTAAAGTATCTATGCATCTCT ACAGCTGATGGTAAA AAAGAATGTTCGAATGAAAA 
3' 5 TTCTTTTCACAACACTGTCAT  ACCATCTGTAATGAGCATTTC AGTAGGTCAAGTTCAAATGC 
3' 6 TACATTCTTCATCCACATTAT  CTGCTTTGTGTCAAA ATGGGGTCATGAGTACATG  !
 
4.3.2 Deleting Tyr boundaries in vitro with TALENs 
We performed the in vitro cleavage assay (adapted from Jinek et al. 2011, 
section 3.5.3) to validate the activity of each of the assembled TALENs. Two 
plasmids encoding the two monomers of each TALEN pair were transfected in 
HEK 293 cells. Cells were then lysed and protein extracts were used to digest a 
PCR product containing the target site of each nuclease. With this assay, we 
aimed to verify that each individual TALEN had been assembled correctly and 
that was able to cleave the corresponding target site. As shown in Figure r16, all 
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six TALEN pairs of the Tyr 5’ series are able to cleave the respective target 
sequence, with exception of the Tyr 5’3 TALEN. Notably, the cleavage is more 
efficient when obligate-heterodimeric vectors (FokIELD/KKR mutant) were used. For 
this reason, obligate-heterodimeric vector series were used systematically in the 
following experiments.  
 
Figure r16 In vitro cleavage assay of the Tyr 5’ TALENs. A Position of the TALEN target sites across the 
Tyr 5’ sequence. The A, B and G boxes (Giraldo et al. 2003) are indicated as black boxes. TALENs binding 
sites are indicated as red triangles B Protein extracts of cells transfected with each TALENs pair were 
incubated with a PCR product containing the corresponding target sequence. Each TALE array was cloned 
and tested in the homodimeric FokI vector and in its heterodimeric derivatives, the mutants FokIELD/KKR. 
The same in vitro cleavage assay was performed with the Tyr 3’ series, in order 
to validate that TALENs were correctly assembled, and that the resulting artificial 
protein is able to recognize and cut its target sequence. 
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Figure r17  In vitro cleavage assay of the Tyr TALENs. A Position of the TALEN target sites across the 
Tyr 3’ sequence. The core sequence is indicated as black box. TALENs binding sites are indicated as red 
triangles B Protein extracts of cells transfected with each TALENs pair were incubated with a PCR product 
containing the corresponding target sequence.  Cleavage products are analysed by agarose gel electrophoresis. 
Each TALE array was cloned and tested in the homodimeri FokI vector and in its heterodimeric derivatives, 
the mutants ELD and KKR. 
TALENs 3’3, 3’5 and 3’6 showed the highest cleavage activity. On the contrary, 
TALEN 3’1 showed no detectable cleavage. TALEN Tyr 3’2 displayed 
intermediate cleavage activity. Also in this case, obligate-heterodimeric FokI 
vectors performed better and were chosen for the next experiments (Figure r17). !
After the validation of individual TALENs using the in vitro cleavage assay, we 
next tested whether we could delete the intervening DNA by co-transfecting two 
TALEN pairs targeting distal sites flanking each of the two Tyr boundaries. To this 
end, we transfected different combinations of TALEN pairs to mouse Neuro2A 
cells (Olmsted et al. 1970) that we can transfect with good efficiency.  
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r2 Figure r18 Transfection of TALEN sets in mouse N2A cells. A Position of the different TALEN pairs 
combinations transfected in Neuro2A cells. TALENs binding sites are indicated as red triangles B PCR 
analysis indicating that no detectable chromosomal deletions are produced in mouse Neuro2A cells. C Size of 
the expected bands in case that deletions are produced using the TALENs combination indicated. 
 Genomic DNA was collected 72 hours post-transfection and analysed by PCR. 
Surprisingly, none of the tested TALEN pair combinations resulted in a detectable 
chromosomal deletion (Figure r18). We speculated that the transfection 
efficiency we obtained in Neuro2A cells could be not as high as necessary. Either 
TALENs were not expressed at a sufficient level to trigger two simultaneous 
DSBs, or the number of cells in which the deletion occurred was below the PCR 
detection limit. We therefore decided to use another cell line, human HEK 293 
cells, that we can transfect with very high efficiency. Being HEK 293 a human-
derived cell line, we needed to co-transfect a plasmid carrying the full mouse Tyr 
boundaries sequences. For the Tyr 5’ deletion, we used the pHS6.1 plasmid 
(Gimenez et al. 2004), containing the complete sequence of the Tyr 5’ boundary, 
including target sites of all designed TALENs (Figure r19 A) along with Tyr 
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promoter and a Tyr minigene. With this approach, we could observe the expected 
deletion in six out of the nine TALEN combinations tested (Figure r19 B). 
 !
Figure r19 Expected deletions with episomal template (Tyr 5’) A Position of the different TALEN pairs 
combinations transfected in human HEK 293 cells carrying the pHS6.1 plasmid, containing the mouse Tyr 
LCR sequence. TALENs binding sites are indicated as red triangles B PCR analysis indicating that some of 
the expected deletions are produced, indicated by yellow marks. C Size of the expected bands. 
 
Similarly, we used HEK 293 cells to test in vitro which TALENs combinations 
would be the best to delete the Tyr 3’ boundary. We took advantage of the BAC 
PR24-276I14 (Figure r20 A), containing the Tyr locus previously used for the 3C 
assay. BAC DNA along with different combinations of TALEN pairs were co-
transfected in HEK 293 cells. Total DNA was analysed by PCR 72 hours post-
transfection. In this experiment, four out of the nine tested combinations 
successfully produced the expected deletion (Figure r19 B). Notably, the TALEN 
3’1, that was unable to cleave its target in the in vitro cleavage assay, also failed 
when combined with other TALENs, confirming the previous results. !
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Figure r20 Expected deletions with episomal template (Tyr 3’) A Position of the different TALEN pairs 
combinations transfected in human HEK 293 cells carrying the RP24-276I14 BAC, containing the mouse Tyr 
3’ sequence. TALENs binding sites are indicated as red triangles B PCR analysis indicating that some of the 
expected deletions are obtained, indicated by yellow marks. C Size of the expected bands. !
4.3.3 Deleting Tyr 5’ boundary in vivo with TALENs  
 !
As a result of the experiments in cultured cells, we selected two TALEN pairs to 
be used in combination for the chromosomal deletion of the Tyr 5’ boundary in 
mouse. We focused the TALEN set 5’0 + 5’5 that are, among the TALEN 
combinations successfully tested in cultured cells, the ones that enable the 
largest deletion (1230 bp) (Figure r21). The same vectors used for the 
transfection in cultured cells were used to produce TALENs mRNA (section 3.5) 
TALEN mRNA mix was delivered by cytoplasmic injection (Hermann et al. 2014) 
in mouse fertilized oocytes (C57BL/6J). These microinjection experiments were 
carried out in the laboratory of Dr. Pawel Pelczar, Institute of Laboratory Animal 
Science, University of Zürich, Switzerland. 
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Figure r21 Selected TALEN pairs for Tyr 5’ deletion in vivo. A The chromosomal position of each 
TALEN pair is indicated. A, B and G boxes are indicated as black boxes. TALENs binding sites are indicated 
as red triangles. B Genotyping strategy and sequence of the oligonucleotides used. 
 
Table r2 illustrates the result of the first microinjection session for the Tyr 5’ 
deletion, performed using a 40 ng/µl RNA solution containing 10 ng/µl of each 
TALEN monomer. 
 
Table r2 Results of TALENs 5’0+5’5 microinjection. 
TALEN 
concentration 
Injected Transferred Fosters Pups (Total - stillbirths) 
4 x 10 ng/µ l 150 97 (64%) 5 39-4 = 35  
 
Out of the 35 live pups obtained, we could not find any positive mice (Figure 
r22). 
 
!
Figure r22 Result of Tyr 5’ TALENs microinjection A The expected deletion induced by the TALENs 5’0 
and 5’5 will reduce the size of the amplified fragment to 215 bp.  B None of the analyzed mice showed the 
smaller 215 bp band, nor any other band. 
We next asked if at least one of the two nucleases reached its target site and 
induced any detectable mutations through the NHEJ repair pathway. The TAL 5’0 
Tyr Grm5Nox4
2150 bp
7\U·
BA
· ·
G
250 bp
wt
del
A
B LCRdelFw CAACCAGGCTTTCATCAGAAT
LCRdelRv TTTTCTCTGTATCATGATTGCCTA
B
A
BA
· ·
Tyr Grm5Nox4 Tyr 5’
G
1    2   3    4   5   6    7   8    9  10  11 12 13  14 15 16  17 18  19 20  21 22  23 24 25  26  27 28             29  30  31 32 33  34  35     wt  ntc                   M M M M
2150 pb (wt)
250 bp (deletion)
! 97 
spacer sequence contains a MwoI restriction site. If TAL 5’0 induced a DSB on its 
target site, the resulting indels would disrupt the MwoI restriction site. We 
therefore PCR amplified the TAL 5’0 region and digested the PCR with MwoI. As 
illustrated in Figure r23, of the 18 mice analysed, none showed the loss of the 
MwoI site, indicating no TALEN activity. 
!
Figure r23. Activity of the TALEN Tyr 5’0 in vivo.  A Indels produced by the TALEN 5’0 disrupts a MwoI 
restriction site located on the TALEN spacer sequence, resulting in the loss of the restriction site. B All PCRs 
from selected individuals of the TALENs microinjection can be digested by MwoI, suggesting that TALEN 
5’0 is not active in vivo at the tested concentration. A wild-type control is included in lane 1 (undigested) and 
2 (MwoI digested). !
The injection of 10 ng/µl of each TALEN mRNA did not produce any mutation in 
the resulting offspring. We considered increasing the RNA dose and therefore 
injected 50 ng/µl of each TALEN RNA species, 200 ng/µl of total RNA. Results of 
this second microinjection session are summarized in Table r3. 
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Table r3 Results of TALENs 5’0+5’5 microinjection/2 
TALEN 
concentration 
Injected Transferred Fosters Pups (Total - stillbirths) 
4 x 50 ng/µ l 205 125 (60%) 6 35  
 
Also from the 50 ng/µl microinjection series we could not obtain any founder 
carrying the desired deletion, as no band corresponding to a deleted allele could 
be observed by PCR (Figure r24). 
!
Figure r24 Result of Tyr 5’ TALENs second microinjection. A The expected deletion induced by the 
TALENs 5’0 and 5’5 will reduce the size of the amplified fragment to 215 bp.  B None of the analyzed mice 
showed the smaller 215 bp band, nor any other band. 
Similarly to what had been done for the 10 ng/ml injection series, we analysed 
the activity of the TAL 5’0. In the eight mice analysed, we could not detect any 
trace of TALEN activity (Figure r25). In conclusion, we could not obtain the Tyr 5’ 
deletion using neither of the two different concentrations of TALENs mRNA that 
we used. In addition, analyses of individual TALEN target sites showed no 
TALEN activity in all mice that we analysed. 
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Figure r25 T7 Endonuclease I assay for the TALEN Tyr 5’0. A Bands of the approximate size of 83 and 
475 bp are expected in case of activity of the TALEN 5’0. B Digestion of PCR using T7 Endonuclease I did 
not produced bands, indicating that TALEN 5’0 didn’t induced DSB at the targeted site. 
 
4.3.4 Deleting Tyr 3’ boundary in vivo with TALENs 
 
For the Tyr 3’ deletion in vivo we focused on the TALENs combination 3’3 + 3’5 
(Figure r26). This combination was successfully used to generate a 2570 bp 
deletion in cultured cells (Figure r20). 
!
Figure r26: Selected TALEN set for Tyr 3’ inactivation in vivo. A The chromosomal position of each 
TALEN pair is indicated. The Tyr 3’ core element, composed of a SINEB2 element and a CTCF-binding site, 
is indicated as a black box. TALENs binding sites are indicated as red triangles. B Genotyping strategy and 
sequence of the oligonucleotides used. 
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As done for the Tyr 5’ series, we performed two series of cytoplasmatic 
microinjection: using a 40 ng/µl RNA solution containing 10 ng/µl of each RNA 
species (table r4) and using a 200 ng/µl RNA solution containing 50 ng/µl of 
each RNA species (table r5). 
Table r4 Results of TALENs 3’3 + 3’5 microinjection  
TALEN 
concentration 
Injected Transferred Fosters Pups (Total - stillbirths) 
4 x 10 ng/µ l 135 80 (59%) 4 39-7 = 32  
 
Out of the 32 pups generated in this microinjection session, none carried the 
desired large chromosomal deletion. A second microinjection session was 
performed with a 5-fold more concentrated RNA solution. Results are 
summarized in the following table. 
Table r5 Results of TALENs 3’3 + 3’5 microinjection using 50ng/µ l of each TALEN mRNA 
TALEN 
concentration 
Injected Transferred Fosters Pups (Total - stillbirths) 
4 x 50 ng/µ l 117 70 (59%) 4 29-5 = 24  
 
No animals carrying the desired (and any other) deletions were obtained from this 
second microinjection session. !
4.3.5 CRISPRs  
 
When we began microinjecting the first combination of TALEN mRNA, the first 
proof-of-principle experiments of CRISPR/Cas9 mediated genome editing in mice 
were published (Shen et al. 2013; Wang et al. 2013). We hypothesized that the 
Tyr locus could be efficiently targeted using this new, apparently more powerful 
tool. According to the first published works (Jinek et al., 2013; Mali et al. 2013), 
CRISPR binding sites (5’-N(20)-NGG) were picked manually on repeat-masked 
regions flanking the Tyr 3’ and 5’ insulators. As done with TALENs, we designed 
nucleases targeting the A and B boxes, but not the G box. Targeting the G box 
would require the production of a large deletion including all the LINE1 element. A 
custom-made bowtie script (see section 3.6.1) was used to identify potential off-
targets sites and select the most specific CRISPR sites. 
In table r6 are reported the results of the bowtie analysis indicating the best 
CRISPR binding sites sequences (Figure r27): 
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Table r6 Selected CRISPR target sites for Tyr 3’ and 5’ deletion. The 20-mer target site is indicated for 
each region to target. The PAM motif, that is necessary to trigger the CRISPR/Cas9-mediated DNA cleavage 
is shown in green. Genomic coordinates of the selected CRISPR target sites are given, based on assembly 
NCBI37/mm9 (July 2007). 
 ID  target 5’-N(20)  PAM  chromosomal position 
CRISPR 3’3:  AGCTCAGTAGAGTACTAGGT AGG   chr7: + 94559177 
CRISPR 3’5:  ACAAACGCTAATTGGTAAAA TGG   chr7: + 94562048 
CRISPR 5’0:  GTGTGACAGTGCAAGATAAC AGG  chr7: + 94656546 
CRISPR 5’5:  GTGATAAAACTAGGCAATTT TGG  chr7: - 94657775 
 
 
!
Figure r27 Selected CRISPR sets for Tyr 5’ and 3’ inactivation. A Chromosomal position of CRISPR 
target sites to be used for the deletion of Tyr 5’ boundary. Contemporary cleavage of CRISPR 5’0 and 5’5 
will result in a 1.2 kb deletion. B Chromosomal position of CRISPR target sites to be used for the deletion of 
Tyr 3’ boundary. Contemporary activity of CRISPR 3’3 and 3’5 will produce a 2.9 kb deletion. 
These CRISPR binding sites were further analysed using the CRISPR design tool 
developed by the Feng Zhang laboratory (crispr.mit.edu). This tool assigns a 
score to each predicted off-target, ranging from 0.1 to 100, taking in consideration 
the number and the position of mismatches with the desired target sequence. 
The higher the score, the higher the probability that the off-target might be 
targeted by the CRISPR in study. This second search confirmed the good quality 
of the selected CRISPR sites (the complete list of predicted off-target sites can be 
found in the Appendix 9.2). 
 
4.3.6 Deleting Tyr boundaries in vitro with CRISPRs 
 
Four sgRNA (small guide RNA) expression vectors needed to transcribe the 
small RNA molecule homologous to the targeted sites (described in section 3.1.5) 
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were produced for each of the selected CRISPR targets, as described in section 
3.1.11, by Golden Gate Cloning (3.1.9).  
Mouse Neuro2A cells were transfected with each sgRNA pair, along with a Cas9 
expression vector, as described in section 3.6.4. The presence of the expected 
deletion was tested by PCR 72 hours post-transfection using primers mapping 
outside the targeted sequences. Indeed, the co-transfection of Cas9 and two 
different sgRNA, mapping on distal sequences on the same chromosome, 
produced the deletion of the intervening DNA, (Figure r28 and r29). Hence, 
using CRISPRs, but not TALENs, we could successfully delete the Tyr 5’ and the 
Tyr 3’ boundaries in the genome of mouse Neuro2A cells.  !
 
Figure r28: Targeted deletion in mouse Neuro2A cells with CRISPR/Cas9 (Tyr 5’). A Position of the 
CRISPR target sites (indicated as red triangles) on the mouse Tyr 5’ sequence. Simultaneous cuts at both 
target sequence results ina 1.2 kb large deletion. Only when both sgRNA expression vectors are co-
transfected alogn with a Cas9 expression vector, the expected deletion occurs. !
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Figure r29: Targeted deletion in mouse Neuro2A with CRISPR/Cas9 (Tyr 3’). A Simoultaneous cuts 
would induce the deletion of the 2.8kb intervening sequence. B A 420 bp band corresponding to the targeted 
deletion of the mouse Tyr 3’ insulator is observed only when both sgRNA expression vectors and Cas9 
expression vector are transfected.!
4.3.7 Deleting Tyr 5’ boundary in vivo with CRISPRs 
 
After in vitro validation, we adapted the CRISPR expression vectors for the 
delivery into mouse fertilized eggs. By PCR, we added the T7 RNA polymerase 
promoter sequence 5’ to the Cas9 ORF and produced 5’ capped, 3’ poly A-tailed 
mRNA (see section 3.6.4 for a detailed protocol). Similarly, by PCR we obtained 
a 120 bp DNA fragment composed of 100 bp of target-specific sgRNA preceded 
by the T7 promoter sequence. sgRNA PCR products were used for RNA in vitro 
transcription without capping and polyA tailing. The first microinjections were 
performed using 20 ng/µl Cas9 mRNA and 10 ng/µl of each of the two sgRNA 
(sgRNA 5’0 and sgRNA 5’5). Table r7 illustrates the results of the first three 
3283bp
420bp
Ca
s9 
+ s
gR
NA
 3’3
Ca
s9 
+ s
gR
NA
 3’5
Ca
s9 
+ s
gR
NA
 3’3
 
    
    
  +
 sg
RN
A 3
’5
B
A Tyr Grm5Nox4 7\U·
7\U·FRUH
· ·
M
3283bp
 104 
microinjection sessions performed in the laboratory of Pawel Pelczar, University 
of Zurich, Switzerland performed on B6D2F1 genetic background. 
Table!r7 Results of CRISPR 5’0 + 5’5 microinjection 
RNA 
concentration 
Injected Transferred Fosters Pups (Total - stillbirths) 
20 ng/µ l + 2 x 10 
ng/µ l 
120 62 (51%) 3 20  
20 ng/µ l + 2 x 10 
ng/µ l 
120 60 (50%) 3 13  
20 ng/µ l + 2 x 10 
ng/µ l 
135 84 (70%) 3 10  
TOTAL 510 290 (56%) 9 43  
A total of 43 pups were obtained and genotyped by PCR. A 2150 bp band is 
expected for wild-type animals, whereas a 950 bp is expected if the deletion is 
produced correctly. None of the analysed mice showed the 950 bp band 
corresponding to the expected deletion, although animal #40 showed a smaller 
PCR product, probably indicating a partial deletion (Figure r30) 
!
Figure r30 Genotyping of animal obtained from CRISPR 5’0 + 5’5 microinjection. A A 2150 bp band is 
expected from the full Tyr 5’ amplification. Upon CRISPR/Cas9-mediated deletion, a smaller 950 bp band is 
produced. B Genotyping by PCR. N2a cells transfected with CRISPR/Cas9 plasmids are used as positive 
control. Untransfected N2a cells and DNA from a wild-type mouse were used as negative, wild-type control.  
None of the analysed mice showed the expected deletion pattern. Mouse #40 showed a smaller band, 
probably indicating a small, partial deletion derived by cellular exonuclease activity following the CRISPR-
induced DSB. 
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The partial deletion was confirmed by cloning and Sanger sequencing (Figure 
r31): 202 bp of genomic DNA were deleted in mouse #40. 
!
Figure r31 Characterization of animal TYRINS5 #40. A sgRNA position with respect of the Tyr locus and 
the Tyr 5’ element. B A 202 bp deletion was confirmed by Sanger Sequencing, starting from 4 bp upstream 
the PAM of the CRISPR 5’0 binding site. The finding was confirmed in 4 independent clones. C 
Surprisingly, footprint of CRISPR activity was found, on the same allele, in correspondence of the CRISPR 
 106 
5’5 binding site. Sequencing of two independent clones showed a 9 bp deletion. D The indels at the CRISPR 
5’5 site were also confirmed by T7 Endonuclease I assay. 
The observation of the partial deletion in animal #40 represents the first proof of 
activity of targeted nucleases in vivo, in this work. In animal TYRINS5#40, the Tyr 
5’ boundary sequence was targeted by both CRISPRs on the same allele, but 
unfortunately, not simultaneously.  
We proceeded with a second series of microinjections, using a higher 
concentration of RNA. The Cas9 mRNA was raised up to 25 ng/µl, and the 
sgRNA was increased from 10 ng/µl to 45 ng/µl. 
 
RNA 
concentration 
Injected Transferred Fosters Pups (Total - stillbirths) 
25 ng/µ l + 2 x 45 
ng/µ l 
239 104 (43%) 4 12  
25 ng/µ l + 2 x 45 
ng/µ l 
162 88 (54%) 4 28 
 
 
TOTAL 401 192 (47%) 8 40  
Table!r8!Results of CRISPR 5’0 + 5’5 microinjection/2 
 
We obtained a total of 40 animals. By PCR, we concluded that none of them 
carried the desired deletion. Analysis of individual nuclease activity, by T7 
Endonuclease I assay at the CRISPR 5’0 and 5’5 site, showed no nuclease 
activity (Figure r32 and r33). Considering that we could indeed detect nuclease 
activity for both CRISPRs 5’0 and 5’5 in the previous injection series (Figure 
r31), we concluded that a technical problem could have occurred in this second 
injection series. 
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Figure r32 T7 Endonuclease I assay. A Position of the CRISPR target sites with respect of the Tyr locus. B 
A 505 bp sequence centred on the sgRNA 5’0 site was PCR-amplified using the oligonucleotides. The region 
surrounding the CRISPR 5’5 binding site was PCR amplified with the oligonucleotides T7EILCR123Fw and 
T7EILCR123Rv. In indels are present at the sgRNA 5’0 site, the T7 Endonuclease I digestion will produce a 
328 bp and 177 bp bands. C We could not detect any indel in all tested individuals. D Similarly, a 689 bp 
region corresponding to the CRISPR 5’5 site was PCR amplified with the oligonucleotides  67Fw and 
LCRdelRv. A 405 bp and 284 bp bands are expected when indels are present at the expected position. E All 
tested animals are negative also for the T7 Endonuclease I assay for the sgRNA 5’5 site. 
According to the results reported in the latest publications (Wang et al. 2013; 
Yang et al. 2013), we decided to increase the concentration of the RNA mix (50 
ng/µl Cas9 mRNA and 90 ng/µl of each sgRNA; 35 ng/µl Cas9 mRNA and 60 
ng/µl of each sgRNAs). These microinjection experiments were performed in 
Madrid at the CNB-CBMSO Transgenic facility in pigmented B6.CBA genetic 
background  
Table!r9 Results of CRISPR 5’0 + 5’5 microinjection/3 
RNA 
concentration 
Injected Transferred Fosters Pups (Total - stillbirths) 
50 ng/µ l + 2 x 90 
ng/µ l 
88 32 (36%) 2 5  
50 ng/µ l + 2 x 90 
ng/µ l 
137 67 (48%) 5 28  
35ng/µ l + 2 x 60 
ng/µ l 
163 86 (52%) 5 31  
TOTAL 388 185 (47%) 12 64  
!
Finally, animals carrying the desired deletion were obtained in the first 
microinjection session using 50 ng/µl Cas9 mRNA and 90 ng/µl of each sgRNAs 
(Figure r33). Partial deletions were also obtained. 
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Figure r33 Successful deletion using higher RNA concentration. A Position of the CRISPR target sites 
with respect of the Tyr locus. B Genotyping of the five individuals obtained from the microinjection session 
using 50 ng/µl Cas9 along with 90 ng/µl of each sgRNA. Animal 3 shows a band of about 900 bp, compatible 
with the expected deletion. Animal 5 and 2 show bands suggesting that partial, smaller deletions occurred. 
Animals 1 and 4 do not show additional bands.  
By cloning-sequencing we confirmed the full deletion of individual #3 (Figure 
r34). This animal carries a 1274 bp deletion including the A and B boxes of the 
Tyr LCR. The breakpoint is observed between 81 bp upstream the sgRNA 5’0 
site (Figure R34 A) and the sgRNA 5’5 site, with an insertion of 76 bp (Figure 
R34 B and C) that does not match with any genomic sequence associated with 
the mouse Tyr locus. 
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Figure r34 Sequence characterization of animal TYRINS5 #3. A Position of the CRISPR target sites with 
respect of the Tyr locus. B Sequence alignment of the deletion break-point at the sgRNA 5’0 site. Four 
independent clones were sequenced and aligned with the reference genome (NCBI37/mm9). The deletion 
spanned some 1274 bp including 81 bp upstream to the sgRNA 5’0 target site. sgRNA binding site is shown 
in bold, PAM motif in red. C Alignment of the deletion break-point at the sgRNA 5’5 site. The nuclease cut 
happened exactly downstream the PAM motif (in red) and resulted in a 76 bp insertion (shown in blue). D 
The chromatogram of the region is given. The region 5’ upstream the deletion is highlighted in red, the 
inserted nucleotides are shown in blue. The 3’ break-point sequence is shown in red 
From the second microinjection session using 50 ng/µl Cas9 mRNA and 90 ng/µl 
of each sgRNA we obtained 28 live pups. In nine of these individuals deletions 
were detected at the targeted site (Figure r35). Of these, six individuals carry the 
full 1250 bp deletion of the Tyr 5’ boundary element (#6; #11; #18; #20; #21 and 
#30). In the founder #18, in addition to the band corresponding to the full deletion, 
we could observe a second larger band. This band represents a second, smaller 
deletion present in this individual. Nevertheless, we could not detect such allele 
when cloning and sequencing a PCR product obtained from the founder. Indeed, 
we could sequence it when the allele segregated in the F1 generation. Two 
individuals carry partial deletions (#8 and  #16). Interestingly, one individual 
carries a deletion larger than expected (#13). 
From the third microinjection session (performed using 35 ng/µl Cas9 mRNA and 
60 ng/µl of each sgRNA) we obtained 31 animals, of which seven carry deletions 
in the targeted sequence. Five individuals carry a deletion of the expected size 
and two animals carry a slightly bigger deletion.  
A summary of the results obtained, including schematic and sequencing of all the 
deletions generated is shown in Figure r36. 
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Figure r35 Successful deletion using higher RNA concentration/2. A Position of the CRISPR target sites 
with respect of the Tyr locus. B Genotyping of the offspring of the second microinjection session using 
50ng/µl Cas9 along with 90 ng/µl of each sgRNA. Nine out of 28 individuals carry deletions of various sizes. 
Six individuals carry a deletion compatible with the expected size. In three individuals, smaller deletion could 
be observed. Individual #13 show a smaller band suggesting that a larger deletion may have occurred. 
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Figure r36 Founder individuals of the TYRINS5 line. A Position of the CRISPR target sites with respect 
of the Tyr locus. The DpnII fragment interacting with the Tyr promoter (in the 3C assay) is highlighted. The 
position of A, B and G boxes is indicated along with a basic restriction map. B Position and dimension of the 
deletion for each positive individual obtained. The deleted DNA region is indicated as black box. Fourteen 
animals show a deletion the closely approximate the expected size. One individual carries a smaller, 700 bp 
deletion centred on the A and B boxes. One animal shows a larger deletion produced by loss of DNA 3’ to the 
sgRNA 5’0 site. C Sequence alignment of two independent clones per individual. sgRNA binding sites are 
shown in bold, PAM motif in red. Inserted bases are shown in blue. Alignments refer to the NCBI37/mm9 
mouse genome assembly. 
reference: CAAGAATTAAGTGTGACAGTGCAAGATAACAGGAAAATAA.......//...........CTCTAGGCCAAAATTGCCTAGTTTTATCACTACAAAACTT
TYRINS5#3_1: -------------------------------------------(del 1294bp)---------------AAATTGCCTAGTTTTATCACCTATAGTGTT
TYRINS5#3_2: -------------------------------------------(del 1294bp)---------------AAATTGCCTAGTTTTATCACCTATAGTGTT
TYRINS5#6_1: CAAGAATTAAGTGT-----------------------------(del 1212bp)---------------------------------ACTACAAAACTT
TYRINS5#6_2: CAAGAATTAAGTGTGACAGTGCAAGAAGTTTTGC---------(del 1151bp)---------------AAACACTTGCCTAGTTTTATCACTACAAAA
TYRINS5#8_1: CAAGAATTAAGTGTGACAGTGCAAGGTCGA-------------(del  728bp).....CTCTAGGCCAAAAGTTTATCACTTAATTGCCTAGTTTTAT
TYRINS5#8_2: CAAGAATTAAGTGTGACAGTGCAAGGTCGA-------------(del  728bp).....CTCTAGGCCAAAAG------------TTGCCTAGTTTTAT
TYRINS5#11_1: CAAGAATTAAGTGTGACAGTGCAAGATG---------------(del 1196bp)------------------TTGCCTAGTTTTATCACTACAAAACTT
TYRINS5#11_2: CAAGAATTAAGTGTGACAGTGCAAGATG---------------(del 1196bp)------------------TTGCCTAGTTTTATCACTACAAAACTT
TYRINS5#13_1: -------------------------------------------(del 1783bp)---------------------CCTAGTTTTATCACTACAAAACTT
TYRINS5#13_2: -------------------------------------------(del 1783bp)---------------------CCTAGTTTTATCACTACAAAACTT
TYRINS5#18a1: CAAGAATTAAGTGTGACAGTGCAAGAT----------------(del 1196bp)------------------TTGCCTAGTTTTATCACTACAAAACTT
TYRINS5#18a2: CAAGAATTAAGTGTGACAGTGCAAGAT----------------(del 1196bp)------------------TTGCCTAGTTTTATCACTACAAAACTT
TYRINS5#18b1: -------------------------------------------(del  784bp).....CTCTAGGCCAAAATTGCCTAGTTTTATCACTACAAAACTT
TYRINS5#20_1: CAAGAATTAAGTGTGACAGTG----------------------(del 1268bp)---------------------------------------------
TYRINS5#20_2: CAAGAATTAAGTGTGACAGTG----------------------(del 1268bp)---------------------------------------------
TYRINS5#21_1: CAAGAATTAAGTGTGACAGTGC---------------------(del 1205bp)----------------------CTAGTTTTATCACTACAAAACTT
TYRINS5#21_2: CAAGAATTAAGTGTGACAGTGC---------------------(del 1205bp)----------------------CTAGTTTTATCACTACAAAACTT
TYRINS5#30_1: CAAGAATTAAGTGTGACAGTGCAAGA-----------------(del 1201bp)----------------------CTAGTTTTATCACTACAAAACTT
TYRINS5#30_2: CAAGAATTAAGTGTGACAGTCCAAGA-----------------(del 1201bp)----------------------CTAGTTTTATCACTACAAAACTT
TYRINS5#35_1: CAAGAATTAAGTGTGACAGTGC---------------------(del 1205bp)----------------------CTAGTTTTATCACTACAAAACTT
TYRINS5#48_1: CAAGAATTAAGTGTGACAGTGCAAGAT----------------(del 1196bp)------------------TTGCCTAGTTTTATCACTACAAAACTT
TYRINS5#48_2: CAAGAATTAAGTGTGACAGTGCAAGAT----------------(del 1196bp)------------------TTGCCTAGTTTTATCACTACAAAACTT
TYRINS5#50_1: CAAGAATTAAGTGTGACAGTGCAAGATATTTAG----------(del 1097bp).....CTCTAGGCCAAAATTGCCTAGTTTTATCACTACAAAACTT
TYRINS5#50_2: CAAGAATTAAGTGTGACAGTGCAAGATATTTAG----------(del 1097bp).....CTCTAGGCCAAAATTGCCTAGTTTTATCACTACAAAACTT
TYRINS5#53_1: CAAGAATTAAGTGTGACAGTGCAAGAT----------------(del 1196bp)------------------TTGCCTAGTTTTATCACTACAAAACTT
TYRINS5#53_2: CAAGAATTAAGTGTGACAGTGCAAGAT----------------(del 1196bp)------------------TTGCCTAGTTTTATCACTACAAAACTT
TYRINS5#57_1: -------------------------------------------(del 1437bp)--------------------------TTTTATCACTACAAAACTT
TYRINS5#57_2: -------------------------------------------(del 1437bp)--------------------------TTTTATCACTACAAAACTT
TYRINS5#60_1: -------------------------------------------(del 1297bp)-----------------ATTGCCTAGTTTTATCACTACAAAACTT
TYRINS5#60_2: -------------------------------------------(del 1297bp)-----------------ATTGCCTAGTTTTATCACTACAAAACTT
TYRINS5#62_1: CAAGAATTAAGTGTGACAGTGCAAG------------------(del 1416bp)---------------------------------------------
TYRINS5#62_2: CAAGAATTAAGTGTGACAGTGCAAG------------------(del 1416bp)---------------------------------------------
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In summary, using the CRISPR/Cas9 system to target the Tyr 5’, we produced a 
battery of 14 individual carrying a deletion approximately of the expected size, 
plus one individual carrying a smaller deletion (which removes the AB boxes plus 
additional flanking sequences) and another carrying a larger deletion. Another 
two animals bear smaller deletions, in the range of 100-200 bp, resulting from the 
nuclease activity of only one of the two nucleases. The most interesting alleles 
are found in founder #13, that bears the largest deletion, in animals #8, carrying a 
0.7 kb deletion centred the AB boxes, and in animal #18. In addition to the full 
deletion, this founder bears on the other allele a 0.7 kb deletion, inactivating the 
AB box and other sequences 3’ upstream. The comparison of the phenotype 
obtained in these distinct lines will help to narrow the size of the functional Tyr 5’ 
core sequence. 
Careful sequencing of the deleted alleles indicated that each line 
represents an independent event of DNA break and repair, with differences in the 
range of single bases to tens and hundreds of bases. This reflects the error-
prone repair mechanism at the base of this technique, the non-homologous end-
joining repair pathway (Barnes et al. 2001). Interestingly, the same break-point 
sequence is found in animal #18, 48 and 53. 
 
4.3.8 Inverting Tyr 5’ boundary in vivo with CRISPRs 
 
Next, we asked if, in addition to the desired mutation, we have been able 
to induce also the inversion of the DNA sequences included between the two 
sgRNA sites, being this a possible resolution of two distal DSBs, as published by 
Xiao and colleagues (Xiao et al. 2013). By PCR, using a forward oligonucleotide 
mapping outside the targeted region, in combination with a second forward 
oligonucleotide mapping inside the targeted region, we could detect specific 
inversion of the targeted sequence in seven individuals (Figure r37). 
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Figure r37: Chromosomal inversion of the Tyr 5’ fragment. A Position of the CRISPR target sites with 
respect of the Tyr locus. B PCR strategy used to detect inversions: two oligonucleotides are used, LCRdelFw 
and 67_Fw both mapping on the same DNA strand. Only upon inversion of the DNA fragment flanked by the 
two CRISPR sites, the two oligonucleotides indicated yield a 1070 bp product. C Five individuals are positive 
for the inversion of the sequence flanked by the two sgRNA sites. Notably, individual #30 also carries a 
chromosomal deletion of the very same sequence, on the other allele. D Sequence alignment of two 
independent clone obtained from the animals in C. As observed for the deletions, also each inversion event is 
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reference:  TCCCAAGAATTAAGTGTGACAGTGCAAGAT****TTTTGGCCTAGAGCTTTGCAGTGATGATTA
TYRINS5#19_1: TCCCAAGAATTAAGTGTGACAG-----(+120-8)--TGGCCTAGAGCTTTGCAGTGATGATTA
TYRINS5#19_2: TCCCAAGAATTAAGTGTGACAG-----(+120-8)--TGGCCTAGAGCTTTGCAGTGATGATTA
TYRINS5#23_1: TCCCAAGAATTAAGTGTGACAGTGCAAGA(+6-2)TTTGGCCTAGAGCTTTGCAGTGATGATTA
TYRINS5#23_2 TCCCAAGAATTAAGTGTGACAGTGCAAGA(+6-2)TTTGGCCTAGAGCTTTGCAGTGATGATTA
TYRINS5#27_1: TCCCAAGAATTAAGTGTGACAGTGCAAGAT****TTTTGGCCTAGAGCTTTGCAGTGATGATTA
TYRINS5#27_2: TCCCAAGAATTAAGTGTGACAGTGCAAGAT****TTTTGGCCTAGAGCTTTGCAGTGATGATTA
TYRINS5#30_1: TCCCAAGAATTAAGTGTGACAGTGCAAGAT(+5)TTTTGGCCTAGAGCTTTGCAGTGATGATTA
TYRINS5#30_2: TCCCAAGAATTAAGTGTGACAGTGCAAGAT(+5)TTTTGGCCTAGAGCTTTGCAGTGATGATTA
TYRINS5#31_3: TCCCAAGAATTAAGTGTGACAGTGCAAGA-****------------GCTTTGCAGTGATGATTA
TYRINS5#41_1: TCCCAAGAATTAAGTGTGATA---------****TTTTGGCCTAGAGCTTTGCAGTGATGATTA
TYRINS5#41_1: TCCCAAGAATTAAGTGTGATA---------****TTTTGGCCTAGAGCTTTGCAGTGATGATTA
VJ51$· VJ51$·
A
 1   2    3   4    5    6   7    8   9   10  11 12  13 14  15 16  17  18 19  20  21  22  23 24
 25  26  27 28 29  30 31 32  33        -    +    /
C
Tyr Grm5Nox4
A
Tyr 5’
B 67_Fw
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unique.! Inversion!break0point! is! found!in!the!close!proximity!of!the!sgRNA!site!(in!bold,!PAM!motif! in!red),!and!insertion!(in!blue)!and!small!deletions!are!frequently!found. 
4.3.9 Assessing overall mutagenesis rate 
 
In order to evaluate the overall mutagenesis rate of each single sgRNA, we 
performed T7 Endonuclease I assay of all the 64 individuals obtained in the 
microinjection session performed using the two highest RNA concentrations, 
indicated in Table r9. These data are useful to estimate the overall mutagenesis 
efficiency of the CRISPR/Cas9 system and also to evaluate the frequency of 
double-positives in relation with the number of large deletion produced. Figure 
r38 and r39 show the result of the T7 Endonuclease assay directed of the 
sequences flanking the sgRNA 5’0 and 5’5.  
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Figure r38 T7 endonuclease I assay of CRISPR 5’5. A Position of the CRISPR target sites with respect of 
the Tyr locus. A 689 bp sequence centred on the sgRNA 5’5 site was PCR amplified using the 
oligonucleotides 67Fw and LCRdelRv and subjected to T7 Endonuclease I digestion. B 66% of the animals 
analysed showed indels at the CRISPR 5’5 target site. The intensity of the digested bands might indicate the 
degree of moisaicism of the animal. Samples are scored as positive are indicated with a star.  
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Figure!r39!T7 endonuclease I assay of CRISPR 5’0. A Position of the CRISPR target sites with respect of 
the Tyr locus. A 897 bp sequence centred on the sgRNA 5’0 site was PCR amplified and subjected to T7 
Endonuclease I digestion. B 50% of the animals analysed showed indels at the CRISPR 5’0 target site. The 
intensity of the digested bands might indicate the degree of moisaicism of the animal. Samples are scored as 
positive are indicated with a star. 
 
B
1*     2*     3      4*     5*    6*     7      8      9*    10   11    12*             wt
* * * * * * *
13*   14*  15*   16   17*   19*   21*  22    23   24*
25*   26*  27*   28*   29     30   31   32*   33           wt
34   35  36*   37  38   39   40 41*  42* 43* 44* 45* 46* 47*   48  49  50*
51   52*   53  54  55  56*  57   58 59*  60* 61   62  63   64         wt 
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The table below summarises the results obtained in vivo, in transgenic mice, with 
all the tested RNA concentrations. 
 
Table!r10:!Overall!mutagenesis!rate!
!
Considering the last two microinjection sessions we obtained an overall deletion 
frequency of 18%. If we refer only to the most successful condition, using 50 ng/ul 
of Cas9 mRNA, this frequency reaches the 33%. Inversions are obtained with a 
frequency of 11%. Frequencies of deletion, inversion and individual targeting to 
each of the two sgRNA sites are dose dependent. Notably, 86% of the animals 
carry at least a mutation. Of a total of 64 animals, we could only find nine mice 
that do not carry any mutation. 
 
4.3.10 Deleting Tyr 3’ boundary in vivo with CRISPRs 
 
As done for the Tyr 5’ boundary, Tyr 3’ CRISPR sgRNAs were prepared for 
microinjection in mouse fertilized eggs (B6D2F1 background). A first 
microinjection session was performed with 20 ng/µl Cas9 mRNA along with 10 
ng/µl of the sgRNAs 3’3 and 3’5. 
 
Table!r11!Results of CRISPR 3’3 + 3’5 microinjection 
RNA 
concentration 
Injected Transferred Fosters Pups (Total - stillbirths) 
20 ng/µ l + 2 x 10 
ng/µ l 
130 72 (55%) 4 14  
20 ng/µ l + 2 x 10 
ng/µ l 
140 72 (51%) 4 18  
TOTAL 270 144 (53%) 8 32  
 
We genotyped the 32 animals generated from this microinjection series and we 
could not detect any animal carrying the desired deletion (Figure r40).  
RNA 
concentration
positive for 
deletion
positive for 
inversion
positive for 
T7EI 5’0
positive for 
T7EI 5’5
20 ng/+l Cas9
10 ng/+l sgRNA 1 (2%) na
* taking in account only the last two microinjection sessions
1 (2%)1 (2%)
25 ng/+l Cas9
45 ng/+l sgRNA 0 na0 0
35 ng/+l Cas9
60 ng/+l sgRNA
50 ng/+l Cas9
90 ng/+l sgRNA
7 (20%) 2 (6.5%)
11 (33%) 5 (15%)19 (57%) 25 (75%)
17 (60%)13 (41%)
any 
mutation
24 (77%)
31 (93%)
1
0
TOTAL* 18 (28%) 7 (11%)32 (50%) 42 (66%) 55  (86%)
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Figure r40 Results of the Tyr 3’ CRISPR/Cas9 micro-injection. A Position of the Tyr 3’ sgRNA sites with 
respect of the Tyr locus.  A 3283 bp PCR is used for genotyping. A 420 bp PCR product is expected in case 
of deletion. B None of the animals obtained from the CRISPR microinjection resulted in the expected 
deletion. Genomic DNA extracted from Neuro2A cells, transfected with sgRNA 3’3, 3’5 and a Cas9 
expression vector is used as positive control (+), untransfected cells are used as negative control (-).  
 
Next, by T7 Endonuclease assay, cloning and sequencing we studied the 
presence of nuclease footprints at the two targeted sites. As shown in Figure 
r41, 2 out of the 16 tested individuals carry indels in correspondence of the 
CRISPR 3’3 binding site as shown by the T7 assay. Sequencing of animal #12 
confirmed these findings. A 2 bp deletion and a 2 bp insertion is observed in this 
individual and confirmed by the sequencing of 4 independent clones (Figure r41 
A and B). 
By T7 assay of the CRISPR 3’5 target sequence, we observed digestion products 
in all tested animals (Figure r41 D), including wild-type controls. Sequencing of 
the CRISPR 3’5 region highlighted the presence of a microsatellite variation 
(Figure r41 C). Being in heterozygosis, this variation is detected by the T7 
endonuclease I assay although it is not related with nuclease activity. By 
sequencing, the 3’5 CRISPR site appeared unmodified.  
 
 1   2    3   4    5    6    7   8   9   10  11 12 13 1415  16  17  18  19  20  21 22  23 24 25       +    -    H20
  
>
3283bp
A
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B M M
3283 bp
400 bp
sgRNA 3’3 sgRNA 3’5
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Figure r41 Sequence characterization of animal TYRINS3 #12. A Position of the Tyr 3’ sgRNA sites with 
respect of the Tyr locus. B A PCR product centred on the sgRNA site 3’3 was cloned and sequenced. 
Alignments of four independent clones of animal #12 are shown. An indel was found 3 bp upstream the PAM 
motif. C A representative chromatogram of the sgRNA site 3’3 in animal #12  is shown. D Oligonucleotides 
3delFw and 3T7EI123Rv were used to amplify a 411 bp sequence centred on the sgRNA 3’3 site. T7 
Endonuclease assay was performed, indicating that two of the tested individuals carry indels at the targeted 
site. E Sequence alignment of the sgRNA 3’5 region in animal #12. The sgRNA site (in bold) is found 
unmodified, indicating no nuclease activity. F T7 Endonuclease I assay of the same region, amplified with 
oligonucleotides 3T7EI456Fw and Rv, did not show the digestion products corresponding to indels at the 
targeted site. Additional bands are found in all samples, including controls, that are explained by  presence of 
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a microsatellite variation in the mouse strain used for microinjection, generating a mismatch. The 
microsatellite variation is also shown in all clones sequenced in E. 
These findings suggested us that the reagents we were injecting were functioning 
although not at the desired efficiency. We decided to perform a second series of 
microinjections, as done for the Tyr 5’ deletion, using a higher RNA dose. Results 
are summarized below: 
 
RNA 
concentration 
Injected Transferred Fosters Pups (Total - stillbirths) 
25 ng/µ l + 2 x 45 
ng/µ l 
300 142 (47%) 6 10  
25 ng/µ l + 2 x 45 
ng/µ l 
150 78 (52%) 4 33  
TOTAL 450 220 (48%) 10 43  
Table!r12!Results of CRISPR 3’3 + 3’5 microinjection/2 
43 pups were obtained from these microinjections. Genotyping by PCR showed 
that 4 animals carrying a deleted allele including three different kinds of deletions 
(Figure r42) 
 
!
Figure r42 Results of the Tyr 3’ CRISPR/Cas9 micro-injection/2. A Position of the Tyr 3’ sgRNA sites 
with respect of the Tyr locus.  A 3283 bp PCR is used for genotyping. A 420 bp PCR product is expected in 
case of deletion. B Animals #16 and 34 resulted in the expected deletion. Partial deletions are observed in 
animals #10 and #26. Genomic DNA extracted from Neuro2A cells, transfected with sgRNA 3’3, 3’5 and a 
Cas9 expression vector is used as positive control (+)  
A
B
 +
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From the genotyping PCR we concluded that mouse #10 carries a partial 
deletion, in heterozygosis (the full-length PCR product corresponding to the wild-
type sequence can be observed). Mouse #16 and #34 show the desired, full Tyr 
3’ deletion. From this PCR, it is impossible to discriminate if these mice carry one 
or two deleted alleles, since the small PCR product competes with the larger 3.2 
kb PCR product. Mouse #26 carries an intermediate deletion. The PCR 
fragments of these mice were cloned and sequenced to confirm the genotype and 
to finely map the breakpoint of the deletions (Figure r43 and r44). 
!
Figure r43 Sequence characterization of animals TYRINS3 #16 and #34. A Position of the Tyr 3’3 
sgRNA site with respect of the Tyr locus. B Scheme illustrating the deletion produced in animals #16 and #34 
with respect of the sgRNA sites. C Alignment of the cloning/sequencing of the deletion break-point. The 
sgRNA sites are shown in bold, PAM motif in red, inserted bases in blue. D Representative chromatograms 
of the break-point in animal 16. 
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Figure r44 Sequence characterization of animals TYRINS3 #26. A Position of the Tyr 3’3 sgRNA site 
with respect of the Tyr locus. B Scheme illustrating the deletion produced in animals #26 with respect of the 
sgRNA sites. C Alignment of the cloning/sequencing: the 3’ break point is found 565 bp upstream the 
expected CRISPR 3’5 cleavage site. The sgRNA sites are shown in bold, PAM motif in red, inserted bases in 
blue. D Representative chromatograms of the break-point in animal 26. The two distal sequences are 
highlighted in green and red. Indels are highlighted in blue. 
 
The core of the Tyr 3’ boundary, composed by a SINEb2 element and a CTCF-
binding site, was successfully deleted in both TYRINS3#16 and TYRINS3#26. 
In conclusion, we obtained different mutated alleles of the Tyr 3’ boundary region, 
that are summarized in Figure r45. 
!
 
Figure r45 Founder individuals of the TYRINS3 series lines A Position of the sgRNA sites with respect of 
the Tyr locus. B Scheme of the deletions produced in vivo with CRISPR. All the sequences associated with 
regulatory features analysed in this work, including a DpnII fragment interacting with the Tyr promoter, a 2.5 
kb insulator sequence and its core element, 271 bp large, including a SINEB2 element and a CTCF-binding 
site, are deleted in animals #16, 26 and 34, but not in #10.  
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4.3.11 Germline transmission 
 
Selected individuals from the cohort of TYRINS5 founders were bred with albino 
outbred HsdWin:NMRI wild-type mice. All individuals carrying a deletion and 
presenting alterations in coat colour were considered for breeding. Additionally, 
animals carrying a partial deletion (individual #8) and larger deletion (#13) were 
bred. Animals carrying inversions and a combination of deletion and inversion 
were also selected for breeding. Table r13 illustrates the germ-lime transmission 
of the tested founders. 
Founder feature GLT Transgenic/total 
TYRINS5#8 Partial deletion YES 10/24 
TYRINS5#11 Full deletion YES 1/19  
TYRINS5#13 Larger deletion YES 5/15 
TYRINS5#18 Full deletion 
Partial deletion 
YES 
YES 
6/9 
3/9 
TYRINS5#19 Inversion YES 1/7 
TYRINS5#23 Inversion NO 0/2 
TYRINS5#30 Deletion 
Inversion 
YES 
NO 
2/12  
0/12  
TYRINS5#31 Inversion NO 0/27 
TYRINS5#35 Full deletion YES 3/21 
TYRINS5#41 Inversion YES 7/17 
TYRINS5#50 Full deletion YES 7/13 
TYRINS5#60 Deletion 
Inversion 
YES 
NO 
8/21  
0/21 
TYRINS5#40 Partial deletion NO 0/14 
Tabel r13 Germline transmission of selected Tyr 5’ series founder mice. 
Founder TYRINS5#18 carries a 1.2 kb deletion, plus a second smaller deletion 
that we could not verify by cloning and sequencing in the founder animal (Figure 
35), probably because the smaller band competes with the larger one in the PCR 
reaction as well as in the cloning reaction. Upon segregation of the two different 
alleles in the TYRINS5#18 F1 generation, we could indeed detect this additional 
band, that is now confirmed as a second, smaller deletion present in the founder 
and transmitted to three of the nine F1 individuals (Figure 46). All the lines 
carrying a deletion transmitted to the germline. The ratio of GLT for each founder 
may reflect different degrees of mosaicism. Transmission of the inverted 
TYRINS5 allele is problematic: out of six founders (including male and female 
founders) tested for GLT, only two (TYRINS5#19 and #41) transmitted the 
genetic modification to the F1 generation. 
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Figure 46 Genotyping of TYRINS5-series F1 individuals. A Position of the Tyr 5’ element with respect of 
the Tyr locus. A 2150 bp band corresponds to the wild-type allele. Smaller PCR product are obtained 
according to the size of the deletion. B Genotyping of the F1 individuals from lines TYRINS5#13, #18, #30 
and  #35. Note that two different deletions segregated in the TYRINS5#18 line. Positive samples are 
indicated with a star. 
 
 
 
Two individuals carrying full and partial deletion of the targeted Tyr 3’ (TYRINS3 
#16 and #26, both female) were crossed with C57B6/J males. Analysis of the 
resulting F1 animals confirmed the germ-line transmission of the genetic 
modifications (Table r14). 
Table r14 Germline transmission of selected Tyr 3’ series founder mice. 
Founder feature GLT Transgenic/total 
TYRINS3#16 Full deletion YES 4/6  
TYRINS3#26 Partial deletion YES 1/7 !!!!!
VJ51$· VJ51$·
2150bp
 
2150 bp
1650 bp
Tyr Grm5Nox4A Tyr 5’
B TYRINS5#13 F1 TYRINS5#18 F1 7<5,16)
7<5,16) TYRINS5#35 F1
367 bp
950 bp
2150 bp
950 bp
                      *                                    *       *        *       *       *        *       *       *         *       *        *       *
                     *        * 
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4.3.12 Analysis of predicted CRISPR off-targets !
Several independent laboratories reported that the CRISPR/Cas9 system might 
be able to induce mutation at chromosomal loci with high sequence similarity with 
the intended target (Fu et al. 2013; Mali et al. 2013; Pattanayak et al. 2013; Hsu 
et al. 2013). Table r15 illustrates the sequences of three top-scoring predicted 
off-targets for sgRNA 5’0 and 5’5, that were used to delete the Tyr 5’ boundary. 
Table r16 shows the top three predicted off-target sites for the sgRNA used to 
delete the Tyr 3’ boundary element. 
  Taking this observation in account, we analysed the presence of mutations at 
the three most similar sequences for each of the sgRNA sequence that were 
used to delete the Tyr 5’ element.  
 
Table r15 Predicted off-targets of sgRNA 5’0 and 5’5. The top three off-target (OT) sites for each sgRNA 
used are shown. Mismatching bases are shown in red. All off-target sites map on intronic or intergenic, non-
coding region. None of the predicted off-targets maps on chromosome 7. 
 !
Table!r16 Predicted off-targets of sgRNA 3’3 and 3’5. The top three off-target (OT) sites for each sgRNA 
used are shown. Mismatching bases are shown in red. All off-target sites map on intronic or intergenic, non-
coding region. None of the predicted off-targets maps on chromosome 7.!
!!
sgRNA 5’5  GTGATAAAACTAGGCAATTT-TGG  chr7: 94657775   intergenic
5’5-OT1  CAGATAAAAGCAGGCAATTT-TGG  chr1: 9300003      intergenic
5’5-OT2  GAGCAAAAACTTGGCAATTT-GGG  chr19: 31071409   intronic (Prkg1)  
5’5-OT3  GTATTAAAATGAGGCAATTT-GGG  chr14: 112763119   intergenic 
    ID    sequence    chromosomal position   feature
sgRNA 5’0  GTGTGACAGTGCAAGATAAC-AGG  chr7: 94656546   intergenic
5’0-OT1  CTGTCACAGAACAAGATAAC-CGG  chr6: 99084014     intronic (Foxp1) 
5’0-OT2  GGGAGACTGTGCAAGATAAG-GGG  chrX: 69682563     intronic (Gabra3)
5’0-OT3  TTTTGACAGAGCAAGATAAA-TGG  chr3: 60502350     intergenic
sgRNA 3’5  ACAAACGCTAATTGGTAAAA-TGG  chr7: 94657775   intergenic
3’5-OT1  ACAATTGGTAATTGGTAAAA-TGG  chr12: 36137724     intergenic
3’5-OT2  AGATTCGCTGATTGGTAAAA-AGG  chr5: 42142945      intergenic  
3’5-OT3  ACAAATAGTAATTGGTAAAA-AGG  chr15: 15417522     intergenic 
    ID    sequence    chromosomal position   feature
sgRNA 3’3  AGCTCAGTAGAGTACTAGGT-AGG  chr7: 94656546   intergenic
3’3-OT1  AGCTGGGCAGAGTACTAGGT-TGG  chr11: 74783860     intronic (Smg6) 
3’3-OT2  CTCTGAGTAAAGTACTAGGT-TGG  chr11: 17927436     intergenic
3’3-OT3  AGCTCAGGAGAGTCCTAGGT-AGG  chr5: 135521999     intronic (Stx1a)
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By T7 Endonuclease assay, we scanned the presence of mutations in all the 64 
individuals obtained in the last two series of microinjection. We analysed positive 
individuals as well as littermates not bearing the desired deletions. In total, we 
performed six series of T7 EndonucleaseI assays each one involving the 64 
founders plus a number of control animals of the same genetic background.  With 
few exceptions (illustrated below) we could not detect mutations at the six off-
target sites in anaysis. Regarding the off-target site 5’0 OT1, located in the 
intronic region of Foxp1, individuals #13, #14, #29 (Figure r46 B) and #57 
showed faint digested bands at the T7 Endonuclease I assay. However, 
sequencing of three independent clones did not confirmed the presence of off-
target mutations (Figure r46 C), probably indicating that the mutations detected 
were present in a very small number of cells in the sampled biopsies.  
Similarly, by T7 Endonuclease I assay we detected the presence of a mutation at 
the first predicted off-target for the 5’5 sgRNA sequence (55 OT1) in two: #1 and 
#24. Also in this case, by sequencing three independent clones, no mutation 
could be detected (Figure r47 D). 
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Figure r47 Analysis of off-target sites 5’0 OT1 and 5’5 OT1. A Position of the off-target site 5’0 OT1. B 
Analysis of the presence of indels by T7 Endonuclease I assay. Faint bands were obtained in samples #13, 14 
and 29. The size of the observed bands does not match with the pattern expected upon off-target mutation C 
The sgRNA 5’0 site is aligned with the sequence of its predicted off-target. Black arrows indicate 
mismatches. By cloning and sequences, we could not identify any mutation induced at the off-target site 5’0-
OT1. D Position of the off-target site 5’5 OT1. E Similarly, the 5’5 OT1 off-target site was tested by T7 
Endonuclease I assay. Faint bands were observed in samples #1 and #24 (the latter not shown). F By cloning 
and Sanger sequencing, no mutation at the sgRNA 5’5 OT1 off-target site were found in individuals 
previously screened by T7 Endonuclease assay.  ! !
13   14   15   16  17   18   19  20   21   22   23   24  25   26   27   28  29   30
189 bp
478 bp
667 bp
5’0 off-target 1A
B
C sgRNA 5’0:                      CCTGTTATCTTGCACTGTCACAC
reference:  TGCACAGGGTATTTACTGATCCGGTTATCTTGTTCTGTGACAGGCAGAATCAATCAATCAGGA
TYRINS5#13_1: TGCACAGGGTATTTACTGATCCGGTTATCTTGTTCTGTGACAGGCAGAATCAATCAATCAGGA
TYRINS5#13_2: TGCACAGGGTATTTACTGATCCGGTTATCTTGTTCTGTGACAGGCAGAATCAATCAATCAGGA
TYRINS5#13_3: TGCACAGGGTATTTACTGATCCGGTTATCTTGTTCTGTGACAGGCAGAATCAATCAATCAGGA
TYRINS5#14_1: TGCACAGGGTATTTACTGATCCGGTTATCTTGTTCTGTGACAGGCAGAATCAATCAATCAGGA
TYRINS5#14_2: TGCACAGGGTATTTACTGATCCGGTTATCTTGTTCTGTGACAGGCAGAATCAATCAATCAGGA
TYRINS5#14_3: TGCACAGGGTATTTACTGATCCGGTTATCTTGTTCTGTGACAGGCAGAATCAATCAATCAGGA
TYRINS5#13_1: TGCACAGGGTATTTACTGATCCGGTTATCTTGTTCTGTGACAGGCAGAATCAATCAATCAGGA
TYRINS5#29_1: TGCACAGGGTATTTACTGATCCGGTTATCTTGTTCTGTGACAGGCAGAATCAATCAATCAGGA
TYRINS5#29_2: TGCACAGGGTATTTACTGATCCGGTTATCTTGTTCTGTGACAGGCAGAATCAATCAATCAGGA
TYRINS5#57_1: TGCACAGGGTATTTACTGATCCGGTTATCTTGTTCTGTGACAGGCAGAATCAATCAATCAGGA
TYRINS5#57_2: TGCACAGGGTATTTACTGATCCGGTTATCTTGTTCTGTGACAGGCAGAATCAATCAATCAGGA
TYRINS5#57_3: TGCACAGGGTATTTACTGATCCGGTTATCTTGTTCTGTGACAGGCAGAATCAATCAATCAGGA
TYRINS5#57_4: TGCACAGGGTATTTACTGATCCGGTTATCTTGTTCTGTGACAGGCAGAATCAATCAATCAGGA
sgRNA 5’5:          CCAAAATTGCCTAGTTTTATCAC
reference:  GTATTCACGTGCACCTGTTACCAAAATTGCCTGCTTTTATCTGTGAATCTACCTTTCGTTGAC
TYRINS5#1_1: GTATTCACGTGCACCTGTTACCAAAATTGCCTGCTTTTATCTGTGAATCTACCTTTCGTTGAC
TYRINS5#1_2: GTATTCACGTGCACCTGTTACCAAAATTGCCTGCTTTTATCTGTGAATCTACCTTTCGTTGAC
TYRINS5#1_3: GTATTCACGTGCACCTGTTACCAAAATTGCCTGCTTTTATCTGTGAATCTACCTTTCGTTGAC
TYRINS5#24_1: GTATTCACGTGCACCTGTTACCAAAATTGCCTGCTTTTATCTGTGAATCTACCTTTCGTTGAC
TYRINS5#24_2: GTATTCACGTGCACCTGTTACCAAAATTGCCTGCTTTTATCTGTGAATCTACCTTTCGTTGAC
TYRINS5#24_4: GTATTCACGTGCACCTGTTACCAAAATTGCCTGCTTTTATCTGTGAATCTACCTTTCGTTGAC
213 bp 697 bp
5’5 off-target 1D
484 bp
chr6: 99084014 - intronic (Foxp1) 
chr1: 9300003 - intergenic
667 bp478 bp 189 bp
 1        2      3      4      5       6      7       8      9      10    11             wt
697 bp
484 bp
213 bp
E
F
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4.4 Characterization of the TYRINS5 and TYRINS3-series of transgenic mouse 
lines  
 
4.4.1 Phenotype of TYRINS5-series founder animals 
 
Previous experiments in our laboratory showed that YAC constructs of the mouse 
Tyr locus lacking the Tyr 5’ insulator (3.7 kb, LCR) failed to fully rescue the albino 
phenotype when injected in albino fertilized eggs (Figure i6; Montoliu et al. 
1996). Additionally, YACs carrying the specific deletion of the A box alone or of A 
plus B boxes, showed a partial rescue of pigmentation, indicating that these 
sequences are indeed relevant for Tyr expression. However, the degree of 
pigmentation in transgenic mouse lines generated with YRT2ΔA and YRT2ΔAB 
YACs varies between transgenic lines. (Figure i7; Giraldo and Montoliu, 2002; 
PhD thesis of Patricia Giraldo, 2002). 
 
By deleting a 1.2 kb fragment of the Tyr LCR in the endogenous locus, we 
obtained – out of the eighteen positive animals generated – four individual 
founder mice bearing evident reduction in coat colour pigmentation. Considering 
that Tyr is a dominant allele, chromosomal deletion must have happened at both 
alleles. This phenotype suggests the relevance of the Tyr 5’ element within its 
natural, chromosomal location and suggests its potential implication on a 
mutation associated to OCAI (King et al. 2003; Regales et al. 2003; Montoliu et 
al. 2014).  
In these four founder animals (Figure r48) both copies of the target element 
could be deleted in a consistent number of cells. The degree of pigmentation is 
variable between the four founder animals, both in term of intensity and spatial 
distribution, indicating different degree of mosaicism, likely caused by the time 
during embryonic development in which these deletion took place. Animal #18 
shows the strongest phenotype, hence the weakest pigmentation, suggesting that 
the Tyr 5’ element was deleted very early in embryogenesis and, thus, this 
element is completely absent in most cells of the mouse body. Next, animal #11 
shows a darker coat colour, with grey patches. This suggests that the deletion of 
the Tyr 5’ element in both alleles could have happened later in embryogenesis. 
Finally, Individuals #35 and #60 show only spare patches of grey coat, 
suggesting a very little content in biallelic deleted-cells. 
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Figure r48 Alteration in coat color in F0 individuals. A-D Four individual obtained from CRISPR mRNA 
embryo microinjection show reduction in coat colour pigmentation. The reduction is more evident in animals 
TYRINS5#11 (in A, compared with a non-transgenic littermate) and #18 (B, compared with a non-transgenic 
littermate). Alterations in animals #35 (C) and #60 (D) are less evident and could only be observed in the 
ventral part on the animal, during the manipulation at the weaning time. E Schematic of the deletion present 
in mice shown in A-D. 
 
4.4.2 Phenotype of distinct TYRINS5 transgenic lines 
 
Selected individuals from the large cohort of founder animals (22 animals carrying 
either a deletion or inversion or both) were bred with albino, outbred 
HsdWin:NMRI wild-type mice, the genetic albino background were all the YAC-
Tyr-based transgenic lines were generated and currently maintained. NMRI 
outbred mouse strain carries the classical homozygous mutation in the Tyr 
coding sequence (C103S, Tyrc/c) resulting in albino phenotype (Jackson and 
Bennet 1990). In an albino background, alterations in Tyr expression will be 
evident even if only one copy of the Tyr 5’ element is inactivated.  
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F1 pups that inherited the deletion, show a grey coat and pigmented eyes, but 
still darker than the albino coat colour (Figure r49 A). As indicated before, the 
TYRINS5#18 founder bears two distinct deletions that segregated independently 
in the F1 generation, named TYRINS5#18a (full deletion) and TYRINS5#18b 
(partial deletion). Interestingly, all F1 individuals from the TYRINS5#18 founder 
have the same grey coat colour, indicating that both type of deletions, are 
sufficient to inactivate key sequences necessary for proper Tyr expression 
(Figure r49 B). Of the F1 generation of the line TYRINS5#30, obtained from a 
founder carrying a combination of deletion and inversion, only two individuals – 
that inherited the deleted allele – have grey coat (Figure r49 C). Finally, the 
TYRINS5#50 F1 that inherited a deleted copy of the Tyr 5’ sequence show the 
same phenotype observed in lines #8, #13, #18 and #30. In a second line that 
carries both inversion and deletion, line TYRINS5#60, a grey coat is observed in 
animals carrying a deletion. 
By comparing the coat colour phenotype of lines #18a, #30, #50 and #60 with 
that of line #13, we can conclude that the DNA region 5’ upstream to the sgRNA 
5’0, deleted only in line #13, are not relevant to the regulation of Tyr expression. 
By comparing again lines #18a, #30, #50 and #60 with line #8, carrying a 0.7 kb 
deletion centred on the AB box, we can conclude that all additional sequences 
found upstream to the 3’ end on the deletion in line #8 are not relevant to the 
proper Tyr expression. In fact, different lines show the same coat colour in the 
presence and in the absence of these sequences. Finally, by comparing lines #8 
and #18b, we could trim the size of the Tyr 5’ fragment that, when deleted, is able 
to alter Tyr expression. The lack of a 410 bp sequence, included between the 
sgRNA 5’0 site and the 3’ break-point of the deletion in line #18b, is sufficient to 
alterate Tyr expression in vivo. 
Of the two lines carrying the inversion and successfully transmitting to the F1 
generation, both display a grey coat colour (Figure r49 D). This indicates that 
inverting a regulatory element (and particularly an insulator) reduces the 
functioning of the regulatory circuit.  
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Figure r49 Phenotype of TYRINS5 lines F1 offspring. A Four out of nine pups of the TYRINS5#13 F1 
offspring carry a 1.7 kb deletion of the Tyr 5’ element and show a grey coat colour and pigmented eyes. As 
comparison, an age-matched, albino Hsd:Win wild-type animal is added aside. B All nine pups from the 
TYRINS5#18 F1 offspring show a grey coat colour and pigmented eyes, indistinguishable from the 
phenotype of the TYRINS5#13 line. Six of the nine TYRINS5#18 F1 individuals carry a 1.2 kb deletion, 
while three inherited a smaller deletion that was also produced in the founder. C The TYRINS5#30 founder 
carries a deleted and an inverted allele. Only those the two F1 individuals that inherited the deleted allele 
show a grey coat colour and pigmented eyes as seen in TYRINS5#13 and #18 F1s. The F1s that inherited the 
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inverted Tyr 5’ sequence do not show evident alterations in coat colour pigmentation. D F1 individuals from 
the TYRINS#19 offspring. Only one mouse inherited the inverted allele and shows a grey coat similar to the 
TYRINS5 lines carrying a deletion of the same sequence. E Two out of the nine TYRINS5#8 F1 offspring 
show the same grey coat colour as seen for the other lines carrying the inactivation of the Tyr 5’ element. F 
None of theTYINS5#31 F1 offspring inherited the inversion. The genotype matches with the lack of germline 
transmission of the inversion. G F1 offspring of the TYRINS5#50 lines. Three individuals show the same 
grey coat phenotype as observed for the previous lines.  H The same phenotype can be observed in four 
individuals of the TYRINS5#60 F1 offspring, the same individuals that inherited the deleted allele from the 
founder. 
 
Line feature With alterations 
in coat colour  
TYRINS5#8 Partial deletion 2/2 
TYRINS5#11 Deletion 1/1 
TYRINS5#13 Larger deletion 4/4 
TYRINS5#18/a Deletion 6/6 
TYRINS5#18/b Partial deletion 3/3 
TYRINS5#19 Inversion 1/1 
TYRINS5#30 Deletion  2/2 
TYRINS5#35 Deletion 3/3 
TYRINS5#41 Inversion 7/7 
TYRINS5#50 Full deletion 3/3 
TYRINS5#60 Deletion 4/4 
Table!r17:!Coat!color!phenotype!of!Tyr!5’!F1!offspring.! 
At the histological level, the grey coat colour observed in the TYRINS5 lines 
corresponds to a reduced pigment accumulation in the hair follicle (Figure r50). 
 
!
Figure r50 Skin histological sections. A Back skin section from a YRT2 transgenic mouse. Melanin is 
accumulated in the base of the hair follicle. B Similarly, pigmented hair follicles can be observed in the skin 
from a YRT3 mouse.  C and D Skin sections from two individuals of the TYRINS5#18a line. Less dense 
melanin accumulation is observed, causing the coat colour to be grey. Scale bars 100 µm and 20 µm in insets. 
Hematoxylin-eosin staining. 
At macroscopical observation, the eyes of all TYRINS5 lines appears pigmented 
and indistinguishable from wild-type mice. However, by histological analysis, a 
difference is observed. In the absence of the Tyr 5’ element, Tyr expression is 
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dramatically reduced in the choroid melanocytes and but not in the RPE cells 
(Figure r51). 
!
Figure r51 Eye histological sections. A Section from a pigmented, agouti wild-type mouse. At higher 
magnification, two distinct pigmented layers can be observed: the choroid and the RPE cell layer. B Eye 
section of a TYRINS5#18 mouse. Pigmentation of the choroid is almost completely lost but not in the RPE 
layer.  
 
 
4.4.3 Phenotype of TYRINS3 series founder animals 
 
In contrast of what had been observed with the TYRINS5 series of 
microinjections, no biallelic deletions were obtained in TYRINS3 F0 individuals. 
None of the founder individuals carrying deletion of the Tyr 3’ element showed 
evident alternations in coat colour or eye pigmentation.  
 
4.4.4 Phenotype of distinct TYRINS3 transgenic lines 
 
TYRINS3 F0 animals (obtained in the pigmented genetic background B6D2F1) 
were crossed with C57B6/J individuals in the laboratory of Dr. Pawel Pelczar, 
University of Zurich, Switzerland. In such pigmented genetic background, coat 
colour alteration could not be observed. After being imported at the CNB animal 
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house, F1 individuals were crossed with albino outbred HsdWin:NMRI wild-type 
animals, as it was done with the TYRINS5 project founders. TYRINS3 F2 
individuals, now in albino background, do not show coat colour alterations, 
suggesting that the lack of the Tyr 3’ element does not affect Tyr expression 
(Figure r52).  
 
!
Figure r52 Phenotype of TYRINS3 lines F2 offspring. A TYRINS3#16 F2 offspring in albino background: 
normal coat colour is observed. B TYRINS3#26 F2 offspring in albino background show normal pigmented 
phenotype. !!!
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5. Discussion
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5.1 The Tyr locus is flanked by chromatin insulators 
 
The expression pattern of the flanking genes Nox4 and Gmr5 (Figure r3), and 
the very specific expression of Tyr, suggests that the latter needs to be 
‘’protected’’ from the nearby regulatory signals belonging to the Nox4 and Grm5 
expression units. Indeed, both 5’ and 3’ intergenic regions contain sequences 
able to block enhancer activity when tested in vitro (Figure r6) in vivo (Figure r7 
and Bessa et al. 2009). The Tyr locus thus contains a complete expression unit 
flanked at either side by chromatin boundaries and containing all regulatory 
elements necessary to coordinate its expression in the relevant tissues and 
developmental stages. 
The activity of the Tyr 3’ boundary is largely depending on CTCF 
occupancy. After mutagenesis of the CTCF binding site, we observed a 
significant drop in enhancer-binding activity, but notpub a full loss of insulator 
capability. The residual insulator activity detected after mutagenesis of the CTCF 
binding site (Figure r7 and r8) could be due to the transcriptional activity of 
polymerase II and III promoters contained in the SINEB2 repeat, which is, per se, 
an element capable of transducing insulator properties (Lunyak et al. 2007; 
Lunyak, 2008). Another hypothesis is that with the mutagenesis strategy we used 
didn’t abolish but only reduced the binding of CTCF. We designed the mutation 
following a strategy that supposedly allowed for complete loss of protein binding  
in human cells (Xie et al. 2007). Nevertheless, CTCF binding motif is far from 
being fully characterized and additional information are continuously added that 
changes the canonical CTCF binding consensus sequence (Schmidt et al. 2012; 
Plasschaert et al. 2014). Very recently, additional consensus motives found 
upstream and downstream to the canonical CTCF-binding motif were reported 
(Nakahashi et al. 2014). The central motif is recognised by Zinc Fingers 4-7, 
while ZFs 9/11 bind to the upstream motif stabilizing the DNA-protein interaction.   
The insulator property of the Tyr 5’ boundary or LCR was previously 
described in our laboratory and was found associated with three sequences or 
motives, named A box, B box and G box (Ganss, Montoliu et al. 1994; Giraldo el 
al. 2003). Previous data shows that the sum of these three elements conveys the 
biological function, likely by cooperatively binding a series of transcription factors 
(Giraldo et al. 2003). Nevertheless, 3C data produced in this work indicate that 
only the DpnII fragment containing the AB box is able to interact with the Tyr 
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promoter, and not the one containing the G box, suggesting that the role of this 
sequence might be less relevant that previously anticipated. 
Furthermore, all mouse lines that we have generated, lacking the AB box and 
carrying the intact G box, display reduced Tyr expression. Further analysis of the 
chromatin marks in vivo will reveal if the loss of the Tyr 5’ element results in the 
spreading of repressive chromatin marks from the LINE1 element till the Tyr 
promoter. 
 
5.2 The Tyr locus in 3D 
  
In this work, we described the structural architecture of the mouse Tyr locus using 
Chromosome Conformation Capture. In our model, two conserved elements, 
located at either ends of the Tyr coding sequence, contact the gene promoter 
(Figure d1). One of these interactions, involving the Tyr promoter and the Tyr 3’ 
element, produces a constitutive DNA loop, found in both Tyr expressing and 
non-expressing cells, that is mediated by CTCF-binding. The interaction between 
Tyr promoter and the Tyr 5’ boundary is cell-type specific, since it was detected 
more frequently in Tyr positive, B16 mouse melanoma cells. For this reason, we 
speculate that the melanocyte master transcription factor, Mift (which binds to 
three sites on the Tyr promoter on Tyr-expressing cells) interacts with other 
transcription factors bound to the 5’ element, including AP-1, CREB (Giraldo et al. 
2003) and CTCF (Angel Diaz PhD thesis, 2007). In addition, specific RNA 
molecules interacting with CTCF (as observed by Saldaña-Meyer et al. 2014), 
may be involved in the differential binding observed in the cell types studied.  
!
Figure d1 Model of the chromatin architecture of the mouse locus The locus is organized in one major 
loop constituted by the interaction between the Tyr promoter and the Tyr 3’ element. In Tyr-expressing cells, 
a second loop is formed involving the Tyr 5’ element.  
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Another interaction was found between the Tyr promoter and a sequence in the 
Tyr third intron, weaker but cell type-specific. The nature and the function of this 
interaction haven’t been investigated in the present work, although a weak CTCF-
binding could be observed in public ChIP-seq datasets.   
 Due to technical limitations, the architecture of the Tyr locus could not be 
described in the RPE cells, a second pigmented cell types, not of neural-crest 
origin. Both primary cultures and stable cell lines lack of Tyr expression. Our 
data, along with other works (Liu et al. 2009), remark that the transcriptional 
silencing of Tyr and of its master regulator, Mitf, is a consequence of the 
Epithelial-Mesenchymal transitions (EMT) that rapidly occurs upon culturing. In 
fact, we detect a strong expression of Zeb1, which is a transcriptional repressor 
associated with EMT, in both primary RPE cultures and in B6-RPE07 cells 
(Figure r14). The only chance to perform 3C on Tyr-expressing RPE cells would 
be to collect these cells directly from the mouse eye. Nevertheless, the procedure 
of eye dissection to access and collect these cells is time-consuming and yields a 
very small number of cells per eye. This discourages the ex vivo approach. One 
alternative, that was recently reported, would be to differentiate ES cells into 
RPE-like cells (Aruta et al. 2011; Bertolotti et al. 2014), a possibility that should 
be explored in future experiments.  
 
 The structure of other loci related with pigmentation has been studied 
recently. In humans, a key enhancer required for proper expression of OCA2 was 
found in the intron 80 of the flanking HERC2 gene, 21 kb upstream of OCA2. By 
3C analysis, this element was found to be contacting the OCA2 promoter. SNPs 
associated with human skin pigmentation map on this sequence. In fact, darkly 
pigmented melanocytes (carrying the rs12913832 T-allele) show higher OCA2 
expression and DNA looping between the enhancer and the OCA2 promoter, 
while lightly-pigmented melanocytes (carrying the C-allele), have reduced OCA2 
expression and DNA looping (Visser et al 2012; Visser et al. 2014).   
Similarly, other SNPs in non-coding region were found to be associated with hair 
pigmentation. In humans, Guenther and colleagues described a far-upstream 
KITLG (encoding KIT ligand) enhancer associated with blond hair colour 
(Guenther et al. 2014). In mice, chromosomal inversion of the orthologous region 
causes a lighter coat colour pigmentation (Bedell et al. 1995). All these examples 
underline the importance that non-coding DNA elements play in development and 
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disease and the fact that investigating gene loci from a structural point of view 
facilitates the discovery of relevant functional regulatory elements. 
 
5.3 Why did TALENs fail? 
 
TALENs represent the second generation of targeted nucleases after ZFNs. 
Rapidly after the first reports, the scientific community largely abandoned ZFNs to 
use the more versatile, cheaper and apparently more powerful TALENs (Chen et 
al. 2012). Nevertheless, in our experience, we could not observe a single indel 
event when we used TALENs against a chromosomal target, either in vitro or in 
vivo. On the contrary, we could observe nuclease activity when TALENs were 
used to digest purified PCR products (Figure r15 and r16) in a cell-free assay or 
to target a multi-copy, episomal DNA template in transfected cells (Figure r18 
and r19). These results clearly indicate that (our) TALENs activities on single-
copy chromosomal targets are limited. A reason could be the low affinity of 
TALENs with their substrate DNA sequence. In fact, we could rescue TALEN 
activity by providing a large excess of the substrate DNA. As an alternative, 
epigenetic marks present at the chromosomal target may be responsible of the 
lack of activity of our TALENs. In fact, these reagents appear to be unable to 
reach a target when the latter is found in repressive chromatin state (Ding et al. 
2013; Hsu et al. 2013).  
 
5.4 Why did CRISPR work? 
 
After a series of test microinjections aimed to determine the optimal RNA 
concentration for embryo microinjection, we obtained with a number of founder 
animals larger than expected and larger than what we could handle and breed 
easily in our facility (22 potential founders out of 64 pups, Table r10). We 
hypothesize that the key of success using CRISPR depends on the way that the 
target recognition is mediated. On one hand, the Watson&Crick interaction 
between the guide RNA and the target DNA is in fact strong, predictable and 
energetically convenient. On the other hand, protein-DNA recognition, required 
using TALENs, is a less predictable and energy-consuming process. Although 
helicase activity of Cas9 was questioned (Mali et al. 2013), no energy-dependant 
activity was found. Possibly, the PAM binding could trigger a general 
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destabilization of the DNA duplex leading to the formation of the RNA-DNA 
heteroduplex (Sternberg et al. 2014).  
 
5.5 Pay one, get more 
 
When the error-prone non-homologous end-joining repair (NHEJ) pathway 
repairs a DSB, the resulting DNA scar varies according to micro-homologies 
found in the sequences flanking the DNA double-strand break (Lieber et al. 2003) 
and probably, according to which cell-cycle phase of the cell cycle is undergoing. 
As expected, when targeting two distal sites, in some lines we observed small 
sequence variations (in the order of tens of base pairs) around the break-point, 
where the two distal DNA ends are joined. What we did not expect to observe are 
the partial deletions, that we observed in both the TYRINS3 and TYRINS5 
experiments, and the larger deletions, that spans hundreds of bases upstream to 
the targeted sequence. This variability in DNA repair has some advantages and, 
of course, some disadvantages. The main advantage, as suggested by the title of 
this paragraph, is that in one microinjection experiment (and using the same 
reagents) several distinct mouse lines can be generated. This is extremely useful 
for the study of non-coding regulatory element, where partial deletion can be 
used to restrict the DNA region that is relevant for a particular function. For 
example, we could take advantage of the line TYRINS5#8, carrying a partial, 0.7 
kb deletion, to reinforce the concept that the AB boxes are relevant for the 
function of the Tyr 5’ element. Similarly, larger deletion can be used to remark 
that the removal of additional DNA does not alter the phenotype observed with 
the exact or with the partial deletion. This is true for the line TYRINS5#13, that 
carries a larger, 1.7 kb deletion and is phenotypically indistinguishable from the 
other TYRINS5 lines. Moreover, chromosomal inversions can be generated that 
might be used to study if the function of the Tyr 5’ element depends on its 
orientation. However, we could only confirm germline transmission in two out of 
seven founders.  
All the additional mouse lines were generated using a number of animals 
that was calculated for the generation of a single line. Considering the 3Rs of 
animal experimentation ethics, this is a great example of Reduction. This can 
also be seen the other way around: the more efficient is genome editing in 
embryos, more transgenic lines will be generated, and more organism will be 
genetically altered and used in the laboratory (Combes and Balls, 2014). 
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On the other hand, the variability associated with CRISPR/Cas activity in 
embryos discourages its use in transient experiments, where it might be 
complicate to correlate an observed phenotype with a very unpredictable and 
complex genotype. In fact – considering our data - both the size of the deletion 
(Figure r36), the contribution of the edited cells to the organism, and the degree 
of mosaicism (Figure r48 and Figure d2) can vary consistently between 
individuals obtained within the same microinjection session. With CRISPR, we 
and others (Yen et al. 2014) could observe a phenotype in founder animals, 
targeting recessive alleles. Nevertheless, founder animals generated with this 
technology can be genetically complex. We observed, for example, individuals 
carrying two different deletions (TYRINS5#18) or others carrying one deleted and 
one inverted allele (TYRINS5#30 and #60). All these genetic combinations can’t 
be obviously used directly for experimentation but require accurate breeding. 
 
5.6 Mosaicism 
 
!
Figure d2 Mosaicism in CRISPR/Cas9-generated mice. A Litter obtained from the targeting of Tyr exon 1 
in B6.CBA mouse embryos. Albino animals can be obtained (full, biallelic inactivation), as well as complex 
chimeras composed by wild-type cells, cells carrying a single targeting event and cells carrying both 
inactiveated copy of Tyr. B Targeting of a single copy EGFP transgene in embryos obtained from 129-
Gt(ROSA)26Sor<tm1(CAG-EGFP)Luo/J mice. Confocal images of transgenic mouse fetuses. The number of 
EGFP+ cells is reduced by injecting CRISPR but not fully abolished. These experiments were carried on in 
collaboration with Dr. Sagrario Ortega, CNIO. 
In classical additive transgenesis, a mosaic is an organism in which the 
transgene integrated in the genome after the first cell divisions. As a result, the 
founder animal is composed of cells carrying the transgene and cells that do not 
harbour the transgene. In contrast, in nuclease-based genetic manipulation, a 
mosaic is an animal that carries multiple alleles, either a combination of a wild-
mouse Tyr EGFP transgene
Rosa26
A B
control injected
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type and a mutated allele, or even a complex mixture of diverse mutated alleles, 
each of them having occurred in different stages and/or different cell lineages. In 
our experience with CRISPR, mosaicism is a frequent phenomenon. As shown in 
Figure d2 A, targeting Tyr coding sequence can lead to an albino phenotype 
(biallelic inactivation of the Tyr gene), or to patchy animals in which none, one or 
both copies of the gene have been targeted. Similarly, when we used CRISPR to 
target one single copy of EGFP (in heterozygous transgenic embryos), CRISPR 
activity after the first cell division resulted in the loss of GFP in many cells, but not 
all of them. Currently there are several strategies to reduce the degree of 
mosaicism: the use of Cas9 protein, and not Cas9 mRNA, could promote early 
cleavage of the target DNA (Gagnon et al. 2014). Interestingly, a Cas9-transgenic 
mouse has been recently reported (Platt et al. 2014). Injecting the sgRNA into 
oocytes that already contain Cas9 protein might increase transgenesis efficiency 
and reduce mosaicism. 
 
5.7 Role of the Tyr 5’ element in vivo 
 
In this work we have proved the relevance of the Tyr 5’ element in the 
endogenous locus. Similar but not conclusive evidences were collected using 
chromosome-type transgenes carrying deletion or mutation in the Tyr 5’ element. 
In fact, Tyr-YAC lacking the full Tyr 5’ element (YRT4 and ΔLCR, Figure d3) 
failed to fully rescue the pigmentation in albino background. These experiments 
were fundamentally useful to identify the presence of a key element (included in 
YAC YRT2 and YRT3, Figure d3), but technical limitations hampered the 
description of the core sequences in the Tyr 5’ element. In fact, the inactivation of 
the A box and both A and B boxes in YACs (Figure i7 and Figure d3), resulted 
in a variable reduction in pigmentation, not consistent in all the transgenic mouse 
lines generated using these constructs. 
On the contrary, several independent lines generated with CRISPR targeting the 
Tyr 5’ element showed robustly the same phenotype, as shown in Figure d3 and 
Figure r49. 
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Figure'd2'Comparison'of'the'different'Tyr'transgenic'mouse'lines.'A'Individuals!from!the!different!mouse! models! generated! to! study! the! Tyr! locus! are! shown.! An! albino! NMRI! mouse! (left)! and! a!B6CBAF2!mouse!(right)!are!shown!as!albino!and!pigmented!controls.!Individuals!from!lines!YRT4!and!DLCR!show!pigmented!eyes!but! lack!of!pigment! in! coat.!A!DA! individual! show!a!greyish!coat! colour.!Individuals!from!three!independent!DAB!lines!show!a!variable!phenotype.!Lines!TYRINS5#18!and!#13!are! indistinguishable.! Spontaneous! mutants! TyrcSm! and! TyrcSem! are! also! included,! carrying! a!chromosomal!rearrangement!5’!to!the!Tyr!coding!sequence.! !Mice!carrying!the!full!YRT2!YAC!and!the!YRT3!YAC!(that!includes!the!Tyr!5’!element)!show!a!pigmented!phenotype!indistinguishable!from!that!of! a! wildStype! pigmented! individual.! Animals! are! not! ageSmatched.! B! Schematics! of! transgenes,!targeted!and!spontaneous!mutations!of!the!mice!shown!in!A. 
Inactivating the Tyr 5’ element in vivo produced a reduction of Tyr expression in 
skin and choroid melanocytes, two neural-crest derived cell lineages. On the 
contrary, we could not observe gross loss in pigmentation of the RPE layer of the 
retina, indicating that the Tyr 5’ is dispensable to achieve Tyr expression in the 
RPE. 
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By comparing the phenotype of different lines carrying distinct deletion, we could 
identify a smaller sequence – within the Tyr 5’ element – that is necessary for 
proper Tyr expression. The phenotype of lines #18a, #30, #50 and #60 is in fact 
indistinguishable from that of line #13, which carries a bigger deletion. We can 
thus state that the additional DNA missing in line #13 is not relevant for the Tyr 5’ 
element. Similarly, comparing the lines carrying the full deletion with animals 
bearing a partial deletion, we could identify a small 410 bp that is always absent 
in all animals that show alteration in coat colour pigmentation (Figure d4). 
 
 
!
Figure d4 Identification of the Tyr 5’ core sequence. By comparing the phenotype resulting from different 
deletions, a small, relevant, 410 bp large sequence was identified. It cannot be excluded that the size of this 
element can be further reduced without loosing the underlying phenotype. Genomic coordinates refer to the 
mm37 assembly. 
Interestingly, the inversion of the Tyr 5’ element caused the same phenotype 
observed upon its deletion. This suggests that not only the presence, but also the 
directionality of this element is fundamental. In fact, one possibility is that the Tyr 
5’ element has both enhancer and insulator properties. Upon inversion, the 
insulator element is positioned in between the promoter and the actual enhancer, 
blocking its activity. A similar inversion of the same DNA region was also 
observed in a spontaneous mouse mutant, the Tyrc-m (Porter et al. 1991) and in a 
related mutant Tyrc-em (Lavado et al. 2005), that shows alterations in coat colour 
similar to those observed in our Tyr 5’ lines.   
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5.8 The role of the Tyr 3’ element in vivo  
 
The inactivation of one copy of the Tyr 3’ element in albino background did not 
produced any evident alteration in coat colour, suggesting that this element is not 
necessary for the regulation of Tyr. One possibility is that this element, of which 
insulator activity has been detected in human cells and in zebrafish embryos, is 
required for the regulation of the flanking Nox4 gene. This option is in contrast 
with our 3C data, in which the Tyr 3’ element is clearly contacting the Tyr 
promoter. To verify this, mice carrying the Tyr 3’ inactivation in both alleles must 
be analysed.  
 
5.9 Reduced GLT of a chromosomal inversion  
 
Targeting two distal DNA sites on the same chromosome led to the loss of the 
intervening DNA sequence. However, in a limited number of cases, we obtained 
the inversion of the DNA sequence flanked by the targeted sites. Similar results 
have been obtained in vitro by other groups (Choi et al. 2014). Furthermore, in 
our experiments, five out of seven founder animals carrying targeted inversions 
failed to transmit this genomic alteration to the F1 generation. We could observe 
germline transmission in just two founders out of seven (28%), TYRINS5#19 and 
#41, in contrast with the higher GTL observed for deletions (almost 100%). We 
therefore hypothesise that such inversion might cause problems in meiosis and, 
therefore, a reduced number functional gametes are produced carrying this 
edited allele (Figure d5).  
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Figure' d5' Gametes' obtained' by' meiosis' of' a' heterozygous' inversion.' A' A! locus! contains! an!inversion! indicated! in!the!purple!box.!B' If!crossover'happens!at! the!position! indicated!by!the!orange!cross,!in!correspondence!with!the!inversion,!the!chromatids!align!forming!a!loop.!C'As!a!consequence,!only!half!of!the!gametes!produced!are!funtional.!The!other!50%!is!either!acentric!or!dicentrinc. 
Failure in germline transmission of the inversion was observed in both male and 
female founder mice. In humans, individuals carrying non-pathological inversion 
in autosomal chromosomes are described to be either infertile or subfertile 
(Rouen et al. 2013). 
 
5.10 Experiments in progress and perspectives 
 
The analysis of the TYRINS3 and TYRINS5 lines in albino background allowed 
us to detect the role of these elements with respect of Tyr. However, additional 
questions still remain to be answered. Does the Tyr 5’ element influence the 
expression level and pattern of the flanking gene Grm5? Does the Tyr 3’ element 
contribute to the regulatory elements of the Nox4 gene? To answer these 
questions we are currently breeding our mouse lines to obtain homozygous 
animals lacking these regulatory elements. Should they be vital – we plan to 
analyse the expression of each of the three genes in this locus in distinct tissues. 
Also, further experiments are required to understand why the inversion of the Tyr 
5’ element result is a phenotype similar to that obtained upon complete deletion. 
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Does this element is directional? Do we interfere with Grm5 upon inverting the 
Tyr 5’ boundary? These and other questions will be addressed in future 
experiments. 
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6. CONCLUSIONS 
 
 
1.- We identified a chromatin insulator 3’ downstream the mouse Tyr gene 
using sequence conservation, synteny and published ChIP-seq datasets. 
We validated in vitro and in vivo the boundary activity of the Tyr 3’ 
predicted insulator. This element is indeed a chromatin insulator whose 
activity mainly but not only relies on the binding of CTCF. We also 
confirmed in vitro the insulator activity of the Tyr 5’ boundary, also known 
as Tyr LCR. 
 
2.- The hub of the Tyr locus is the Tyr promoter. Both Tyr 3’ and 5’ 
boundaries, as well as other conserved elements found in the third Tyr 
intron, do contact the Tyr promoter. 
 
3.- Our efforts to model the RPE cells in vitro were unsuccessful. The loss 
of RPE features, such as pigmentation, expression of specific markers and 
epithelial morphology associated with all established lines as well as with 
primary cultures prevented from using this approach for 3C experiments. 
 
4.- Targeted nucleases can be used in vivo to obtain mutated alleles at 
non-coding sequences that were refractory to the modification using 
standard gene targeting in ES cells. 
 
5.- By applying the CRISPR/Cas9 system (but not TALENs), we could 
obtain transgenic mouse lines carrying deletions of the Tyr 3’ and Tyr 5’ 
elements. 
 
6.- Due to the error-prone NHEJ DNA repair pathway, we could obtain a 
series of transgenic mice carrying several different partial deletions of the 
Tyr 5’ and 3’sequences of interest. This allowed us to narrow the minimal 
size of the regulatory elements in study. For the same reason, we also 
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obtained transgenic mice carrying the inversion of the Tyr 5’ elements, 
allowing us to assess the directionality of this regulatory element. 
 
7.- Mice lacking one copy of the Tyr 5’ boundary in albino background 
element show a drastic reduction in coat colour pigmentation. At the 
histological level, we observed a reduced accumulation of melanin in the 
skin and variegation at the choroid in the eye as reported before for LCR-
deleted YAC Tyr-transgenes. Pigmentation of the RPE layer does not 
appear affected. The Tyr 5’ boundary seems to act as a lineage-specific, 
enhancer/insulator. 
 
8.- Mice carrying an inversion of the Tyr 5’ boundary in albino background 
have the same altered coat colour as those carrying a full deletion. 
Therefore, the directionality of this element in the genome appears to be 
essential to its function. 
 
9.- Mice lacking one copy of Tyr 3’ boundary in albino background do not 
show any alteration in eye or coat colour. This element appears to be 
therefore dispensable for regulation of Tyr. We could not exclude that such 
boundary is necessary for the proper expression of the flanking gene, 
Nox4. 
 
 
7. CONCLUSIONES 
 
1.- Hemos identificado una frontera genómica en la zona 3’ del gen Tyr del 
genoma del ratón utilizando estrategias de conservación génica, sintenia y 
conjuntos de datos publicados de ChIP-seq. Hemos verificado in vitro e in 
vivo la actividad aisladora del elemento Tyr 3’, postulado anteriormente 
como frontera genómica. Este elemento corresponde en realidad a una 
frontera genómica cuya actividad depende fundamentalmente de la unión 
con el factor CTCF. Hemos confirmado también la actividad in vitro del 
elemento aislador Tyr 5’, también conocido como Tyr LCR.  
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2.- La zona principal del locus Tyr es su promotor. Las dos fronteras 
genómicas, Tyr 3’ y Tyr 5’, además de otros elementos reguladores 
conservados que se encuentran en el tercer intrón de Tyr, contactan con 
el promotor.  
 
3.- No tuvimos éxito en nuestros esfuerzos para reproducir la función de 
las células RPE in vitro. La pérdida de las características como RPE, tales 
como la pigmentación, la expresión de marcadores específicos y su 
morfología epitelial, observadas en todas las líneas celulares 
establecidas, así como en cultivos primarios, nos impidió utilizar esta 
aproximación para los experimentos 3C. 
 
4.- Las nucleasas de edición genómica pueden utilizarse in vivo para 
obtener alelos mutados en secuencias que no codifican para proteínas, y 
que normalmente se mostraban como recalcitrantes a su modificación 
mediante técnicas habituales de inactivación génica en células ES. 
 
5.- Mediante la utilización del sistema CRISPR/Cas9 (pero no el sistema 
de TALENs) pudimos obtener líneas de ratones transgénicos portadoras 
de mutaciones en los elementos Tyr 3’ y Tyr 5’. 
 
6.- Gracias a la vía de reparación del ADN a través del sistema NHEJ, 
propenso a producir errores, pudimos obtener una serie de ratones 
transgénicos portadores de deleciones parciales de distinto tamaño tanto 
en el elemento Tyr 5’ como en el elemento Tyr 3’. Esto nos ha permitido 
delimitar el tamaño mínimo de los elementos reguladores a estudiar. Por 
la misma razón, pudimos igualmente obtener ratones transgénicos 
portadores de inversiones del elemento Tyr 5’, lo cual nos ha permitido 
investigar el efecto de la direccionabilidad de este elemento sobre su 
función reguladora. 
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7.- Los ratones que carecen de una copia del elemento aislador Tyr 5’ en 
un fondo genético albino muestran una reducción significativa de la 
pigmentación del pelaje. A nivel histológico, observamos una reducción en 
la acumulación de melanina en la piel, y una variegación en el coroides 
del ojo, tal y como antes se había observado en los transgenes con YACs 
portadores de deleciones en la LCR. La pigmentación de las células RPE 
no parece estar afectada. El elemento aislador genómico Tyr 5’ parece 
actuar de forma especifica de linaje, como un potenciador/aislador.  
 
8.- Los ratones que portan una inversión del elemento Tyr 5’ en un fondo 
genético albino muestran la misma alteración en la pigmentación que los 
que portan una deleción completa del mismo. Por lo tanto, la dirección de 
este elemento en el genoma parece ser esencial para su función.  
 
9.- Los ratones que carecen de una copia del elemento Tyr 3’, en un fondo 
genético albino, no muestran alteración pigmentaria alguna en el ojo o el 
pelaje. Este elemento no parece ser necesario para la regulación del gen 
Tyr. Sin embargo, no podemos excluir que dicho elemento aislador Tyr 3’ 
sea necesario para la expression correcta del gen vecino Nox4. 
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9.1: Oligonucleotides used in this study 
 
9.1.1 Oligonucleotides used to clone the mouse Tyr 3’ element into the pELuc 
vector 
 
XhoI_Tyr3'Fw CAGCTCGAGACAGAAATGGCCCCACCTAT 
XhoI_Tyr3'Rv CAGCTCGAGTGCATTTGAACTTGACCTACTGA 
PstI_Tyr3'Fw CAGCTGCAGACAGAAATGGCCCCACCTAT 
PstI_Tyr3'Rv CAGCTGCAGTGCATTTGAACTTGACCTACTGA 
XhoI_Tyr3'sineb2Fw CAGCTCGAGCCAGGTGAGGGGTGTGTTTA 
XhoI_Tyr3'sineb2Rv CAGCTCGAGGAAGTGTTTATTGACAATGTG 
PstI_Tyr3'sineb2Fw CAGCTGCAGCCAGGTGAGGGGTGTGTTTA 
PstI_Tyr3'sinb2Rv CAGCTGCAGGAAGTGTTTATTGACAATGTG 
 
9.1.2 Oligonucleotides used for site-directed mutagenesis of the Tyr 3’ CTCF 
binding site 
 
3'CTCFmutFw TGTCTTCAGACACTCGAGAATAGAGCGCCAGATCTTGTTA 
3'CTCFmutRv TAACAAGATCTGGCGCTCTATTCTCGAGTGTCTGAAGACA 
 
9.1.3 Oligonucleotides used for mouse genotyping, in vitro cleavage assay and 
T7 Endonuclease I assay 
 
delLCRFW CAACCAGGCTTTCATCAGAAT 
delLCRRV TTTTCTCTGTATCATGATTGCCTA 
del3'FW TCTGTGCATGGTATACAACAGGG 
del3'RV TGTACTCATGACCCCATTTTGACA 
T7EILCR123FW AACAGCTTCCCTAGAAGCTCAA 
T7EILCR123RV AGAACCAGCTTGAGTGTGTCA 
T7EILCR4FW AATATTGTGGTTTGCCAGGACC 
T7EILCR4RV TCGTGGGTCCACAAATCCATTG 
T7EI3'56FW TCTGCTGTGTTCCAATTTGCAG 
T7EI3'56RV GTGCATTAAAGGAAGCCCAATGA 
T7EI3'123RV TGGAACACAGTGTATTAAAAAGCCA 
LCR67  TGAGCCTAAGAGACAAGATTG 
LCRprobeFw AGCTGTGCAGCCATTTTCCAAG 
5'0OT1_Fw AGACCATTGCTGACCTCTTACAG 
5'0OT1_Rv ACTTTGCTCAGCCCCACATAATA 
5'0OT2_Fw AAGGTACAGATAGAAACGAGCAGTT 
5'0OT2_Rv AGTGGCTAAGGAAACAAAGAATGTG 
5'0OT3_Fw GGGTTCAGACAGGTCAACTATGT 
5'0OT3_Rv GTGAAGTGCCATAAGCTGTGTTT 
5'5OT1_Fw CAGGTTAGAGGCCTAGCCAATAG 
5'5OT1_Rv GGAATACTGAGGACAGGTGACTG 
5'5OT2_Fw AGGAATATGACGGCAGCATTAGT 
5'5OT2_Rv GAGGAAGTTGCCTCTGGTTGAAT 
5'5OT3_Fw TCTCATGCCTCCAGCACTATTTT 
5'5OT3_Rv TGATTGCCAGATTCAGGAGGAAA 
 
9.1.4 Oligonucleotides used for the 3C assay 
 
DpnII_1 AGGGGTTGCTGGAAAAGAAG 
DpnII_4 GGCAGGATGGGACTGAAGTA 
DpnII_5 ATTTGTCTGGGGGCTCATAAC 
DpnII_8 CACACAACTATCACTACTATCACCAC  
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DpnII_10 TGTTGAATCCCACCTTTACTCC 
DpnII_1B CCATGCCCTGCTAAATGTGTA 
DpnII_CNS2 TGTAGAAGGAAGGGCTCAGTGT 
DpnII_dwCNS2 TGGAAAATGAGACACAACGAAG 
DpnII_i1 AAGGACGGAGTGGAGGTTG 
DpnII_i3 TTGGACCTGTGCTGTGACTAA   
DpnII_C0 TCTTAATGTTGGAAAGTGCAAAGT  
DpnII_C3 TCACAACACTGTCATACCATCTG  
DpnII_D3 TTTTCTTGACTTTGTGTCCCTATG 
DpnII_8i1 TTCTCTTTTCTTTCGCACCA 
DpnII_8i3 AAAGACACCATCCCTCCAAC 
DpnII_Grm5 CTATGGACATCAAAAATGCTAAGGT 
DpnII_8CNS2 CCCAGACCCTTCCAAGTCAGTAT 
DpnII_8Grm5 TACAGCAACACATTAGAACCAGA 
DpnII_CNS2-3’ TCTCAAATCCCTCCTATCCAA 
DpnII_CNS2-Tyrp AGGCTGAGAGTATTTGATGTAAGAA 
DpnII_XBP1 GTCTGTCTTTGTTGCTGAAGTATG 
DpnII_XBP2 AAGTCCAGTGTGCTGAGGTATT 
 
9.1.5 Oligonucleotides used for colony-PCR and sequencing of TALEN plasmids 
 
pCR8_F1 TTGATGCCTGGCAGTTCCCT 
pCR8_R1 CGAACCGAACAGGCTTATGT 
TAL_F1 TTGGCGTCGGCAAACAGTGG 
TAL_R2 GGCGACGAGGTGGTCGTTGG 
seqTALEN5_1 TTGGCGTCGGCAAACAGTGG 
 
9.1.6 Oligonucleotides used for CRISPR sgRNA cloning 
 
LKO_1 5' GACTATCATATGCTTACCGT 
Tyr5'0gRNAFw ACACCGTGTGACAGTGCAAGATAACG  
Tyr5'0gRNARv AAAACGTTATCTTGCACTGTCACACG  
Tyr5'5gRNAFw ACACCGTGATAAAACTAGGCAATTTG 
Tyr5'5gRNARv AAAACAAATTGCCTAGTTTTATCACG 
Tyr3'3gRNAFw ACACCAGCTCAGTAGAGTACTAGGTG 
Tyr3'3gRNARv AAAACACCTAGTACTCTACTGAGCTG  
Tyr3'5gRNAFw ACACCACAAACGCTAATTGGTAAAAG  
Tyr3'5gRNARv AAAACTTTTACCAATTAGCGTTTGTG  
 
9.1.7 Oligonucleotides used for Cas9 and sgRNA in vitro transcription 
 
Tyr50-FwJae TTAATACGACTCACTATAGGGTGTGACAGTGCAAGATAAC 
Tyr55-FwJae TTAATACGACTCACTATAGGGTGATAAAACTAGGCAATTT 
Tyr33-FwJae TTAATACGACTCACTATAGGAGCTCAGTAGAGTACTAGGT 
Tyr35-FwJae TTAATACGACTCACTATAGGACAAACGCTAATTGGTAAAA 
gRNA-RvJae AAAAGCACCGACTCGGTGCC 
T7_Cas9Fw TAATACGACTCACTATAGGGAGAATGGACAAGAAGTACTCCATTG 
Cas9Rv(T7) CGGTAGGGATCGAACCCTTTCA 
 
9.2: CRISPR predicted off-target sites 
 
Comprehensive list of top-scoring off-target sites relative to the sgRNA used in 
this study, predicted using CRISPR Design online tool (crispr.mit.edu). Note that 
only a fraction of the predicted off-targets contains the PAM motif (NGG). The 
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genomic coordinates refer to the mouse genome assembly NCBI37/mm9 (July 
2007). 
 
9.2.1 The top 20 predicted off-targets of CRISPR 3’3  
 
sequence score mismatch position chromosomal 
coordinates 
TGCTCAGGAGTGTACTAGGTTAG 1.6    3MMs [1:8:11]     chr12:+104596952  
AGCTGGGCAGAGTACTAGGTTGG 1.4     3MMs [5:6:8]     chr11:+74783860   
CTCTGAGTAAAGTACTAGGTTGG 1.3   4MMs [1:2:5:10]    chr11:-17927436   
AGCTCAGGAGAGTCCTAGGTAGG 1     2MMs [8:14]      chr5:+135521999   
AGCTCTGGTGAGTACTAGGTGGG 0.9     3MMs [6:8:9]     chr4:-122729022   
AGCTTAAAATAGTACTAGGTCAG 0.8   4MMs [5:7:8:10]    chrX:-17285464    
TGCTTAGTAGAGTAATAGGTGAG 0.8    3MMs [1:5:15]     chr5:-14857691    
ATCTCAGTAGTTTACTAGGTCAG 0.8    3MMs [2:11:12]    chr17:+27459237   
TGCCCAGTAATGTACTAGGTAAG 0.7   4MMs [1:4:10:11]   chr7:-150041150   
AGATCATTAGAGAACTAGGTCAG 0.7    3MMs [3:7:13]     chr9:-63341008    
ACATAAGTAGAGTACTAGGGAAG 0.7   4MMs [2:3:5:20]    chr5:+48853286    
TACTCAGTACAGTACTAGGAAGG 0.7   4MMs [1:2:10:20]   chr17:+92410256   
AGCAGAGGAGAGTACTGGGTAGG 0.6   4MMs [4:5:8:17]    chr6:-66223870    
GACTCAGAAGAGAACTAGGTGGG 0.6   4MMs [1:2:8:13]    chr7:+51356271    
GACTCAGAAGAGAACTAGGTGGG 0.6   4MMs [1:2:8:13]    chr7:+51306259    
AGTGCACTAGTGTACTAGGTAGG 0.5   4MMs [3:4:7:11]    chr15:+97166248   
ACCATAGTAGAGTACTAGCTGAG 0.5   4MMs [2:4:5:19]    chr13:-36182778   
AGCAAAGTAGAGTACAAGGTGAG 0.5    3MMs [4:5:16]     chr16:-40186198   
AGCACAATAAAATACTAGGTGGG 0.4   4MMs [4:7:10:12]   chr17:+61792828   
ACGTCAGGAGAGTAGTAGGTCAG 0.4   4MMs [2:3:8:15]    chr18:+12340803   
 
9.2.2. The top 20 predicted off-targets of CRISPR 3’5  
sequence score mismatch position chromosomal 
coordinates 
ACAATTGGTAATTGGTAAAATGG 1.4     3MMs [5:6:8]     chr12:-36137724   
ATACTCGATAATTGGTAAAACAG 1.4    4MMs [2:4:5:8]    chr3:-41928349    
AGATTCGCTGATTGGTAAAAAGG 1.3   4MMs [2:4:5:10]    chr5:-42142945    
ACTAACGATAATAGGTAAAAGAG 1.1    3MMs [3:8:13]     chr12:-95704167   
ACAAATAGTAATTGGTAAAAAGG 1     3MMs [6:7:8]     chr15:-15417522   
GCAGACAATAATTGGTAAAATAG 0.9    4MMs [1:4:7:8]    chr15:+24340490   
CAAAACTATAATTGGTAAAAAAG 0.9    4MMs [1:2:7:8]    chr9:-95810584    
AGTTACCCTAATTGGTAAAAAAG 0.9    4MMs [2:3:4:7]    chr2:+135082013   
ATCAACTCTGATTGGTAAAAGAG 0.9   4MMs [2:3:7:10]    chr6:+140276804   
ACATTCACTGATTGGTAAAATGG 0.9   4MMs [4:5:7:10]    chr12:-90377648   
CCAAGAGGTAATTGGTAAAATAG 0.8    4MMs [1:5:6:8]    chr8:-30786668    
TCATAAGCTCATTGGTAAAAGAG 0.8   4MMs [1:4:6:10]    chrX:+74303266    
AAAAAAGTTTATTGGTAAAACGG 0.8   4MMs [2:6:8:10]    chr8:-9748974     
ACAAACACTTATTGGTCAAACAG 0.7    3MMs [7:10:17]    chr2:+124209059   
AGGGACGCTAATTGGTTAAATGG 0.6   4MMs [2:3:4:17]    chr19:-22527730   
AAAAACTTTATTTGGTAAAACAG 0.5   4MMs [2:7:8:11]    chr6:+10580070    
AAAAACTCAGATTGGTAAAAAAG 0.5   4MMs [2:7:9:10]    chr6:+141388187   
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9.2.3 The top 20 predicted off-targets of CRISPR 5’0  
 
sequence score mismatch position chromosomal 
coordinates 
CTGTCACAGAACAAGATAACCGG * 0.7   4MMs [1:5:10:11]   chr6:-99084014    
GAGGGACAGACCAAGATAACCAG 0.7   4MMs [2:4:10:11]   chr13:-9319840    
TAATGACAGTGCAAGATAAGTAG 0.7   4MMs [1:2:3:20]    chr1:-12346982    
GGGAGACTGTGCAAGATAAGGGG * 0.7   4MMs [2:4:8:20]    chrX:+69682563    
TTTTGACAGAGCAAGATAAATGG * 0.6   4MMs [1:3:10:20]   chr3:-60502350    
GTGAGAGGCTGCAAGATAACAGG 0.6    4MMs [4:7:8:9]    chr15:+75075785   
GTATGTCTTTGCAAGATAACTAG 0.5    4MMs [3:6:8:9]    chr10:-46557450   
GTCTTAAAGTGGAAGATAACCAG 0.5   4MMs [3:5:7:12]    chr1:+165501357   
GTCAGAGAGTGTAAGATAACAAG 0.5   4MMs [3:4:7:12]    chr1:-158207835   
TTGTGATAGAGAAAGATAACAAG 0.5   4MMs [1:7:10:12]   chr17:+46477157   
CTGTGAAAGAGAAAGATAACAAG 0.5   4MMs [1:7:10:12]   chr13:+23225282   
GTGTGACAGAGAAAGAAAACCAG 0.5   3MMs [10:12:17]    chr14:-75695598   
TTGTTACAATGGAAGATAACTAG 0.4   4MMs [1:5:9:12]    chr11:-37560558   
ATGTGGCTGTGTAAGATAACTAG 0.4   4MMs [1:6:8:12]    chr4:-33292270    
GTGGGATAGAGGAAGATAACCAG 0.4   4MMs [4:7:10:12]   chr4:-46935274    
GGTTGACACTGGAAGATAACAAG 0.4   4MMs [2:3:9:12]    chr4:-95418322    
GTTTGACAAAGTAAGATAACAAG 0.4   4MMs [3:9:10:12]   chr12:-7026399    
GAGTATCAGTGCAAGACAACTAG 0.4   4MMs [2:5:6:17]    chr7:-149497895   
GTGTGACCTGGCAAGATAAGCAG 0.4   4MMs [8:9:10:20]   chr13:+100741631  
TTGTTACAGTCCAAGAAAACTGG 0.3   4MMs [1:5:11:17]   chr6:+59164176    
 
* off-target sites analysed by T7 Endonuclease I assay 
 
9.2.4 The top 20 predicted off-targets of CRISPR 5’5  
 
sequence score mismatch position chromosomal 
coordinates 
GTCTTAAAACTAGGCAATTATGG 1.4    3MMs [3:4:20]     chr8:-34691408    
GCACCAAAACTAGGCAATTTTAG 1.3    4MMs [2:3:4:5]    chr15:+9069056    
GTATAAAAATTAGGCAATTTTAG 1.3   4MMs [3:4:5:10]    chr1:+143945358   
ATGATCAAACAAGGCAATTTAAG 0.9    3MMs [1:6:11]     chr12:-75659983   
GAAGTAAATCTAGGCAATTTGAG 0.8    4MMs [2:3:4:9]    chr12:+38489349   
GGTAAGAAACTAGGCAATTTTAG 0.8    4MMs [2:3:5:6]    chr9:-84939931    
GAGAATAAATTAGGCAATTTGAG 0.8   4MMs [2:5:6:10]    chr3:+138928190   
GATATAACACGAGGCAATTTCAG 0.8   4MMs [2:3:8:11]    chr12:+70579083   
CAGATAAAAGCAGGCAATTTTGG * 0.7   4MMs [1:2:10:11]   chr1:-9300003     
GTGATGAAAGTAGGCAATTATAG 0.7    3MMs [6:10:20]    chr7:-17749834    
GGAATAAAAAAAGGCAATTTAAG 0.7   4MMs [2:3:10:11]   chr9:-28015950    
GAAATAAAAAAAGGCAATTTAAG 0.7   4MMs [2:3:10:11]   chr10:-129601638  
GAGCAAAAACTTGGCAATTTGGG * 0.7   4MMs [2:4:5:12]    chr19:+31071409   
GTATTAAAATGAGGCAATTTGGG * 0.7   4MMs [3:4:10:11]   chr14:+112763119  
TTTATAAAAATAGGCAATTACAG 0.6   4MMs [1:3:10:20]   chr15:+47682160   
TCAGAAGCAAATTGGTAAAAAAG 0.5    4MMs [1:4:6:9]    chr11:-8525080    
GTAAATGCAAATTGGTAAAATGG 0.5    4MMs [1:2:6:9]    chr6:+105330140   
AAAAACAGTAACTGGTAAAAAAG 0.5   4MMs [2:7:8:12]    chr17:+61574199   
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ATGAAAAAAGTAGGCATTTTTGG 0.6   4MMs [1:5:10:17]   chr3:-27282906    
GAGAAAAAAATAGGCATTTTTAG 0.6   4MMs [2:5:10:17]   chr14:+49087050   
GTTTTCTAACTAGGCAATTTAGG 0.5    4MMs [3:4:6:7]    chr16:-45395464   
TTGAGAAAATTAAGCAATTTAAG 0.5   4MMs [1:5:10:13]   chr9:-3459768     
ATGTTAAAAATAAGCAATTTGGG 0.5   4MMs [1:4:10:13]   chr3:-47997909    
 
* off-target sites analysed by T7 Endonuclease I assay 
 
 
 
 
 
 
 
 
 
